| Package | Version | Identity | Name/Title | Status | Date |
|---|
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3614.html  | NonmitralValveArea | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3615.html | ValveArea | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3616.html | HemodynamicPeriodMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3617.html | ValveFlow | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3618.html | HemodynamicFlow | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3619.html | HemodynamicResistanceMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3620.html | HemodynamicRatio | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3621.html | FractionalFlowReserve | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3627.html | MeasurementType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3628.html | CardiacOutputMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3629.html | ProcedureIntent | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3630.html | CardiovascularAnatomicLocation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3640.html | Hypertension | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3641.html | HemodynamicAssessment | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3642.html | DegreeFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3651.html | HemodynamicMeasurementPhase | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3663.html | BodySurfaceAreaEquation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3664.html | OxygenConsumptionEquation/Table | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3666.html | P50Equation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3667.html | FraminghamScore | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3668.html | FraminghamTable | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3670.html | ECGProcedureType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3671.html | ReasonforECGStudy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3676.html | LeadMeasurementTechnique | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3677.html | SummaryCodesECG | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3678.html | QTCorrectionAlgorithm | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3680.html | ECGLeadNoiseDescription | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3687.html | ElectrophysiologyWaveformDuration | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3688.html | ElectrophysiologyWaveformVoltage | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3689.html | ECGGlobalWaveformDuration | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3690.html | ECGControlNumericVariable | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3691.html | ECGControlTextVariable | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3700.html | CathDiagnosis | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3701.html | CardiacValve/Tract | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3703.html | WallMotion | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3704.html | MyocardiumWallMorphologyFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3705.html | ChamberSize | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3706.html | OverallContractility | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3707.html | VSDDescription | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3710.html | CoronaryDominance | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3711.html | ValvularAbnormality | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3712.html | VesselDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3713.html | TIMIFlowCharacteristic | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3714.html | Thrombus | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3715.html | LesionMargin | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3716.html | Severity | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3717.html | LeftVentricleMyocardialWall17SegmentModel | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3718.html | MyocardialWallSegmentsinProjection | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3719.html | CanadianClinicalClassification | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3721.html | CardiovascularSurgery | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3722.html | DiabeticTherapy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3723.html | MIType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3724.html | SmokingHistory | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3726.html | CoronaryInterventionIndication | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3727.html | CatheterizationIndication | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3728.html | CathFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3729.html | AdmissionStatus | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3730.html | InsurancePayor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3733.html | PrimaryCauseofDeath | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3735.html | AcuteCoronarySyndromeTimePeriod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3736.html | NYHAClassification | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3737.html | IschemiaNoninvasiveTest | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3738.html | PreCathAnginaType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3739.html | CathProcedureType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3740.html | ThrombolyticAdministration | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3741.html | LabVisitMedicationAdministration | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3742.html | PCIMedicationAdministration | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3743.html | Clopidogrel/TiclopidineAdministration | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3744.html | EFTestingMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3745.html | CalculationMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3746.html | PercutaneousEntrySite | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3747.html | PercutaneousClosure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3748.html | AngiographicEFTestingMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3749.html | PCIProcedureResult | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3750.html | PreviouslyDilatedLesion | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3752.html | GuidewireCrossing | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3754.html | VascularComplication | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3755.html | CathComplication | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3756.html | CardiacPatientRiskFactor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3757.html | CardiacDiagnosticProcedure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3758.html | CardiovascularFamilyHistory | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3760.html | HypertensionTherapy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3761.html | AntilipemicAgent | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3762.html | AntiarrhythmicAgent | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3764.html | MyocardialInfarctionTherapy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3769.html | ConcernType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3770.html | ProblemStatus | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3772.html | HealthStatus | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3773.html | UseStatus | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3774.html | SocialHistory | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3777.html | CardiovascularImplant | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3778.html | Stage | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3779.html | ImplantedDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3781.html | LeftVentricleMyocardialWall18SegmentModel | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3782.html | LeftVentricleBasalWall6Segments | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3783.html | LeftVentricleMidlevelWall6Segments | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3784.html | LeftVentricleApicalWall4Segments | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3785.html | LeftVentricleApicalWall6Segments | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3802.html | PlaqueStructure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3804.html | StenosisMeasurementMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3805.html | StenosisType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3806.html | StenosisShape | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3807.html | VolumeMeasurementMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3808.html | AneurysmType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3809.html | AssociatedCondition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3810.html | VascularMorphology | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3813.html | StentFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3814.html | StentComposition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3815.html | SourceofVascularFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3817.html | VascularSclerosisType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3820.html | NoninvasiveVascularProcedure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3821.html | PapillaryMuscleIncluded/Excluded | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3823.html | RespiratoryStatus | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3826.html | HeartRhythm | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3827.html | VesselSegment | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3829.html | PulmonaryArtery | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3831.html | StenosisLength | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3832.html | StenosisGrade | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3833.html | CardiacEjectionFraction | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3835.html | CardiacVolumeMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3836.html | TimebasedPerfusionMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3837.html | FiducialFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3838.html | DiameterDerivation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3839.html | CoronaryVein | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3840.html | PulmonaryVein | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3843.html | MyocardialSubsegment | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3850.html | ContrastBolusSubstance | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4.html | AnatomicRegion | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_400.html | AuditEventID | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4005.html | PartialViewSectionforMammography | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4009.html | DXAnatomyImaged | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_401.html | AuditEventTypeCode | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4010.html | DXView | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4011.html | DXViewModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4012.html | ProjectionEponymousName | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4013.html | AnatomicRegionforMammography | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4014.html | ViewforMammography | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4015.html | ViewModifierforMammography | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4016.html | AnatomicRegionforIntraoralRadiography | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4017.html | AnatomicRegionModifierforIntraoralRadiography | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4018.html | PrimaryAnatomicStructureforIntraoralRadiography(PermanentDentitionDesignationofTeeth) | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4019.html | PrimaryAnatomicStructureforIntraoralRadiography(DeciduousDentitionDesignationofTeeth) | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_402.html | AuditActiveParticipantRoleIDCode | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4020.html | PETRadionuclide | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4021.html | PETRadiopharmaceutical | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4025.html | PrimaryAnatomicStructureforIntraoralRadiography(SupernumeraryDentitionDesignationofTeeth) | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4026.html | PrimaryAnatomicStructureforIntraoralandCraniofacialRadiographyTeeth | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4028.html | CraniofacialAnatomicRegion | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4029.html | DermatologyAnatomicSite | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_403.html | SecurityAlertTypeCode | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4030.html | CT,MRandPETAnatomyImaged | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4031.html | CommonAnatomicRegion | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4032.html | MRSpectroscopyMetabolite | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4033.html | MRProtonSpectroscopyMetabolite | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_404.html | AuditParticipantObjectIDTypeCode | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4040.html | EndoscopyAnatomicRegion | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4042.html | XA/XRFAnatomyImaged | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_405.html | MediaTypeCode | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4050.html | DrugorContrastAgentCharacteristic | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4051.html | GeneralDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4052.html | PhantomDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4053.html | CTDIPhantomDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4061.html | HeadandNeckPrimaryAnatomicStructure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4062.html | VLView | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4063.html | VLDentalView | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4064.html | VLViewModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4065.html | VLDentalViewModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4066.html | OrthognathicFunctionalCondition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4067.html | OrthodonticFindingbyInspection | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4068.html | OrthodonticObservableEntity | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4069.html | DentalOcclusion | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4070.html | OrthodonticTreatmentProgress | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4071.html | GeneralPhotographyDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4072.html | DevicesforthePurposeofDentalPhotography | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4100.html | T1MeasurementMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4101.html | TracerKineticModel | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4102.html | PerfusionMeasurementMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4103.html | ArterialInputFunctionMeasurementMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4104.html | BolusArrivalTimeDerivationMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4105.html | PerfusionAnalysisMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4106.html | QuantitativeMethodUsedforPerfusionandTracerKineticModel | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4107.html | TracerKineticModelParameter | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4108.html | PerfusionModelParameter | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4109.html | ModelIndependentDynamicContrastAnalysisParameter | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4110.html | TracerKineticModelingCovariate | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4111.html | ContrastCharacteristic | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_42.html | NumericValueQualifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4200.html | OphthalmicImagingAgent | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4201.html | PatientEyeMovementCommand | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4202.html | OphthalmicPhotographyAcquisitionDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4203.html | OphthalmicPhotographyIllumination | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4204.html | OphthalmicFilter | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4205.html | OphthalmicLens | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4206.html | OphthalmicChannelDescription | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4207.html | OphthalmicImagePosition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4208.html | MydriaticAgent | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4209.html | OphthalmicAnatomicStructureImaged | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4210.html | OphthalmicTomographyAcquisitionDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4211.html | OphthalmicOCTAnatomicStructureImaged | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4214.html | OphthalmicHorizontalDirection | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4215.html | OphthalmicVerticalDirection | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4216.html | OphthalmicVisualAcuityType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4220.html | VisualFixationQualityDuringAcquisition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4221.html | VisualFixationQualityProblem | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4222.html | OphthalmicMacularGridProblem | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4230.html | OphthalmicUltrasoundAxialMeasurementsType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4231.html | LensStatus | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4232.html | VitreousStatus | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4233.html | OphthalmicAxialLengthMeasurementsSegmentName | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4234.html | RefractiveSurgeryType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4235.html | KeratometryDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4236.html | IOLCalculationFormula | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4237.html | LensConstantType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4238.html | RefractiveErrorType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4239.html | AnteriorChamberDepthDefinition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4240.html | OphthalmicMeasurementorCalculationDataSource | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4241.html | OphthalmicAxialLengthSelectionMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4242.html | CorneaMeasurementMethodDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4243.html | OphthalmicQualityMetricType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4244.html | OphthalmicAgentConcentrationUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4245.html | WideFieldOphthalmicPhotographyTransformationMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4250.html | VisualFieldStaticPerimetryTestPattern | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4251.html | VisualFieldStaticPerimetryTestStrategy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4252.html | VisualFieldStaticPerimetryScreeningTestMode | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4253.html | VisualFieldStaticPerimetryFixationStrategy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4254.html | VisualFieldStaticPerimetryTestAnalysisResult | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4255.html | VisualFieldIlluminationColor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4256.html | VisualFieldProcedureModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4257.html | VisualFieldGlobalIndexName | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4260.html | OphthalmicMappingUnitforRealWorldValueMapping | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4261.html | OphthalmicMappingAcquisitionMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4262.html | RetinalThicknessDefinition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4263.html | OphthalmicThicknessMapValueType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4264.html | OphthalmicMapPurposeofReference | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4265.html | OphthalmicThicknessDeviationCategory | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4266.html | OphthalmicAnatomicStructureReferencePoint | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4267.html | CornealTopographyMappingUnitforRealWorldValueMapping | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4268.html | CornealTopographyMapValueType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4270.html | OCTAProcessingAlgorithmFamily | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4271.html | EnFaceImageType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4272.html | OPTScanPatternType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4273.html | RetinalSegmentationSurface | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4274.html | EnFaceProcessingAlgorithmFamily | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4275.html | AnteriorEyeSegmentationSurface | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_43.html | NumericValueFailureQualifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_44.html | NumericValueUnknownQualifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4401.html | FitzpatrickSkinType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4402.html | HistoryofMalignantMelanoma | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4403.html | HistoryofMelanomainSitu | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4404.html | HistoryofNonMelanomaSkinCancer | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4405.html | SkinDisorder | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4406.html | PatientReportedLesionCharacteristic | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4407.html | LesionPalpationFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4408.html | LesionVisualFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4409.html | SkinProcedure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4410.html | TopicalTreatment | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4411.html | LesionColor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4412.html | SpecimenStainforConfocalMicroscopy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_5.html | TransducerApproach | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_50.html | InstanceAvailabilityStatus | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_501.html | VolumetricViewDescription | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_502.html | VolumetricViewModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6.html | TransducerOrientation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_60.html | ImagingAgentAdministrationAdverseEvent | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6000.html | OverallBreastComposition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6001.html | OverallBreastCompositionfromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6002.html | ChangeSinceLastMammogramorPriorSurgery | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6003.html | ChangeSinceLastMammogramorPriorSurgeryfromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6004.html | MammographyShapeCharacteristic | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6005.html | ShapeCharacteristicfromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6006.html | MammographyMarginCharacteristic | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6007.html | MarginCharacteristicfromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6008.html | DensityModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6009.html | DensityModifierfromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_601.html | BiosafetyLevel | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6010.html | MammographyCalcificationType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6011.html | CalcificationTypefromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6012.html | CalcificationDistributionModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6013.html | CalcificationDistributionModifierfromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6014.html | MammographySingleImageFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6015.html | SingleImageFindingfromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6016.html | MammographyCompositeFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6017.html | CompositeFeaturefromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6018.html | ClockfaceLocationorRegion | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6019.html | ClockfaceLocationorRegionfromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_602.html | BiosafetyControlReason | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6020.html | QuadrantLocation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6021.html | QuadrantLocationfromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6022.html | Side | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6023.html | SidefromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6024.html | Depth | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6025.html | DepthfromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6026.html | MammographyAssessment | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6027.html | AssessmentfromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6028.html | MammographyRecommendedFollowup | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6029.html | RecommendedFollowupfromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_603.html | AnimalRoomType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6030.html | MammographyPathologyCode | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6031.html | BenignPathologyCodefromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6032.html | HighRiskLesionPathologyCodefromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6033.html | MalignantPathologyCodefromBIRADS® | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6034.html | CADOutputIntendedUse | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6035.html | CompositeFeatureRelation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6036.html | FeatureScope | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6037.html | MammographyQuantitativeTemporalDifferenceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6038.html | MammographyQualitativeTemporalDifferenceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6039.html | NippleCharacteristic | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_604.html | DeviceReuse | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6040.html | NonlesionObjectType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6041.html | MammographyImageQualityFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6042.html | ResultStatus | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6043.html | MammographyCADAnalysisType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6044.html | ImageQualityAssessmentType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6045.html | MammographyQualityControlStandardType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6046.html | FollowupIntervalUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6047.html | CADProcessingandFindingSummary | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6048.html | CADOperatingPointAxisLabel | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_605.html | AnimalBeddingMaterial | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6050.html | BreastProcedureReported | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6051.html | BreastProcedureReason | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6052.html | BreastImagingReportSectionTitle | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6053.html | BreastImagingReportElement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6054.html | BreastImagingFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6055.html | BreastClinicalFindingorIndicatedProblem | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6056.html | AssociatedFindingforBreast | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6057.html | DuctographyFindingforBreast | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6058.html | ProcedureModifiersforBreast | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6059.html | BreastImplantType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_606.html | AnimalShelterType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6060.html | BreastBiopsyTechnique | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6061.html | BreastImagingProcedureModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6062.html | InterventionalProcedureComplication | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6063.html | InterventionalProcedureResult | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6064.html | UltrasoundFindingforBreast | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6065.html | InstrumentApproach | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6066.html | TargetConfirmation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6067.html | FluidColor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6068.html | TumorStagesFromAJCC | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6069.html | NottinghamCombinedHistologicGrade | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_607.html | AnimalFeedType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6070.html | BloomRichardsonHistologicGrade | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6071.html | HistologicGradingMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6072.html | BreastImplantFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_608.html | AnimalFeedSource | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6080.html | GynecologicalHormone | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6081.html | BreastCancerRiskFactor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6082.html | GynecologicalProcedure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6083.html | ProceduresforBreast | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6084.html | MammoplastyProcedure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6085.html | TherapiesforBreast | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6086.html | MenopausalPhase | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6087.html | GeneralRiskFactor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6088.html | OBGYNMaternalRiskFactor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6089.html | Substance | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_609.html | AnimalFeedingMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6090.html | RelativeUsage/ExposureAmount | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6091.html | RelativeFrequencyofEventValue | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6092.html | Usage/ExposureQualitativeConcept | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6093.html | Usage/Exposure/AmountQualitativeConcept | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6094.html | Usage/Exposure/FrequencyQualitativeConcept | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6095.html | ProcedureNumericProperty | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6096.html | PregnancyStatus | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6097.html | SideofFamily | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6098.html | ClinicalCourseofDisease | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6099.html | RacialGroup | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_610.html | WaterType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6100.html | ChestComponentCategory | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6101.html | ChestFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6102.html | ChestFindingorFeatureModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6103.html | AbnormalLinesFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6104.html | AbnormalOpacityFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6105.html | AbnormalLucencyFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6106.html | AbnormalTextureFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6107.html | WidthDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6108.html | ChestAnatomicStructureAbnormalDistribution | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6109.html | RadiographicAnatomyFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_611.html | AnesthesiaCategoryCodeTypeforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6110.html | LungAnatomyFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6111.html | BronchovascularAnatomyFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6112.html | PleuraAnatomyFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6113.html | MediastinumAnatomyFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6114.html | OsseousAnatomyFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6115.html | OsseousAnatomyModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6116.html | MuscularAnatomy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6117.html | VascularAnatomy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6118.html | SizeDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6119.html | ChestBorderShape | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_612.html | AnesthesiaCategoryCodeTypefromAnesthesiaQualityInitiative | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6120.html | ChestBorderDefinition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6121.html | ChestOrientationDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6122.html | ChestContentDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6123.html | ChestOpacityDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6124.html | LocationinChest | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6125.html | GeneralChestLocation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6126.html | LocationinLung | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6127.html | SegmentLocationinLung | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6128.html | ChestDistributionDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6129.html | ChestSiteInvolvement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_613.html | AnesthesiaInductionCodeTypeforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6130.html | SeverityDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6131.html | ChestTextureDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6132.html | ChestCalcificationDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6133.html | ChestQuantitativeTemporalDifferenceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6134.html | ChestQualitativeTemporalDifferenceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6135.html | ImageQualityFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6136.html | ChestTypesofQualityControlStandard | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6137.html | CADAnalysisType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6138.html | ChestNonlesionObjectType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6139.html | NonlesionModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_614.html | AnesthesiaInductionCodeTypefromAnesthesiaQualityInitiative | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6140.html | CalculationMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6141.html | AttenuationCoefficientMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6142.html | CalculatedValue | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6143.html | LesionResponse | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6144.html | RECISTDefinedLesionResponse | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6145.html | BaselineCategory | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6146.html | TimePointType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6147.html | ResponseCriteria | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6148.html | MediastinumFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6149.html | MediastinumAnatomy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_615.html | AnesthesiaMaintenanceCodeTypeforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6151.html | BackgroundEchotexture | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6152.html | Orientation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6153.html | LesionBoundary | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6154.html | EchoPattern | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6155.html | PosteriorAcousticFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6157.html | Vascularity | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6158.html | CorrelationtoOtherFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6159.html | MalignancyType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_616.html | AnesthesiaMaintenanceCodeTypefromAnesthesiaQualityInitiative | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6160.html | BreastPrimaryTumorAssessmentFromAJCC | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6161.html | PathologicalRegionalLymphNodeAssessmentforBreast | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6162.html | AssessmentofMetastasisforBreast | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6163.html | MenstrualCyclePhase | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6164.html | TimeInterval | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6165.html | BreastLinearMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6166.html | CADGeometrySecondaryGraphicalRepresentation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_617.html | AirwayManagementMethodCodeTypeforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6170.html | LobeofLung | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6171.html | ZoneofLung | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_618.html | AirwayManagementMethodCodeTypefromAnesthesiaQualityInitiative | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_619.html | AirwayManagementSubMethodCodeTypeforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_62.html | ImagingAgentAdministrationPhaseType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_620.html | AirwayManagementSubMethodCodeTypefromAnesthesiaQualityInitiative | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6200.html | ColonOverallAssessment | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6201.html | ColonFindingorFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6202.html | ColonFindingorFeatureModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6203.html | ColonNonlesionObjectType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6204.html | AnatomicNoncolonFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6205.html | ClockfaceLocationforColon | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6206.html | RecumbentPatientOrientationforColon | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6207.html | ColonQuantitativeTemporalDifferenceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6208.html | ColonTypesofQualityControlStandard | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6209.html | ColonMorphologyDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_621.html | MedicationTypeforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6210.html | LocationinIntestinalTract | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6211.html | ColonCADMaterialDescription | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6212.html | CalculatedValueforColonFinding | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_622.html | MedicationTypeCodeTypefromAnesthesiaQualityInitiative | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_623.html | MedicationforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_624.html | InhalationalAnesthesiaAgentforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_625.html | InjectableAnesthesiaAgentforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_626.html | PremedicationAgentforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_627.html | NeuromuscularBlockingAgentforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_628.html | AncillaryMedicationsforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_629.html | CarrierGasesforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_63.html | ImagingAgentAdministrationMode | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_630.html | LocalAnestheticsforSmallAnimalAnesthesia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6300.html | ProstateAnatomy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6301.html | ProstateSectorAnatomyfromPIRADSv2 | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6302.html | ProstateSectorAnatomyfromEuropeanConcensus16Sector(Minimal)Model | active | 2025-04 |
| fhir.dicom | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7193.html PhysicalObjectSegmentationPropertyType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7194.html | MorphologicallyAbnormalStructureSegmentationPropertyType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7195.html | FunctionSegmentationPropertyType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7196.html | SpatialandRelationalConceptSegmentationPropertyType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7197.html | BodySubstanceSegmentationPropertyType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7198.html | SubstanceSegmentationPropertyType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7199.html | AnatomicallyLocalizedLesionSegmentationType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_72.html | ImagingAgentAdministrationStepType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7201.html | ReferencedImagePurposeofReference | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7202.html | SourceImagePurposeofReference | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7203.html | ImageDerivation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7205.html | PurposeofReferencetoAlternateRepresentation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7210.html | RelatedSeriesPurposeofReference | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7215.html | SpectroscopyPurposeofReference | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7220.html | RTDoseDerivation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7221.html | RTDosePurposeofReference | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7222.html | ParametricMapDerivationImagePurposeofReference | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7230.html | AutomationofMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7250.html | MultiFrameSubsetType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7260.html | DiffusionAcquisitionValueType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7261.html | DiffusionModelValueType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7262.html | DiffusionTractographyAlgorithmFamily | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7263.html | DiffusionTractographyMeasurementType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7270.html | MRDiffusionComponentSemantic | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7271.html | MRDiffusionAnisotropyIndex | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7272.html | MRDiffusionModelParameter | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7273.html | MRDiffusionModel | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7274.html | MRDiffusionModelFittingMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7275.html | MRDiffusionModelSpecificMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7276.html | MRDiffusionModelInput | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7277.html | DiffusionRateAreaOverTimeUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_73.html | BolusShapingCurve | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7300.html | ImplantMaterial | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7301.html | InterventionType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7302.html | ImplantTemplateViewOrientation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7303.html | ImplantTemplateModifiedViewOrientation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7304.html | ImplantTargetAnatomy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7305.html | ImplantPlanningLandmark | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7306.html | HumanHipImplantPlanningLandmark | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7307.html | ImplantComponentType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7308.html | HumanHipImplantComponentType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7309.html | HumanTraumaImplantComponentType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7310.html | ImplantFixationMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7320.html | PlanningMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_74.html | ImagingAgentAdministrationConsumableCatheterType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7445.html | DeviceParticipatingRole | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7448.html | ThirdPersonPronounSet | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7449.html | ReaderSpecialty | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7450.html | PersonRole | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7451.html | FamilyMember | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7452.html | OrganizationalRole | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7453.html | PerformingRole | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7454.html | AnimalTaxonomicRankValue | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7455.html | Sex | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7456.html | AgeUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7457.html | SexMaleFemaleorBoth | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7458.html | PersonGenderIdentity | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7459.html | CategoryofSexParametersforClinicalUse | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7460.html | LinearMeasurementUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7461.html | AreaMeasurementUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7462.html | VolumeMeasurementUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7464.html | GeneralRegionofInterestMeasurementModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7465.html | MeasurementDerivedFromMultipleROIMeasurements | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7466.html | PETRegionofInterestMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7467.html | GrayLevelCooccurrenceMatrixMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7468.html | TextureMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7469.html | GenericIntensityandSizeMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7470.html | LinearMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7471.html | AreaMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7472.html | VolumeMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7473.html | GeneralAreaCalculationMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7474.html | GeneralVolumeCalculationMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7475.html | GrayLevelRunLengthBasedFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7476.html | GrayLevelSizeZoneBasedFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7477.html | GlobalShapeDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7478.html | IntensityHistogramFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7479.html | GreyLevelDistanceZoneBasedFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7480.html | Breed | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7481.html | BreedRegistry | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7482.html | DXAnatomyImagedforAnimal | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7483.html | CommonAnatomicRegionsforAnimal | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7484.html | DXViewforAnimal | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7486.html | MixedBreed | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7490.html | ResearchAnimalSourceRegistry | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_75.html | LowHighorEqual | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7500.html | NeighbourhoodGreyToneDifferenceBasedFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7501.html | NeighbouringGreyLevelDependenceBasedFeature | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7550.html | AngleMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7551.html | GenericPurposeofReferencetoImagesandCoordinatesinMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7552.html | GenericPurposeofReferencetoImagesinMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7553.html | GenericPurposeofReferencetoCoordinatesinMeasurement | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_76.html | PremedicationType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7600.html | LymphNodeAnatomicSite | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7601.html | HeadandNeckCancerAnatomicSite | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7602.html | VertebralAnatomicStructure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7603.html | Vertebra | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7604.html | IntervertebralDisc | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7701.html | FiberTractInBrainstem | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7702.html | ProjectionandThalamicFiber | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7703.html | AssociationFiber | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7704.html | LimbicSystemTract | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7705.html | CommissuralFiber | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7706.html | CranialNerve | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7707.html | SpinalCordFiber | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7710.html | TractographyAnatomicSite | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8.html | AngiographicInterventionalDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_800.html | ProtocolAssertion | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8101.html | ContainerType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8102.html | ContainerComponentType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8103.html | AnatomicPathologySpecimenType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8104.html | BreastTissueSpecimenType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8109.html | SpecimenCollectionProcedure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8110.html | SpecimenSamplingProcedure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8111.html | SpecimenPreparationProcedure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8112.html | SpecimenStain | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8113.html | SpecimenPreparationStep | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8114.html | SpecimenFixative | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8115.html | SpecimenEmbeddingMedia | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8120.html | WholeSlideMicroscopyImageReferencedImagePurposeofReference | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8121.html | MicroscopyLensType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8122.html | MicroscopyIlluminatorandSensorColor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8123.html | MicroscopyIlluminationMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8124.html | MicroscopyFilter | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8125.html | MicroscopyIlluminatorType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8130.html | StainingProtocol | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8131.html | PathologyImagingProtocol | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8132.html | MagnificationSelection | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8133.html | TissueSelection | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8134.html | AnatomicStructure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8135.html | MicroscopyAnnotationPropertyType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8136.html | MicroscopyMeasurementType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8201.html | SurfaceScanAcquisitionType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8202.html | SurfaceScanModeType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8203.html | SurfaceScanRegistrationMethodType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_83.html | RealWorldValueMappingUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8300.html | VisualEvaluationMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8301.html | TestPatternCode | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8302.html | MeasurementPatternCode | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8303.html | DisplayDeviceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_84.html | PETUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_85.html | SUVUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9.html | ImageGuidedTherapeuticProcedure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9000.html | PhysicalQuantityDescriptor | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_91.html | FunctionalConditionPresentDuringAcquisition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_92.html | JointPositionDuringAcquisition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9231.html | WorkitemDefinition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9233.html | RequestedReportType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9241.html | RadiotherapyGeneralWorkitemDefinition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9242.html | RadiotherapyAcquisitionWorkitemDefinition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9243.html | RadiotherapyRegistrationWorkitemDefinition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9250.html | ScheduledProcessingParameterConceptCodesforRTTreatment | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9260.html | RadiotherapyAcquisitionWorkItemSubtasks | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9261.html | PatientPositionAcquisitionRadiationSourceLocations | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9262.html | EnergyDerivationTypes | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9263.html | KVImagingAcquisitionTechniques | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9264.html | MVImagingAcquisitionTechniques | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9265.html | PatientPositionAcquisitionProjectionTechniques | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9266.html | PatientPositionAcquisition–CTTechniques | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9267.html | PatientPositioningRelatedObjectPurposes | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9268.html | PatientPositionAcquisitionDevices | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9269.html | RTRadiationMetersetUnits | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9270.html | AcquisitionInitiationTypes | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9271.html | RTImagePatientPositionAcquisitionDevices | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9272.html | RTROIImageAcquisitionContext | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9273.html | PatientPositionAcquisition–MRTechniques | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_93.html | JointPositioningMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9300.html | ProcedureDiscontinuationReason | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9301.html | ModalityPPSDiscontinuationReason | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9302.html | MediaImportPPSDiscontinuationReason | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9303.html | InterpretationRequestDiscontinuationReason | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_94.html | PhysicalForceAppliedDuringAcquisition | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9401.html | IEC61217DevicePositionParameter | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9402.html | IEC61217GantryPositionParameter | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9403.html | IEC61217PatientSupportPositionParameter | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9500.html | DosimetricObjectiveType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9501.html | PrescriptionAnatomyCategory | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9502.html | RTSegmentAnnotationCategory | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9503.html | RadiotherapyTherapeuticRoleCategory | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9504.html | RTGeometricInformation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9505.html | FixationorPositioningDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9506.html | BrachytherapyDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9507.html | ExternalBodyModel | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9508.html | NonspecificVolume | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9509.html | PurposeofReferenceforRTPhysicianIntentInput | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9510.html | PurposeofReferenceforRTTreatmentPlanningInput | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9511.html | GeneralExternalRadiotherapyProcedureTechnique | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9512.html | TomotherapeuticRadiotherapyProcedureTechnique | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9513.html | FixationDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9514.html | AnatomicalStructureforRadiotherapy | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9515.html | RTPatientSupportDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9516.html | RadiotherapyBolusDeviceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9517.html | RadiotherapyBlockDeviceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9518.html | RadiotherapyAccessoryNoSlotHolderDeviceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9519.html | RadiotherapyAccessorySlotHolderDeviceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9520.html | SegmentedRTAccessoryDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9521.html | RadiotherapyTreatmentEnergyUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9522.html | MultiSourceRadiotherapyProcedureTechnique | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9523.html | RoboticRadiotherapyProcedureTechnique | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9524.html | RadiotherapyProcedureTechnique | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9525.html | RadiationTherapyParticle | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9526.html | IonTherapyParticle | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9527.html | TeletherapyIsotope | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9528.html | BrachytherapyIsotope | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9529.html | SingleDoseDosimetricObjective | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9530.html | PercentageandDoseDosimetricObjective | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9531.html | VolumeandDoseDosimetricObjective | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9532.html | NoParameterDosimetricObjective | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9533.html | DeliveryTimeStructure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9534.html | RadiotherapyTarget | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9535.html | RadiotherapyDoseCalculationRole | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9536.html | RadiotherapyPrescribingandSegmentingPersonRole | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9537.html | EffectiveDoseCalculationMethodCategory | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9538.html | RadiationTransportBasedEffectiveDoseMethodModifier | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9539.html | FractionationBasedEffectiveDoseMethodModifer | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9540.html | MovableBeamLimitingDeviceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9541.html | BeamLimitingDeviceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9542.html | CompensatorDeviceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9543.html | RadiotherapyTreatmentMachineMode | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9544.html | RadiotherapyDistanceReferenceLocation | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9545.html | FixedBeamLimitingDeviceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9546.html | RadiotherapyWedgeType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9547.html | RTBeamLimitingDeviceOrientationLabel | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9548.html | GeneralAccessoryDeviceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9549.html | RadiationGenerationModeType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9550.html | CArmPhotonElectronDeliveryRateUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9551.html | TreatmentDeliveryDeviceType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9552.html | CArmPhotonElectronDosimeterUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9553.html | TreatmentPoint | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9554.html | EquipmentReferencePoint | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9555.html | RadiotherapyTreatmentPlanningPersonRole | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9556.html | RadiotherapyRoboticNodeSet | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9557.html | TomotherapeuticDosimeterUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9558.html | TomotherapeuticDoseRateUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9559.html | RoboticDeliveryDeviceDosimeterUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9560.html | RoboticDeliveryDeviceDoseRateUnit | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9561.html | TreatmentTerminationReason | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9562.html | RadiotherapyTreatmentDeliveryPersonRole | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9563.html | RadiotherapyInterlockResolution | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9564.html | TreatmentSessionConfirmationAssertion | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9565.html | TreatmentToleranceViolationCause | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9566.html | ClinicalToleranceViolationType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9567.html | MachineToleranceViolationType | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9568.html | RadiotherapyTreatmentInterlock | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9569.html | IsocentricPatientSupportPositionParameter | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9570.html | RTOverriddenTreatmentParameter | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9571.html | PatientTreatmentPreparationMethod | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9572.html | PatientShieldingDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9573.html | PatientTreatmentPreparationDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9574.html | PatientPositionDisplacementReferencePoint | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9575.html | PatientAlignmentDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9576.html | ReasonsforRTRadiationTreatmentOmission | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9577.html | PatientTreatmentPreparationProcedure | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9578.html | MotionManagementSetupDevice | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9579.html | RTSegmentMaterial | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9580.html | RTSegmentationPropertyCategory | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9581.html | RadiotherapyRegistrationMark | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9582.html | RadiotherapyDoseRegion | active | 2025-04 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9583.html | RTPlanRadiotherapyProcedureTechnique | active | 2025-04 |
| hl7.fhir.us.nhsn-med-admin | R4 | ImplementationGuide/hl7.fhir.us.nhsn-med-admin | NHSN Reporting: Inpatient Medication Administration | draft | 2021-03 |
| hl7.fhir.us.nhsn-med-admin | R4 | StructureDefinition/Composition-inpatient-med-admin | Composition - Inpatient Medication Administration | active | 2021-10 |
| hl7.fhir.us.nhsn-med-admin | R4 | StructureDefinition/Condition-lab-confirmed-covid | Condition - Lab Confirmed COVID-19 | active | 2021-10 |
| hl7.fhir.us.nhsn-med-admin | R4 | StructureDefinition/Condition-suspected-covid | Condition - Suspected COVID-19 | active | 2021-10 |
| hl7.fhir.us.nhsn-med-admin | R4 | StructureDefinition/MedicationAdministration-inpatient-med-admin | Medication Administration - Inpatient Med Admin | active | 2021-10 |
| hl7.fhir.us.nhsn-med-admin | R4 | StructureDefinition/Observation-lab-sars-cov | Observation Laboratory SARS COVID-19 | active | 2021-10 |
| hl7.fhir.us.carin-rtpbc | R4 | CapabilityStatement/rtpbc-requester | RTPBC Requester Capability Statement | active | 2019-12 |
| hl7.fhir.us.carin-rtpbc | R4 | CapabilityStatement/rtpbc-responder | RTPBC Responder Capability Statement | active | 2019-12 |
| hl7.fhir.us.carin-rtpbc | R4 | CodeSystem/rtpbc-benefit-restriction | RTPBC Benefit Restriction Code System | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | CodeSystem/rtpbc-event-type | RTPBC Event Type Code System | active | 2019-12 |
| hl7.fhir.us.carin-rtpbc | R4 | CodeSystem/rtpbc-patient-pay-type | RTPBC Patient Pay Type Code System | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | ImplementationGuide/hl7.fhir.us.carin-rtpbc | Consumer Real-Time Pharmacy Benefit Check | draft | 2020-08 |
| hl7.fhir.us.carin-rtpbc | R4 | MessageDefinition/rtpbc-request | RTPBC Request Message Definition | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | MessageDefinition/rtpbc-response | RTPBC Response Message Definition | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-benefitRestriction | RTPBC benefitRestriction Extension | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-coverage | RTPBC Coverage | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-isAlternative | RTPBC isAlternative Extension | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-medicationrequest | RTPBC Medication Request | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-patient | RTPBC Patient | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-pharmacy-organization | RTPBC Pharmacy Organization | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-request-bundle | RTPBC Request Bundle | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-request-claim | RTPBC Request Using Claim | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-request-messageheader | RTPBC Request MessageHeader | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-response-bundle | RTPBC Response Bundle | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-response-claimresponse | RTPBC Response Using ClaimResponse | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-response-messageheader | RTPBC Response MessageHeader | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-benefit-restriction | RTPBC Benefit Restriction Value Set | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-billing-unit | RTPBC Billing Unit Value Set | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-country-code | RTPBC Country Code Value Set | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-error-code | RTPBC Error Code Value Set | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-event-type | RTPBC Event Type Value Set | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-patient-pay-type | RTPBC Patient Pay Type Value Set | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-pharmacy-type | RTPBC Pharmacy Type Value Set | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-prescribable-product-code | RTPBC Prescribable Product Code Value Set | active | 2020-05 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-state-and-province-code | RTPBC Two Letter State and Province Code Value Set | active | 2020-05 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/qualification | Qualification | active | 2022-04 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/region | SignalRegion | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceReferred | SignalServiceReferred | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestAuthorizedAmount | SignalServiceRequestAuthorizedAmount | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestDateOfReferral | SignalServiceRequestDateOfReferral | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestGuardian | SignalServiceRequestGuardian | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestNoOfUnits | SignalServiceRequestNoOfUnits | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestParentFee | SignalServiceRequestParentFee | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestParentFlatRate | SignalServiceRequestParentFlatRate | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestPatient | SignalServiceRequestPatient | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestProvider | SignalServiceRequestProvider | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestReferringOrg | SignalServiceRequestReferringOrg | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestTrailsClientID | SignalServiceRequestTrailsClientID | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestTrailsCountyHouseholdID | SignalServiceRequestTrailsCountyHouseholdID | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestTrailsID | SignalServiceRequestTrailsID | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/StateActivityStatus | SurveyStateActivityStatus | draft | |
| signal.core.r4 | R4 | http://hl7.org/fhir/StructureDefinition/patient-adoptionInfo | Patient Adoption Info | draft | 2023-06 |
| signal.core.r4 | R4 | http://hl7.org/fhir/StructureDefinition/no-fixed-address | Patient No Fixed Address | draft | 2023-05 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/documentreference | DocumentReference Profile | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/account | Account Profile | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/encounter | Encounter Profile | active | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/episodeofcare | EpisodeOfCare Profile | active | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/healthcareservice | HealthcareService Profile | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/invoice | Invoice | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/location | Location Profile | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/organization | Organization Profile | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/patient | Patient Profile | draft | 2023-06 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/practitionerrole | PractitionerRole Profile | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalQuestionnaireResponse | SignalQuestionnaireResponse | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/servicerequest | ServiceRequest Profile | draft | |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/omb-race-category | OMB Race Categories | active | 2022-09 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/contact-attempt-results | Contact Attempt Results | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/signal-healthcare-service-category | Signal Healthcare Service Category | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/signal-program | Signal Program | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/signal-healthcare-service-type | Signal Healthcare Service Type | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/signal-organization-license | Signal Organization License | active | 2019-11 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/CodeSystem/signal-organization-type | Signal Organization Type | draft | 2019-11 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/place-of-service | Place Of Service | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/progress-made-towards-goals | Progress Made Towards Goals | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/provider-taxonomy-na | Provider Taxonomy NA | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-action-types | Questionnaire CCARS Action Types | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-activity-involvement-rating | Questionnaire CCARS Overall Activity Involvement Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-aggression-danger-to-others-rating | Questionnaire CCARS Aggression Danger To Others Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-alcohol-use-rating | Questionnaire CCARS Alcohol Use Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-cognition-rating | Questionnaire CCARS Cognition Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-considerations-for-providers | Questionnaire CCARS Considerations For Providers | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-issues | Questionnaire CCARS Current Issues | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-living-arrangement | Questionnaire CCARS Current Living Arrangement | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-non-prescription-substance-use | Questionnaire CCARS Current Non-Prescription Substance Use | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-primary-role | Questionnaire CCARS Current Primary Role | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-depressive-issues-rating | Questionnaire CCARS Depressive Issues Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-disabilities | Questionnaire CCARS Disabilities | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-drug-use-rating | Questionnaire CCARS Drug Use Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-empowerment-rating | Questionnaire CCARS Empowerment Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-enrollment-payer | Questionnaire CCARS Enrollment Payer | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-ethnicity | Questionnaire CCARS Ethnicity | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-existence-presenting-problem | Questionnaire CCARS Existence Presenting Problem | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-family-rating | Questionnaire CCARS Family Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-gender | Questionnaire CCARS Gender | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-highest-education-level | Questionnaire CCARS Highest Education Level | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-history-current-victimization | Questionnaire CCARS History Current Victimization | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-history-of-issues | Questionnaire CCARS History Of Issues | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-history-of-mental-health-services | Questionnaire CCARS History Of Mental Health Services | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-hope-rating | Questionnaire CCARS Hope Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-interpersonal-rating | Questionnaire CCARS Interpersonal Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-legal-rating | Questionnaire CCARS Legal Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-legal-status | Questionnaire CCARS Legal Status | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-marital-status | Questionnaire CCARS Marital Status | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-medication-psychiatric-service | Questionnaire CCARS Medication Psychiatric Service | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-mental-health-services-program | Questionnaire CCARS Mental Health Services Program | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-multiple-issues-rating | Questionnaire CCARS Multiple Issues Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-overall-level-of-functioning-rating | Questionnaire CCARS Overall Level Of Functioning Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-overall-recovery-rating | Questionnaire CCARS Overall Recovery Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-overall-symptom-severity-rating | Questionnaire CCARS Overall Symptom Severity Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-physical-health-rating | Questionnaire CCARS Physical Health Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-place-of-residence | Questionnaire CCARS Place Of Residence | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-previous-concurrent-services | Questionnaire CCARS Previous Concurrent Services | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-psychosis-rating | Questionnaire CCARS Psychosis Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-race | Questionnaire CCARS Race | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-rae-aso-identification-codes | Questionnaire CCARS RAE ASO Identification Codes | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-reason-for-discharge | Questionnaire CCARS Reason For Discharge | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-role-performance-rating | Questionnaire CCARS Role Performance Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-school-development | Questionnaire CCARS School Development | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-school-problems | Questionnaire CCARS School Problems | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-security-supervision-rating | Questionnaire CCARS Security Supervision Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-self-care-basic-needs-rating | Questionnaire CCARS Self Care Basic Needs Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-sexual-orientation | Questionnaire CCARS Sexual Orientation | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-social-support-rating | Questionnaire CCARS Social Support Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-socialization-rating | Questionnaire CCARS Socialization Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-suicide-danger-to-self-rating | Questionnaire CCARS Suicide Danger To Others Rating | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-tobacco-use | Questionnaire CCARS Tobacco Use | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-type-of-discharge | Questionnaire CCARS Type Of Discharge | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-type-of-update | Questionnaire CCARS Type Of Update | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-yes-no-na | Questionnaire CCARS Yes No NA | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-yes-no-unable-to-assess | Questionnaire CCARS Yes No Unable To Assess | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-yes-no | Questionnaire CCARS Yes No | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-admission-route-of-administration | Questionnaire DACODS Admission Route Of Administration | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-client-disability | Questionnaire DACODS Client Disability | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-clinician-diagnostic-impression | Questionnaire DACODS Clinician Diagnostic Impression | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-discharge-progress-towards-measurable-treatment-goals | Questionnaire DACODS Discharge Progress Towards Measurable Treatment Goals | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-discharge-route-of-administration | Questionnaire DACODS Discharge Route Of Administration | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-discharge-status | Questionnaire DACODS Discharge Status | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-drug-type-code | Questionnaire DACODS Drug Type Code | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-education-employment-problems | Questionnaire DACODS Education Employment Problems | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-employment-status | Questionnaire DACODS Employment Status | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-family-issues-and-problems | Questionnaire DACODS Family Issues And Problems | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-health-insurance-status | Questionnaire DACODS Health Insurance Status | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-living-situation | Questionnaire DACODS Living Situation | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-marital-status | Questionnaire DACODS Marital Status | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-medical-physical-problems | Questionnaire DACODS Medical Physical Problems | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-reason-for-discharge | Questionnaire Dacods Reason For Discharge | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-secondary-tertiary-drug-type-code | Questionnaire DACODS Secondary Tertiary Drug Type Code | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-sexual-orientation | Questionnaire DACODS Sexual Orientation | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-socialization-problems | Questionnaire DACODS Socialization Problems | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-source-of-illicit-drugs | Questionnaire DACODS Source Of Illicit Drugs | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-source-of-income | Questionnaire DACODS Source Of Income | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-source-of-payment-for-treatment | Questionnaire DACODS Source Of Payment For Treatment | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-statutory-commitment | Questionnaire DACODS Statutory Commitment | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-tobacco-use | Questionnaire DACODS Tobacco Use | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-transfer-referral-source | Questionnaire DACODS Transfer Referral Source | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no-na | Questionnaire DACODS Yes No NA | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no-unable-to-assess | Questionnaire DACODS Yes No Unable To Assess | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no-unknown | Questionnaire DACODS Yes No Unknown | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no | Questionnaire DACODS Yes No | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/reason-for-discharge | Reason For Discharge | draft | 2023-08 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/CodeSystem/signal-filerepo-classification | Signal FileRepo Classification | draft | 2019-11 |
| signal.core.r4 | R4 | http://signalbhn.org/fhir/us/core/CodeSystem/signal-filerepo-docreviewstatus | Signal FileRepo Doc Review DocStatus | draft | 2019-11 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/signal-region | Signal Region | active | 2023-09 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/CodeSystem/signal-state-activity-status | Signal State Activity Status | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-screening-assessment-observation-category | US Core Screening Assessment Observation Category | active | 2023-03 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/account-status | AccountStatus | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/account-type | Account Types | draft | 2019-11 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/fips-county-co | CO FIPS Counties | draft | 2023-06 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/address-type | AddressType | active | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/address-use | AddressUse | active | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/birthsex | Birth Sex | active | 2022-09 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/chargeitem-status | ChargeItemStatus | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/composition-status | CompositionStatus | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/condition-clinical | Condition Clinical Status Codes | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/condition-severity | Condition/Diagnosis Severity | draft | |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/condition-ver-status | ConditionVerificationStatus | draft | 2019-11 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/contact-attempt-results | Contact Attempt Results | draft | |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/coverage-class | Coverage Class Codes | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/coverage-copay-type | Coverage Copay Type Codes | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/coverage-financial-exception | Example Coverage Financial Exception Codes | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/data-absent-reason | DataAbsentReason | active | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/days-of-week | DaysOfWeek | active | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/detailed-ethnicity | Detailed ethnicity | active | 2022-09 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/detailed-race | Detailed Race | active | 2022-09 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/device-action | Procedure Device Action Codes | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/device-kind | FHIR Device Types | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/diagnosis-role | DiagnosisRole | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/document-classcodes | Document Class Value Set | active | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/document-reference-status | DocumentReferenceStatus | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/document-relationship-type | DocumentRelationshipType | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-admit-source | Admit source | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-diet | Diet | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-location-status | EncounterLocationStatus | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-participant-type | Participant type | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-special-arrangements | Special arrangements | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-special-courtesy | Special courtesy | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-status | EncounterStatus | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/episode-of-care-status | EpisodeOfCareStatus | draft | 2019-10 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/episodeofcare-type | Episode of care type | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/event-status | EventStatus | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/c80-facilitycodes | Facility Type Code Value Set | active | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/fm-status | Financial Resource Status Codes | draft | 2019-10 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/formatcodes | DocumentReference Format Code Set | active | 2019-11 |
| signal.core.r4 | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.32 | Gender Identity | active | 2022-03 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-healthcare-service-category | Signal Healthcare Service Category | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/healthcare-service-procedure-code-cpt | HealthCare Service Procedure Code CPT | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-program | Signal Program | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-healthcare-service-type | Signal Healthcare Service Type | draft | |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/identifier-use | IdentifierUse | draft | 2019-10 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/invoice-priceComponentType | InvoicePriceComponentType | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/invoice-status | InvoiceStatus | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/languages | Common Languages | draft | 2016-08 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/location-mode | LocationMode | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/location-physical-type | Location type | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/location-status | LocationStatus | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/observation-category | Observation Category Codes | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/observation-status | ObservationStatus | active | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/omb-ethnicity-category | OMB Ethnicity Categories | active | 2022-09 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/organization-role | Organization Affiliation Role | draft | 2019-11 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-organization-license | Signal Organization License | draft | 2023-07 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/ValueSet/signal-organization-type | Signal Organization Type | draft | 2023-07 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/performer-role | Procedure Performer Role Codes | draft | 2019-11 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/place-of-service | Place Of Service | draft | |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/procedure-category | Procedure Category Codes (SNOMED CT) | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/procedure-followup | Procedure Follow up Codes (SNOMED CT) | draft | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/procedure-not-performed-reason | Procedure Not Performed Reason (SNOMED-CT) | active | 2019-11 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/procedure-outcome | Procedure Outcome Codes (SNOMED CT) | draft | 2019-11 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/progress-made-towards-goals | Progress Made Towards Goals | draft | |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/provider-taxonomy | Provider Taxonomy Codes | draft | 2023-03 |
| signal.core.r4 | R4 | http://terminology.hl7.org/ValueSet/v2-2.7-0360 | v2 table 0360, Version 2.7 | active | |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/questionnaire-answers-status | QuestionnaireResponseStatus | draft | 2019-10 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-action-types | Questionnaire CCARS Action Types | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-activity-involvement-rating | Questionnaire CCARS Overall Activity Involvement Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-aggression-danger-to-others-rating | Questionnaire CCARS Aggression Danger To Others Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-alcohol-use-rating | Questionnaire CCARS Alcohol Use Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-cognition-rating | Questionnaire CCARS Cognition Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-considerations-for-providers | Questionnaire CCARS Considerations For Providers | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-issues | Questionnaire CCARS Current Issues | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-living-arrangement | Questionnaire CCARS Current Living Arrangement | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-non-prescription-substance-use | Questionnaire CCARS Current Non-Prescription Substance Use | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-primary-role | Questionnaire CCARS Current Primary Role | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-depressive-issues-rating | Questionnaire CCARS Depressive Issues Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-disabilities | Questionnaire CCARS Disabilities | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-drug-use-rating | Questionnaire CCARS Drug Use Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-empowerment-rating | Questionnaire CCARS Empowerment Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-enrollment-payer | Questionnaire CCARS Enrollment Payer | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-ethnicity | Questionnaire CCARS Ethnicity | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-existence-presenting-problem | Questionnaire CCARS Existence Presenting Problem | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-family-rating | Questionnaire CCARS Family Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-gender | Questionnaire CCARS Gender | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-highest-education-level | Questionnaire CCARS Highest Education Level | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-current-victimization | Questionnaire CCARS History Current Victimization | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-of-issues | Questionnaire CCARS History Of Issues | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-of-mental-health-services | Questionnaire CCARS History Of Mental Health Services | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-hope-rating | Questionnaire CCARS Hope Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-interpersonal-rating | Questionnaire CCARS Interpersonal Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-legal-rating | Questionnaire CCARS Legal Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-legal-status | Questionnaire CCARS Legal Status | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-marital-status | Questionnaire CCARS Marital Status | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-medication-psychiatric-service | Questionnaire CCARS Medication Psychiatric Service | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-mental-health-services-program | Questionnaire CCARS Mental Health Services Program | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-multiple-issues-rating | Questionnaire CCARS Multiple Issues Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-level-of-functioning-rating | Questionnaire CCARS Overall Level Of Functioning Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-recovery-rating | Questionnaire CCARS Overall Recovery Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-symptom-severity-rating | Questionnaire CCARS Overall Symptom Severity Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-physical-health-rating | Questionnaire CCARS Physical Health Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-place-of-residence | Questionnaire CCARS Place Of Residence | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-previous-concurrent-services | Questionnaire CCARS Previous Concurrent Services | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-psychosis-rating | Questionnaire CCARS Psychosis Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-race | Questionnaire CCARS Race | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-rae-aso-identification-codes | Questionnaire CCARS RAE ASO Identification Codes | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-reason-for-discharge | Questionnaire CCARS Reason For Discharge | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-role-performance-rating | Questionnaire CCARS Role Performance Rating | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-school-development | Questionnaire CCARS School Development | draft | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-school-problems  http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.124 | Neonatal Jaundice | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.125 | Maternal Drug Use | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.126 | Maternal Drug Use | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.127 | Maternal Drug Use | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.128 | Fetal Conditions | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.129 | Fetal Conditions | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.130 | Fetal Conditions | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.131 | Congenital Malformations | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.132 | Congenital Malformations | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.133 | Congenital Malformations | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.134 | Social Indications | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.135 | Social Indications | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.136 | Social Indications | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.137 | Neonatal Severe Birth Trauma | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.138 | Neonatal Severe Birth Trauma | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.139 | Neonatal Severe Birth Trauma | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.140 | Neonatal Severe Hypoxia or Asphyxia | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.141 | Neonatal Severe Hypoxia or Asphyxia | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.142 | Neonatal Severe Hypoxia or Asphyxia | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.143 | Neonatal Severe Shock and Resuscitation | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.144 | Neonatal Severe Shock and Resuscitation | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.145 | Neonatal Severe Shock and Resuscitation | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.146 | Neonatal Severe Respiratory Complications | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.147 | Neonatal Severe Respiratory Complications | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.148 | Neonatal Severe Respiratory Complications | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.149 | Neonatal Severe Infection | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.150 | Neonatal Severe Infection | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.151 | Neonatal Severe Infection | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.152 | Neonatal Severe Neurological Complications | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.153 | Neonatal Severe Neurological Complications | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.154 | Neonatal Severe Neurological Complications | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.155 | Neonatal Severe Shock and Resuscitation Procedures | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.156 | Neonatal Severe Shock and Resuscitation Procedures | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.157 | Neonatal Severe Shock and Resuscitation Procedures | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.158 | Neonatal Severe Respiratory Procedures | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.159 | Neonatal Severe Respiratory Procedures | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.160 | Neonatal Severe Respiratory Procedures | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.161 | Neonatal Severe Neurological Procedures | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.162 | Neonatal Severe Neurological Procedures | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.163 | Neonatal Severe Neurological Procedures | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.164 | Neonatal Severe Septicemia | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.165 | Neonatal Severe Septicemia | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.166 | Neonatal Severe Septicemia | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.167 | Neonatal Moderate Birth Trauma | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.168 | Neonatal Moderate Birth Trauma | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.169 | Neonatal Moderate Birth Trauma | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.170 | Neonatal Moderate Respiratory Complications | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.171 | Neonatal Moderate Respiratory Complications | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.172 | Neonatal Moderate Respiratory Complications | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.173 | Neonatal Moderate Respiratory Complications Procedures | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.174 | Neonatal Moderate Respiratory Complications Procedures | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.175 | Neonatal Moderate Respiratory Complications Procedures | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.176 | Neonatal Moderate Birth Trauma with LOS | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.177 | Neonatal Moderate Birth Trauma with LOS | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.178 | Neonatal Moderate Birth Trauma with LOS | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.179 | Neonatal Moderate Respiratory Complications with LOS | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.180 | Neonatal Moderate Respiratory Complications with LOS | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.181 | Neonatal Moderate Respiratory Complications with LOS | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.182 | Moderate Neurological Complications with LOS Procedures | active | 2019-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.183 | Neonatal Moderate Neurological Complications with LOS Procedures | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.184 | Neonatal Moderate Neurological Complications with LOS Procedures | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.185 | Neonatal Moderate Respiratory complications with LOS Procedures | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.186 | Neonatal Moderate Respiratory complications with LOS Procedures | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.187 | Neonatal Moderate Respiratory complications with LOS Procedures | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.188 | Single Liveborn Newborn Vaginal | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.189 | Single Liveborn Newborn Vaginal | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.190 | Single Liveborn Newborn Vaginal | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.191 | Single Liveborn Newborn Cesarean | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.192 | Single Liveborn Newborn Cesarean | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.193 | Single Liveborn Newborn Cesarean | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.194 | Birth Weight | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.195 | Neonatal Moderate Infection with LOS | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.196 | Neonatal Moderate Infection with LOS | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.197 | Neonatal Moderate Infection with LOS | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.203 | Neonatal Intensive Care Unit | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.204 | Intensive Care Unit | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.205 | Neonatal Intensive Care Unit | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.206 | Intensive Care Unit | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.208 | Blood Transfusion Administration | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.209 | Blood Transfusion Administration | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.213 | Blood Transfusion | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.214 | Acute Respiratory Distress Syndrome | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.217 | Amniotic Fluid Embolism | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.219 | Aortic Aneurysm | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.220 | Aortic Aneurysm | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.221 | Cardiac Arrest Ventricular Fibrillation | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.223 | Disseminated Intravascular Coagulation | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.225 | Eclampsia | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.227 | Heart Failure Cardiac Arrest Related to Procedure or Surgery | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.228 | Heart Failure Cardiac Arrest Related to Procedure or Surgery | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.229 | Puerperal Cerebrovascular Disorder | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.231 | Pulmonary Edema | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.233 | Acute Heart Failure | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.235 | Severe Anesthesia Complications | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.237 | Sepsis | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.239 | Shock | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.24 | Blood Transfusion Administration | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.241 | Sickle Cell Disease with Crisis | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.243 | Air and Thrombotic Embolism | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.245 | Blood Transfusion | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.246 | Blood Transfusion | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.247 | Conversion of Cardiac Rhythm | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.248 | Conversion of Cardiac Rhythm | active | 2021-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.249 | Hysterectomy | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.250 | Hysterectomy | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.251 | Tracheostomy | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.252 | Tracheostomy | active | 2021-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.253 | Ventilation | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.254 | Ventilation | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.255 | Severe Maternal Morbidity Diagnoses | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.256 | Severe Maternal Morbidity Procedures | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.267 | Gestational Diabetes | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.269 | Gestational Diabetes | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.271 | HIV in Pregnancy Childbirth and Puerperium | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.272 | HIV in Pregnancy Childbirth and Puerperium | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.274 | Preexisting Diabetes | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.275 | Preexisting Diabetes | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.277 | Previous Cesarean | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.278 | Previous Cesarean | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.279 | Pulmonary Hypertension | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.281 | Pulmonary Hypertension | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.282 | Multiple Pregnancy | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.284 | Multiple Pregnancy | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.286 | Bleeding Disorder | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.287 | Bleeding Disorder | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.289 | Morbid or Severe Obesity | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.290 | Morbid or Severe Obesity | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.291 | Economic Housing Instability | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.292 | Economic Housing Instability | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.295 | Thyrotoxicosis | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.296 | Thyrotoxicosis | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.297 | Preterm Birth | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.299 | Preterm Birth | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.300 | Placenta Accreta | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.302 | Placenta Accreta | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.303 | Placental Abruption | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.305 | Placental Abruption | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.306 | Neuromuscular Disease | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.308 | Neuromuscular Disease | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.309 | Autoimmune Disease | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.311 | Autoimmune Disease | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.312 | Mental Health Disorder | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.314 | Mental Health Disorder | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.315 | Bariatric Surgery | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.317 | Bariatric Surgery | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.318 | Substance Abuse | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.320 | Substance Abuse | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.321 | Anemia | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.323 | Anemia | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.324 | Severe Preeclampsia | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.326 | Mild or Moderate Preeclampsia | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.327 | Severe Preeclampsia | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.329 | Mild or Moderate Preeclampsia | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.330 | Hypertension | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.332 | Hypertension | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.333 | Renal Disease | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.335 | Renal Disease | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.336 | Gastrointestinal Disease | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.338 | Gastrointestinal Disease | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.339 | Cardiac Disease | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.341 | Cardiac Disease | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.344 | Aortic Aneurysm | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.357 | Conversion of Cardiac Rhythm | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.358 | Hysterectomy | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.359 | Tracheostomy | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.360 | Ventilation | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.361 | Venous Thromboembolism in Pregnancy | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.363 | Venous Thromboembolism in Pregnancy | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.364 | Long Term Anticoagulant Use | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.366 | Long Term Anticoagulant Use | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.368 | Preadmission Observation Undelivered Mother | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.369 | ED Visit and OB Triage | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.370 | Present on Admission is No or Unable To Determine | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.371 | COVID 19 Confirmed | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.372 | COVID 19 Confirmed | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.373 | COVID 19 Confirmed | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.374 | Respiratory Conditions Related to COVID 19 | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.375 | Respiratory Conditions Related to COVID 19 | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.376 | Respiratory Conditions Related to COVID 19 | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.377 | Respiratory Support Procedures | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.378 | Respiratory Support Procedures | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.379 | Respiratory Support Procedures Related to COVID 19 | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.387 | Placenta Increta or Percreta | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.388 | Placenta Increta or Percreta | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.67 | Other Health Care Facility | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.10 | Non essential Hypertension SNOMEDCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.102 | Suicide Attempt | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.11 | Cirrhosis ICD9CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.12 | Cirrhosis ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.13 | Cirrhosis SNOMEDCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.14 | Cirrhosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.151 | Polycystic Ovary Syndrome | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.16 | Low Intensity Statin Therapy/Branded | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.17 | Moderate Intensity Statin Therapy/Branded | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.18 | High Intensity Statin Therapy/Branded | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.21 | ALT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.230 | Gestational Diabetes SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.231 | Gestational Diabetes ICD10CM | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.233 | All Results of High Risk HPV Test | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.234 | High Risk HPV Positive Results | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.248 | Suicide Attempt SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.26 | Nonopioid pain medications | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.263 | High Risk Positive HPV Results Without HPV16 or HPV18 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.264 | CDS Pregnancy | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.265 | CDS Pregnancy Intensional | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.266 | Rhabdomyolysis Intensional | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.267 | CDS Rhabdomyolysis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.268 | HPV Negative Results | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.27 | Non pharmacologic treatments for chronic pain ICD10PCS | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.28 | Urine drug screen for pain management | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.29 | Non pharmacologic treatments for chronic pain SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.292 | Non pharmacologic treatments for chronic pain NCI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.296 | SCT Findings 202209 | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.298 | Cervical Cytology Test | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.299 | HPV 16 Tests | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.300 | HPV 18 Tests | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.302 | Test Cervical Excision Procedures | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.303 | Statin Combinations | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.305 | Counseling for Physical Activity CPT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.306 | Counseling for Physical Activity ICD10CM | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.307 | Counseling for Physical Activity CDS | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.308 | Cardiovascular disease 10Y risk | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.309 | SCT Findings 202309 | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.311 | SCT Procedures 202209 | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.312 | SCT Procedures 202309 | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.313 | Statin Allergen Grouping | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.319 | Steward Transfer Test | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.320 | Opioids ATCPROD N02A | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.322 | Test 123 | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.34 | Opioid pain medications | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.36 | Non pharmacologic treatments for chronic pain | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.40 | Suicide attempt | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.42 | Naloxone and Nalmefene medications | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.43 | Benzodiazepine medications | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.44 | Stool softeners and laxatives | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.47 | Anxiety | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.48 | Anxiety | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.50 | Sleep disordered breathing | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.51 | Sleep disordered breathing | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.52 | Anxiety | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.53 | Sleep disordered breathing | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.54 | Adjuvant pain medications | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.55 | Risk assessments relevant to pain management | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.6 | Non essential Hypertension ICD9CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.7 | Non essential Hypertension ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.79 | Behavioral Counseling for Nutrition and Activity Referral | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.85 | Impaired Glucose Tolerance | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.87 | Fasting Plasma Glucose | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.88 | Waist Circumference | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.9 | Hypertension | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.90 | Gestational Diabetes | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.92 | First Degree Family Member | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.94 | Glucose Tolerance Test Results | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.96 | Dependence on dialysis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.99 | Gestational Diabetes | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.460 | Cluster Headache (ICD10CM) | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.461 | Cluster Headache (ICD9CM) | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.464 | Cluster Headache | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.467 | Medication Therapy for Cluster Headache (RXNORM) | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.555 | Patient Declines Treatment for Cluster Headache (SNOMEDCT) | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.558 | Acute Cluster Headache Medication (RXNORM) | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.559 | Long Term Preventive Medication for Cluster Headache | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.561 | Oral Steroid for Cluster Headache | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.569 | Migraine Preventive Medication | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.601 | Acute Migraine Attack Medication | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.605 | NSAID OTC Migraine Attack Medication | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.606 | NSAID Prescribable Migraine Attack Medication | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.640 | Neurologic Disorders | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.641 | Neuromodulation for migraine | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.642 | No pain with headache | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.643 | Antiplatelets | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.644 | Anticoagulants | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.645 | Statin Medications | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.646 | Anxiety Disorders (ICD10 and SNOMED) | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.648 | Depression Diagnosis (ICD10 and SNOMED) | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.649 | Psychosis (ICD10 and SNOMED) | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.650 | Cluster Headache (SNOMED) | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.651 | Galcanezumab (RxNorm) | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.652 | Lithium (RxNorm) | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.653 | Verapamil | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.654 | Long term preventive medications for cluster headache | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.655 | Short term preventive medication for cluster headache | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.656 | Zolmitriptan | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.657 | Sumatriptan | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.658 | Dihydroergotamine | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.659 | Acute cluster headache medication | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.660 | Acute cluster headache treatment | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.661 | Short term preventive treatment for cluster headache | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.662 | Long term preventive treatment for cluster headache | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.663 | Migraine diagnosis (ICD) | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.664 | Prescribable NSAIDs and Acute Migraine Attack Medication | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.103 | Abnormal Presentation | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.105 | Abnormal Presentation | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.114 | Hematocrit Lab Test | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.117 | Potassium Lab Test | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.119 | Sodium Lab Test | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.127 | Platelet Count Lab Test | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.129 | White Blood Cells Count Lab Test | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.130 | Respiratory Rate | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.134 | Glucose Lab Test | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.139 | Bicarbonate Lab Test | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.15 | Intravenous Thrombolytic tPA Therapy | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.151 | Oxygen Saturation by Pulse Oximetry | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.152 | Body Temperature | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.159 | Body Weight | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.16 | Intraarterial Thrombolytic tPA Therapy | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.163 | Systolic Blood Pressure | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.171 | Abnormal Presentation | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.173 | Delivery of Singleton | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.21 | Intravenous or Intraarterial Thrombolytic tPA Therapy | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.26 | Estimated Gestational Age at Delivery | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.27 | Cornual Ectopic Pregnancy | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.38 | General Or Neuraxial Anesthesia | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.39 | Low Dose Unfractionated Heparin for VTE Prophylaxis | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.41 | Glycoprotein IIb IIIa Inhibitors | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.55 | Oxytocin | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.56 | Dinoprostone | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.58 | Delivery Procedures | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.59 | Delivery Procedures | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.66 | PCI | active | 2017-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.67 | PCI | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.68 | Endotracheal Intubation | active | 2018-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.69 | Endotracheal Intubation | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.98 | Delivery of Singleton | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.99 | Delivery of Singleton | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.225 | Opioid Medication Assisted Treatment (MAT) SNOMED | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.241 | Schedule II, III and IV Opioid Medications | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.242 | Opioid Use Disorder | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.243 | Opioid Use Disorder | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.265 | Inpatient, Emergency, and Observation Locations | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.269 | Medications for Opioid Use Disorder (MOUD) | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.274 | NHSN Inpatient Encounter Class Codes | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.277 | Emergency Department Location | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.278 | Emergency Department Treatment Location | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.279 | Triage | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.283 | Emergency Department Location | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.284 | Emergency Department Location | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.285 | Mental Health Diagnosis without Substance Use Disorders | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.286 | Decision to Transfer | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.35 | Healthcare Agent or Proxy Choices | active | 2022-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.10 | Breastfeeding | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.100 | Familial Hypercholesterolemia | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.102 | Rhabdomyolysis | active | 2017-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.107 | Low Intensity Statin Therapy | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.12 | Liver Disease | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.13 | Rhabdomyolysis | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.19 | Atherosclerosis and Peripheral Arterial Disease | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.20 | Atherosclerosis and Peripheral Arterial Disease | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.21 | Atherosclerosis and Peripheral Arterial Disease | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.22 | Liver Disease ICD9 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.37 | Stable and Unstable Angina | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.39 | Cerebrovascular Disease Stroke or TIA | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.41 | Ischemic Heart Disease or Related Diagnoses | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.42 | Liver Disease | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.43 | Liver Disease | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.44 | Cerebrovascular Disease Stroke or TIA | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.46 | Ischemic Heart Disease or Related Diagnoses | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.47 | Stable and Unstable Angina | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.501 | Overweight or Obese | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.502 | Overweight or Obese | active | 2018-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.512 | Elevated Blood Pressure Reading | active | 2019-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.513 | Elevated Blood Pressure Reading | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.514 | Finding of Elevated Blood Pressure or Hypertension | active | 2019-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.515 | Bariatric Procedures | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.517 | Age related macular degeneration intermediate dry | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.518 | Ophthalmologist visit | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.519 | Posterior vitreous detachment (PVD) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.521 | Ophthalmoscopic exam | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.523 | Opthalmoscopic exams with Scleral Depression | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.525 | Referral (ophthalmology) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.526 | Retina Ultrasound | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.527 | Retina visualization inadequate | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.528 | Refusal or Noncompliance with treatment | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.529 | Vitreous hemorrhage | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.530 | Vitreous hemorrhage | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.536 | Macula examination | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.539 | Fluorescein angiography | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.541 | Optical coherence tomography (OCT) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.542 | Intravitreal injection | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.543 | Bevacizumab injection | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.544 | Ranibizumab injection | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.545 | Aflibercept injection | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.552 | Uveitis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.553 | Uveitis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.554 | Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edema | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.555 | Macular edema | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.556 | Corticosteroids for Injection | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.557 | Corticosteroids for Injection | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.560 | Tonometry | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.561 | Intraocular pressure | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.571 | Retinal Vein Occlusion Related Macular Edema | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.576 | Vitreous hemorrhage | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.580 | Intravitreal and Periocular Injections | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.581 | Intravitreal and Periocular Injections | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.582 | Corticosteroids for Injection | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.583 | Endophthalmitis in the Right Eye | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.584 | Endophthalmitis in the Left Eye | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.585 | Panophthalmitis in the Right Eye | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.586 | Panophthalmitis in the Left Eye | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.587 | Lost to follow up | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.588 | Uveitis | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.610 | Scleral depressed exam | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.611 | 3 Mirror Goldmann exam | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.612 | Scleral depressed exam | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.615 | Physical Disability | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.616 | Financial difficulty | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.617 | Vitreous exam findings | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.619 | Scleral depressed exam | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.629 | Post operative follow up | active | 2020-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.67 | Breastfeeding | active | 2017-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.69 | Stable and Unstable Angina | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.70 | Ischemic Heart Disease or Related Diagnoses | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.71 | Cerebrovascular Disease Stroke or TIA | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.73 | Breastfeeding | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.85 | Familial Hypercholesterolemia | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.89 | Rhabdomyolysis | active | 2017-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.9 | Outpatient Encounters for Preventive Care | active | 2019-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.91 | Familial Hypercholesterolemia | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.93 | Hypercholesterolemia ICD 9 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.97 | High Intensity Statin Therapy | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.98 | Moderate Intensity Statin Therapy | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.50 | HIV Lab Tests | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.51 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.52 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.53 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.71 | Human Immunodeficiency Virus (HIV) Viral Load | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.10 | ARBs (Angiotensin Receptor Blockers) | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1000 | OIA_V2_GLP1s_RxNorms | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1001 | OIA_V2_PCSK9s_RxNorms | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1002 | OIA_RFs_Secondary_Prevention_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1003 | OIA_RFs_Secondary_Prevention_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1004 | OIA_RFs_Secondary_Prevention_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1005 | OIA_RFs_Secondary_Prevention_ICD_SM_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1006 | OIA_Asthma_COPD_Combo_Meds | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1007 | OIA_Asthma_COPD_Combo_Meds_SABA_SAMA | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1008 | OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICS | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1009 | PAE_Patient_Conditions | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1012 | PAE Conditions Short | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1016 | OIA_TEST_VS | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1017 | Triptan Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1018 | NSAID Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1019 | Statin Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1021 | Penicillin Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1022 | Macrolide Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1023 | Quinolone Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1025 | Beta blocker Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1026 | ACE inhibitor Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1027 | ARB Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1028 | Sulfonylurea Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1030 | DPP4i Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1031 | GLP1RA Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1032 | Beta blocker allergy intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1033 | SGLT2i Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1034 | MRA Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1036 | Meglitinide Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1037 | Alpha glucosidase inhibitor Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1038 | TZD Allergy NDFRT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1041 | Hemoglobin | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1042 | Hematocrit | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1043 | Anemia for Erythropoesis Simulating Agents I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1044 | Anemia for Erythropoesis Simulating Agents SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1045 | Anemia for Erythropoesis Simulating Agents | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1046 | AZT Meds | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1047 | Ferritin | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1048 | Knee pain I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1049 | Knee pain SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.105 | conditions_heartfailure | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1050 | Knee pain | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1051 | Knee decreased ROM SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1052 | Knee effusion I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1054 | Knee effusion | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1055 | Knee crepitus SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1056 | OIA_Antiemetics | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1057 | OIA_PDE5is | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1058 | OIA_Vitamins | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1059 | OIA_Plavix | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1061 | OIA_Oral_Contraceptives | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1063 | OIA_Topical_Steroids | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1064 | OIA_Cough_Cold_Meds | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1065 | Antiperspirant aluminum salts | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1066 | Antiperspirant anticholinergics | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1067 | Antieplieptic medications | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1068 | Antidepressant medications | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1069 | Urinary incontinence SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1070 | Urinary incontinence I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1071 | Urinary incontinence | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1073 | Hemifacial spasm SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1074 | Hemifacial spasm I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1075 | Hemifacial spasm | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1076 | Spasmodic dysphonia SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1077 | Physical therapy procedure SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1078 | Occupational therapy SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1079 | Hyperhidrosis SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1080 | Hyperhidrosis I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1081 | Hyperhidrosis | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1082 | Tic disorder I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1083 | Tic disorder SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1084 | Tic disorder | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1085 | Esophageal achalasia SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1086 | Esophageal achalasia I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1087 | Esophageal achalasia | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1088 | ET propanolol or primidone | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1089 | ET topiramate alprazolam or gabapentin | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.109 | CKD stage4above I10 | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1090 | Blephraospasm SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1091 | Blepharospasm I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1092 | Blepharospasm | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1093 | Strabismus SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1094 | Strabismus I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1095 | Strabismus | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1096 | Overactive bladder SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1097 | Overactive bladder I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1098 | Overactive bladder | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1099 | Movement disorders SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.110 | CKD stage4above SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1100 | Movement disorders I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1101 | Movement disorders | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1102 | Lateral epicondylitis SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1103 | Lateral epicondyltisis I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1104 | Lateral epicondylitis | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1105 | Plantar fasciitis SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1106 | Plantar fasciitis I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1107 | Plantar fasciitits | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1108 | Cardiac CT SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1109 | Cardiac CT CPT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.111 | CKD stage4above | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1111 | Cardiac CT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1112 | Cardiac MRI SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1113 | Cardiac MRI CPT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1114 | Cardiac MRI | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1115 | CT Angiography of Coronary Artery SCT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1116 | CT Angiography of Coronary Artery CPT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1117 | CT Angiography of Coronary Artery | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.112 | Chronic kidney disease I10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.113 | Chronic kidney disease SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.116 | DigTx Cognitive Impairment I10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.117 | DigTx Cognitive Impairment SCT | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.120 | Diabetic ketoacidosis SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.121 | Diabetic ketoacidosis | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.124 | DKD | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.146 | Long Acting Muscarinic Antagonists (LAMA) | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.147 | HFrEF SCT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.148 | HFrEF I10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.15 | Kidney tansplant | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.150 | History of Hypoglycemia I10 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.151 | History of Hypoglycemia SCD | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.153 | Hyperlipidemia | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.159 | conditions_COPD I10 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.168 | medications_COPD | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.17 | Atrial fibrillation | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.173 | Asthma I10 | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.175 | Asthma | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.184 | DigTx Virtual Reality Contraindications Visual Impairment | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.186 | Beta blockers GDMT for heart failure | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.188 | medications_heart failure | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.189 | SGLT2i | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.193 | relatedconditions_COPD I10 | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.197 | Blood (Serum and Plasma) Potassium | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.202 | Serum Creatinine | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.21 | Thoracic aorta disease | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.214 | Type 1 Diabetes Mellitus SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.224 | Systolic Heart Failure I10 | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.226 | Systolic Heart Failure | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.238 | MRA mineralocorticoid receptor antagonists | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.244 | MRA Mineralocorticoid Receptor Antagonist Allergy | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.252 | relatedconditions_Heart failure I10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.260 | UACR SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.263 | Pregnancy I10 | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.281 | Statins Allergy SCT | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.282 | Statin Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.292 | Metabolic syndrome I10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.3 | Delivery I10 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.314 | relatedconditions_hyperlipidemia I10 | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.322 | Angina I10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.325 | Tachyarrhythmia I10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.337 | Migraine I10 | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.34 | Blood pressure panel | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.35 | Systolic Blood Pressure | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.350 | Coronary artery disease I10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.367 | Trandolapril | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.369 | Candesartan | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.37 | relatedconditions_hypertension SCT | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.377 | Valsartan | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.38 | relatedconditions_hypertension I10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.397 | eGFR | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.409 | Hypertension I10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.412 | Statin Moderate Intensity | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.415 | LDL Cholesterol | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.43 | Urinalysis | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.434 | Insulin | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.437 | TZD Thiazolidinediones | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.438 | medications_T2DM | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.439 | relatedconditions_T2DM I10 | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.440 | relatedconditions_T2DM SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.442 | Blood Glucose | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.45 | ACE inhibitor allergy RXNORM | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.455 | Metabolic acidosis I10 | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.459 | Liver cancer | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.47 | ACE inhibitor allergy SCT | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.473 | Tetanus toxoid, diphtheria (Td) Vaccine | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.474 | Allergy to Tdap Vaccine | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.475 | Allergy to Td Vaccine | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.476 | Allergy To Vaccine Component | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.478 | Allergy to HPV Vaccine | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.481 | medications_hypertension | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.492 | Inhaled Corticosteroids Allergy | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.498 | Metformin AllergyIntolerance SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.5 | Delivery - Procedure | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.508 | Abdominal aortic imaging CPT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.516 | Allergy to Herpes Zoster Vaccine SCT | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.517 | Hemoglobin A1c | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.518 | Drug hypersensitivity I10 | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.519 | Drug hypersensitivity SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.520 | Drug hypersensitivity | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.521 | Diabetic Kidney Disease I10 | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.523 | Diabetic kidney disease | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.524 | Chronic Hepatitis SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.525 | Chronic Hepatitis | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.527 | OCS_Prednisone | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.528 | High Dose Non Combo ICS Adult | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.529 | Medium Dose Non Combo Asthma ICS Adult | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.530 | Low Dose Non Combo ICS | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.531 | Anti IgE Medications | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.532 | IL5 Antagonists | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.533 | Mast cell stabilizers for asthma | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.534 | Vasospastic disease I10 | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.535 | Vasospastic disease SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.536 | Vasospastic disease | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.537 | Hemiplegic and basilar migraine I10 | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.538 | Hemiplegic and basilar migraine SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.539 | Hemiplegic and basilar migraine | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.540 | Peptic ulcer disease I10 | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.541 | Peptic ulcer disease SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.542 | Peptic ulcer disease | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.544 | Bleeding disorder I10 | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.545 | Bleeding disorder SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.548 | Electronic cigarettes or Vaping | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.549 | Bleeding disorder | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.551 | Heart Rate | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.552 | Triptans | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.553 | CGRP receptor antagonists | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.554 | Ditans | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.555 | Ergots | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.556 | Migraine specific NSAIDs | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.557 | OTC migraine analgesics | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.558 | Butalbital analgesics | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.559 | medications_migraine_acute | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.560 | relatedconditions_migraine I10 | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.561 | conditions_migraine | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.562 | relatedconditions_migraine SCT | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.563 | relatedconditions_migraine | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.564 | Triptan Allergy Intolerance SCT | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.565 | Triptan Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.566 | Ischemic bowel disease SCT | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.567 | Ischemic bowel disease I10 | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.568 | Ischemic bowel disease | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.569 | Allergen Immunotherapy | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.570 | Allergy to house dust mites SCT | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.571 | Allergy to house dust mites I10 | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.572 | Allergy to house dust mites | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.573 | conditions_hyperlipidemia I10 | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.574 | conditions_hyperlipidemia SCT | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.575 | conditions_hyperlipidemia | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.578 | PIM_Schedule V | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.580 | PIM_Acarbose | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.581 | PIM_Avandamet | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.582 | PIM_Dulaglutide | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.583 | PIM_Glimepiride | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.585 | PIM_Glucophage | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.587 | PIM_Glucovance | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.588 | Glyburide PIM | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.590 | Alpha glucosidase inhibitors | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.592 | Azotemia | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.594 | Intolerance to ARB SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.595 | ICS Low | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.596 | ICS Medium | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.597 | ICS High | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.598 | Low Dose ICS Formoterol | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.599 | PIM_Vitamin B12 Level_LOINC_CPT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.600 | PIM_Vitamin B12 Level_LOINC | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.601 | PIM_Vitamin B12 Level_CPT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.604 | PIM_Glyburide | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.605 | PIM_Pioglitazone | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.606 | PIM_Semaglutide | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.607 | PIM_Linagliptin | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.609 | Macrolide_Azithromycin | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.61 | Secondary antihypertensives | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.610 | Long Acting Beta Agonists (LABA) Non_Formoterol | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.611 | relatedconditions_Asthma I10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.612 | Wolff Parkinson White SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.613 | Wolff Parkinson White I10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.614 | Wolff Parkinson White | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.615 | medications_Asthma | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.617 | HighICS_LABA_NonFormoterol | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.618 | relatedconditions_Asthma SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.619 | ICS_LABA_LAMA | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.620 | Low Dose ICS_LABA_Non Formoterol | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.621 | Medium ICS_LABA Non Formoterol | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.622 | relatedconditions_Asthma | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.623 | LAMA Allergy SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.624 | LABA Allergy SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.625 | BetaBlock NonCS Secondary Allergy SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.626 | Eplerenone Allergy SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.627 | Spironolactone Allergy SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.628 | SGLT2 Inhibitors Allergy SCT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.629 | PIM_Refill_Request_Antilipemics_LFTs | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.630 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.631 | Pneumococcal Vaccine Allergy SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.632 | Meglitinides Allergy SCT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.633 | DPP4i Allergy SCT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.635 | Alpha_glucosidase inhibitors allergy SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.636 | Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.637 | Insulins Allergy SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.638 | TZD Allergy SCT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.639 | T2DM_Medications Allergy SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.642 | T2DM_Medications Allergy RXNORM | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.643 | T2DM_Medications Allergy SNOMED | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.646 | T2DM_Medication Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.647 | Statins Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.649 | ACE Inhibitors Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.650 | ARB Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.652 | Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.653 | Long Acting Beta Agonists (LABA) Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.654 | BetaBlocker NonCS Secondary Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.656 | MRA Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.657 | Eplerenone Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.658 | Spironolactone Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.659 | SGLT2i Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.660 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.661 | Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.665 | Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.666 | Human Papillomavirus (HPV) vaccine Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.667 | Herpes Zoster Vaccine Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.670 | Pneumococcal Vaccine Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.671 | Inhaled Corticosteroids(ICS) Allergy Intolerance | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.672 | LABA(Formoterol only) | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.674 | PIM_Tirzepatide | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.675 | GLP1RA Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.676 | PIM_Diabetes_Testing_Supplies | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.677 | PIM_H2_Antagonists | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.678 | SGLT2i DM CKD | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.679 | SGLT2i DM ASCVD | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.680 | GLP1RA DM ASCVD | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.683 | OIA_Gout_Medications | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.684 | GlumetzaSubstitution | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.685 | MetforminER500mg | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.686 | PIM_Metformin | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.687 | PIM_Glipizide | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.689 | PIM_Glipizide_Glyburide_Glimepiride | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.690 | PIM_Insulin_Meglitinides | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.691 | PIM_Glyxambi | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.692 | PIM_Farxiga | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.693 | PIM_Invokana | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.694 | PIM_Jardiance | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.695 | PIM_Invokana_Jardiance | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.696 | Reclast | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.697 | LAMA_LABA Combination 1 Inhaler | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.698 | PIM_Contraceptives | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.699 | Selected Oral Antiemetics for Migraine | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.700 | PIM_DEXA_Scan | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.701 | PIM_DEXA_Scan_CPT_LOINC | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.702 | PIM_SSRIs | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.703 | PIM_SNRIs | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.704 | PIM_NRIs | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.705 | PIM_TCAs | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.706 | PIM_Citalopram | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.707 | PIM_Hydroxyzine | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.708 | PIM_Buspirone | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.709 | PIM_Bupropion | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.710 | PIM_Mirtazapine | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.711 | PIM_Trazodone | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.712 | PIM_IHD_CHD_CAD_ICD10 | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.713 | PIM_IHD_CHD_CAD_SNOMED | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.714 | PIM_Gabapentin | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.715 | PIM_Allergy_Nasal_Sprays | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.716 | PIM_Allergy_Oral_Meds | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.717 | PIM_Allergy_Nasal_Oral | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.719 | OCS_Prednisolone | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.72 | Inhaled corticosteroids (IC) | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.720 | COPD_Ofloxacin | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.721 | COPD_Ciprofloxacin | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.722 | COPD_Doxycycline | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.723 | Macrolide Allergy SCT | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.724 | Macrolide Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.725 | Prednisone Allergy SCT | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.727 | Tetracycline Allergy SCT | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.728 | Tetracycline Allergy Intolerance | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.729 | Fluoroquinolones Allergy SCT | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.730 | Fluoroquinolone Allergy Intolerance | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.731 | Penicillin Allergy RXNORM | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.732 | Penicillin Allergy SCT | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.733 | Penicillin Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.734 | PIM_Metformin_Single_Ingredient_Only | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.735 | PIM_Metformin_Combo_Ingredient_Only | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.736 | Pneumonia I10 | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.737 | Pneumonia SCT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.738 | Pneumonia | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.739 | Pulmonary Embolism I10 | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.742 | Pulmonary Embolism SCT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.743 | Pulmonary Embolism | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.744 | Influenza I10 | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.745 | Influenza SCT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.746 | Influenza (Tests for influenza A or B virus Antigen) | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.747 | Influenza | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.748 | COVID 19 I10 | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.749 | COVID19 SCT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.750 | COVID19 | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.752 | RSV I10 | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.753 | RSV SCT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.754 | RSV | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.755 | Respiratory Rate SCT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.756 | Respiratory Rate LOINC | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.757 | Respiratory Rate | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.758 | Acute Respiratory Failure I10 | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.759 | Acute Respiratory Failure SCT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.760 | Acute Respiratory Failure | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.761 | Dyspnea SCT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.762 | Dyspnea I10 | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.763 | Dyspnea | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.764 | Confusion I10 | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.765 | Confusion SCT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.766 | Confusion | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.767 | Drowsiness SCT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.768 | Drowsiness I10 | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.769 | Drowsiness | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.770 | Cyanosis I10 | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.771 | Cyanosis SCT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.772 | Cyanosis | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.775 | Arterial oxygen saturation LOINC | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.776 | Arterial oxygen saturation SCT | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.777 | Arterial oxygen saturation | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.779 | PIM_Potassium_Supplements | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.780 | PIM_PPIs | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.781 | PIM_Migraine_Medications_Abortive | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.782 | PIM_Migraine_Medications_Preventive | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.783 | PIM_Bisphosphonates | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.784 | PIM_BPH_Medications | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.785 | PIM_Thyroid_Replacement_Medications | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.786 | PIM_Overactive_Bladder_Medications | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.787 | PIM_Topical_Acne_Medications | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.788 | PIM_Antidepressant_Anxiolytic_Medications | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.789 | Simple Knee Pain I10 | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.790 | Simple Knee Pain SCT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.791 | Simple Knee Pain | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.792 | Simple Left Knee Pain SCT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.793 | Simple Right Knee Pain SCT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.794 | Simple Right Knee Pain I10 | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.795 | Simple Left Knee Pain I10 | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.796 | Simple Right Knee Pain | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.797 | Simple Left Knee pain | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.798 | Knee joint surgery CPT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.799 | Knee joint surgery SCT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.800 | Knee joint surgery | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.801 | Knee Osteoarthritis I10 | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.802 | Knee Osteoarthritis SCT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.803 | Knee Osteoarthritis | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.804 | Osteoarthritis of right knee SCT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.805 | Osteoarthritis of left knee SCT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.806 | Osteoarthritis of right knee I10 | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.807 | Osteoarthritis of left knee I10 | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.808 | Osteoarthritis of right knee | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.809 | Osteoarthritis of left knee | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.810 | Hip Osteoarthritis SCT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.811 | Hip Osteoarthritis I10 | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.812 | Hip Osteoarthritis | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.813 | Hip joint surgery CPT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.814 | Hip joint surgery SCT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.815 | Hip joint surgery | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.816 | Osteoarthritis of right hip I10 | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.817 | Osteoarthritis of left hip I10 | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.818 | Osteoarthritis of right hip SCT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.819 | Osteoarthritis of left hip SCT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.820 | Osteoarthritis of right hip | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.821 | Osteoarthritis of left hip | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.822 | DigTx RelieVR inclusions I10 | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.823 | Aminoglycosides | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.824 | Carbapenems | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.826 | Monobactams | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.827 | Penicillins | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.828 | Antimycobacterials | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.829 | Beta_lactamase | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.830 | Cyclic lipopeptides | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.831 | Lincosamides | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.832 | Macrolides | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.833 | Amphenicol | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.834 | Oxazolidinones | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.835 | Fluoroquinolones | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.836 | Sulfonamides | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.837 | Tetracyclines | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.838 | Phosphonics | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.839 | Pleuromutilin | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.840 | Streptogramins | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.841 | Lipoglycopeptides | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.842 | Nitroimidazoles | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.843 | PIM_Hyd_Bus_Mir_Tra | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.844 | Nitrofurans | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.845 | Rifamycins | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.846 | Glycylcycline | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.847 | Pyrimidines | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.849 | Antibiotics oral and parenteral | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.85 | PCSK9i | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.850 | Medications_hyperkalemia | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.852 | Hyperkalemia_ICD10 | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.853 | Hyperkalemia_SCT | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.854 | Hyperkalemia Conditions | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.855 | Medications_Chronic Hyperkalemia | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.858 | PIM_Alpha_Blockers_2 | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.860 | PIM_Ambulatory_Visits_CPTs | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.862 | PIM_Ambulatory_Visits_SNOMED | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.863 | PIM_Thyroid_Stimulating_Hormone_(TSH) | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.864 | PIM_Triiodothyronine_(T3) | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.865 | PIM_Thyroxine_(T4) | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.866 | PIM_Magnesium_LOINC | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.867 | PIM_BMP_CMP_LOINC | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.868 | PIM_URIC_ACID_LOINC | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.869 | PIM_Migraine_Medications | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.870 | PIM_Triptans | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.871 | ICS_SABA Reliever | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.873 | PIM_Asthma_COPD_Meds | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.874 | PIM_Lipid_Panel_CPTs | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.875 | PIM_Hepatic_Function_Panel_CPTs | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.876 | Alpha Glucosidase Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.877 | Inflammatory bowel disease I10 | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.878 | Inflammatory bowel disease SCT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.879 | Inflammatory bowel disease | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.88 | DEPRECATED Diabetes | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.880 | Gastrointestinal obstruction SCT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.881 | Gastrointestinal obstruction I10 | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.882 | Gastrointestinal obstruction | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.883 | DPP4i Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.884 | Multiple endocrine neoplasia type 2 (MEN II) SCT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.885 | Multiple endocrine neoplasia type 2 (MEN II) I10 | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.886 | Multiple endocrine neoplasia type 2 (MEN II) | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.887 | Gastroparesis SCT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.888 | Gastroparesis I10 | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.889 | Gastroparesis | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.890 | Meglitinide Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.891 | Sulfonylurea Allergy Intolerance | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.892 | Peripheral edema I10 | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.893 | Peripheral edema SCT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.894 | Peripheral edema | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.895 | TZD Allergy Intolerance | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.896 | PIM_Beta_Blockers | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.897 | PIM_CCB_DHPs | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.898 | PIM_Loop_Diuretics | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.899 | PIM_Inhaled_Corticosteroids_(ICS) | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.9 | ACE inhibitors | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.90 | ASCVD I10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.900 | PIM_Leukotrienes | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.901 | OIA_Asthma_COPD_Meds_Inhalers | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.902 | OIA_Asthma_COPD_Meds_Nebulizers | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.903 | OIA_Asthma_COPD_Meds_Oral | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.904 | OIA_GLP1_Injectables | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.905 | OIA_Insulin_Injectables | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.906 | OIA_Oral_Hypoglycemics | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.907 | OIA_DM1_DM2_Meds | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.908 | Medium Dose ICS Formoterol | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.909 | High Dose ICS Formoterol | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.910 | CKD stage5OrESRD I10 | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.911 | CKD stage5OrESRD SCT | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.912 | CKD stage5OrESRD | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.914 | Anxiety_I10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.915 | Anxiety_SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.916 | Anxiety | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.918 | Stress_SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.919 | Stress_I10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.92 | ASCVD | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.920 | Stress | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.921 | PBH_Anxiety_SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.922 | PBH_Depression_SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.923 | PBH_Stress_SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.924 | PBH_Insomnia_SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.925 | PIM_CMP_CPTs | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.926 | Canagliflozin meds | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.927 | Empagliflozin meds | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.928 | Dapagliflozin meds | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.929 | Ertugliflozin meds | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.93 | Albuminuria I10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.930 | Dulaglutide meds | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.931 | Liraglutide meds | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.932 | Semaglutide SC meds | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.933 | T2DM meds benefitting ASCVD | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.934 | T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.935 | T2DM meds benefitting CKD stage 5 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.936 | T2DM meds benefitting HF with eGFR >= 20 mL/min | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.938 | Crohn disease SCT | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.939 | Crohn disease I10 | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.94 | Albuminuria SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.940 | Crohn disease | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.941 | Celiac disease SCT | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.942 | Celiac disease I10 | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.943 | Celiac disease | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.944 | OIA_Bisoprolol | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.945 | OIA_PVD_ICD10 | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.946 | Vibration Controlled Transient Elastography (VCTE) | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.947 | OIA_Antihypertensive_Medications | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.95 | Albuminuria | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.950 | OIA_CAD_ICD10 | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.951 | OIA_DM_ICD10 | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.952 | OIA_Creatinine_Levels_LOINC | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.953 | OIA_DM_SNOMEDCT | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.954 | OIA_CAD_SNOMEDCT | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.955 | OIA_PVD_SNOMEDCT | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.956 | OIA_DM_ICD10_SNOMEDCT | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.957 | OIA_CAD_ICD10_SNOMEDCT | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.958 | OIA_PVD_ICD10_SNOMEDCT | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.959 | ACEi for HFrEF | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.96 | AlcoholicLiverDisease I10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.960 | ARB for HFrEF | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.961 | OIA_AntiHTN_Meds_Inclusion_List | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.962 | OIA_Thiazide_Diuretics | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.963 | OIA_RFs_ACS_ICD10 | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.964 | OIA_RFs_ACS_SNOMED | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.965 | OIA_RFs_ACS__ICD10_SNOMED | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.966 | OIA_Aortic_Calcifications_ICD10 | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.967 | OIA_Aortic_Calcifications_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.968 | OIA_Aortic_Calcifications_ICD10_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.969 | OIA_Microalbumin | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.97 | Sulfonylurea AllergyIntolerance SCT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.970 | OIA_LDL_Cholesterol | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.971 | Pioglitazone | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.972 | MASLD I10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.973 | MASLD SCT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.974 | MASLD | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.975 | OIA_Sulfonylureas | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.976 | Ensifentrine | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.977 | Dupilumab | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.978 | OIA_RFs_ASCVD_ICD10 | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.979 | OIA_RFs_ASCVD_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.98 | BMI LOINC | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.980 | OIA_RFs_ASCVD_ICD10_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.981 | OIA_TIA_ICD10 | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.982 | OIA_TIA_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.983 | OIA_TIA_ICD10_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.984 | OIA_Angina_ICD10 | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.985 | OIA_Angina_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.987 | OIA_Angina_ICD10_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.988 | OIA_Ischemic_Hemorrhagic_Stroke_ICD10 | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.989 | OIA_Ischemic_Hemorrhagic_Stroke_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.99 | BMI SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.990 | OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.991 | OIA_Myocardial_Infarction_ICD10 | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.992 | OIA_Myocardial_Infarction_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.993 | OIA_Myocardial_Infarction_ICD10_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.995 | OIA_PAD_ICD10 | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.996 | OIA_PAD_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.997 | OIA_PAD_ICD10_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.998 | OIA_Coronary_Arterial_Revascularization | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.5 | Contact or Office Visit | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.6 | Contact or Office Visit | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.7 | Contact or Office Visit | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.10 | Nutrition Diagnosis SNOMED CT | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.101 | Hospice Status | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.11 | Nutrition Focused Physical Findings SNOMED CT | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.14 | Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.17 | Pediatric Enteral Formulas SNOMED CT | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.18 | Modified Amino Acid Formulas SNOMED CT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.19 | Nutrition Counseling Approach and Strategies SNOMED CT | active | 2020-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.2 | Food and Nutrient Delivery SNOMED CT | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.20 | Enteral Nutrition Management SNOMED CT | active | 2020-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.21 | Nutrition Assessment | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.24 | Malnutrition Assessment | active | 2015-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.25 | Nutritional Status Severely Malnourished | active | 2016-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.29 | Malnutrition Assessment | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.30 | Malnutrition Risk Screening | active | 2015-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.31 | Malnutrition At Risk | active | 2015-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.32 | Malnutrition Risk Screening | active | 2016-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.33 | Nutrition Assessment Procedure | active | 2015-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.34 | Malnutrition Screening Finding of Not At Risk Result | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.35 | Malnutrition Screening Not at Risk | active | 2015-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.38 | Malnutrition Screening Finding of At Risk Result | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.39 | Malnutrition Risk Screening | active | 2016-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.40 | Malnutrition Risk Screening | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.41 | Nutritional Status Severely Malnourished | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.42 | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.43 | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.44 | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.45 | Nutritional Status Moderately Malnourished | active | 2015-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.46 | Nutritional Status Moderately Malnourished | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.47 | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.48 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.49 | Nutrition Focused Physical Findings Grouping | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.5 | Adult Enteral Formulas SNOMED CT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.50 | Enteral Nutrition Composition SNOMED CT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.51 | Enteral Nutrition Composition Grouping | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.52 | Parenteral Nutrition Management SNOMED CT | active | 2020-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.53 | Malnutrition Diagnosis | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.54 | Malnutrition Diagnosis | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.55 | Malnutrition Diagnosis | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.56 | Malnutrition Diagnosis | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.58 | Nutrition Order Item Grouping | active | 2018-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.59 | Diet Item Grouping | active | 2018-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.60 | Edible Substances | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.61 | Feeding Device SNOMED CT | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.65 | Nutrition Recommendation Grouping | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.7 | Modular Nutrition Formulas SNOMED CT | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.70 | Nutrition Education SNOMED CT | active | 2020-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.71 | Coordination of Care by a Nutrition Professional SNOMED CT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.73 | Nutrition Anthropometric Measurement SNOMED CT | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.74 | Nutrition Anthropometric Measure Panel LOINC | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.75 | Nutrition Anthropometric Measurements Grouping | active | 2018-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.76 | Manage Feeding Environment | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.77 | Special Food Items and Regime/Therapy for Special Food Items SNOMED CT | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.78 | Food and Nutrition Related History LOINC | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.79 | Nutrition Encounter Individual and Group CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.80 | Nutrition Encounters HCPCS | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.81 | Nutrition Encounter Codes Grouping | active | 2018-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.82 | Food and Nutrition Related History Grouping | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.84 | Food and Nutrition Related History SNOMED CT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.85 | Nutrition Diagnosis Grouping | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.87 | Feeding Device Grouping | active | 2018-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.88 | Nutrition Intervention Care Planning | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.89 | Malnutrition Screening Finding of At Risk Result | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.90 | Medical Nutrition Therapy Procedures | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.91 | Dietitian Referral | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.92 | Malnutrition Risk Screening | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.93 | Nutrition Care Plan | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.94 | Malnutrition Screening Finding of At Risk Result | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.95 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.96 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.97 | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.98 | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.99 | Nutrition Diagnosis SNOMED CT (2) | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.1 | Findings Related to Medication Management, Referral Source | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.100 | Recommendations Related to Medication Regimen | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.101 | Interventions Related to Medication Regimen, Initiate Medication | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.102 | Interventions Related to Medication Regimen, Change Medication | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.103 | Interventions Related to Medication Regimen, Change Medication Dose | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.104 | Interventions Related to Medication Regimen, Change Medication Dosage Form | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.105 | Interventions Related to Medication Regimen, Change Medication Course | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.106 | Interventions Related to Medication Regimen, Change Medication Dosing Interval | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.107 | Interventions Related to Medication Regimen, Discontinue Medication | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.109 | Interventions Related to Medication Regimen | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.11 | Interventions Related to Medication Management, Medication Reconciliation | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.110 | Interventions Related to Education, Medications | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.111 | Interventions Related to Education, Medical Equiptment and Devices | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.112 | Interventions Related to Medication Management, Notifications | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.113 | Interventions Related to Medication Management, Refill Synchronization | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.114 | Status of Patient Condition | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.115 | Interventions Related to Education, Diseases and Disorders | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.116 | Interventions Related to Education | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.118 | Interventions Related to Medication Management | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.119 | Interventions Related to Medication Management, Targeted Medication Review | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.120 | Interventions Related to Medication Management, Discussion | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.121 | Reasons for Interventions Related to Medication Management, Cost | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.122 | Interventions Related to Education, Immunizations | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.123 | Status of Recommendations | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.124 | Interventions Related to Medication Management, Provision of Documents | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.125 | Status of Compliance Ability | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.126 | Status of Interventions | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.127 | Status of Disease Control | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.128 | Status of Compliance | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.129 | Occupations of Providers | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.130 | Environments of Care | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.131 | Findings Related to Medication Management, Body Mass Index | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.132 | Findings Related to Medication Management, Alcohol Use | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.133 | Findings Related to Medication Management, Caffeine Use | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.134 | Interventions Related to Education, Diet | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.136 | Findings Related to Medication Management, Exercise | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.137 | Interventions Related to Education, Behavior | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.138 | Findings Related to Medication Management, Diet | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.139 | Status of Care Goal | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.140 | Findings Related to Medication Management, Illicit Drug Use | active | 2020-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.141 | Interventions Related to Administration, Immunizations | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.142 | Interventions Related to Care Coordination, Communication Needs | active | 2020-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.144 | Findings Related to Medication Management, Life Event | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.145 | Interventions Related to Medication Management, Device or Equipment Fitting | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.146 | Findings Related to Medication Management, Immunizations | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.148 | Findings Related to Medication Management, Cultural Beliefs | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.149 | Findings Related to Medication Management, Tobacco Use | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.150 | Interventions Related to Medication Regimen, Continue Medication | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.151 | Encounter Type | active | 2020-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.152 | Encounter Class | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.156 | Allergy/Intolerance Severity | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.16 | Reasons for Interventions Related to Medication Management | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.160 | Allergy/Intolerance Manifestation | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.162 | Allergy/Intolerance Substance & Negation | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.163 | Allergy/Intolerance Negation | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.165 | Interventions Related to Care Coordination, Benefit Management | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.166 | Interventions Related to Administration | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.167 | Interventions Related to Administration, Medications | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.168 | Findings Related to Medication Management, Eating Habits | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.169 | Findings Related to Medication Management, Tobacco Exposure | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.170 | Interventions Related to Care Coordination | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.176 | Interventions Related to Medication Management, Information Gathering | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.177 | Interventions Related to Medication Management, Care Planning | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.178 | Interventions Related to Medication Management, Documentation | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.179 | Allergy/Intolerance Substance, Food | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.180 | Allergy/Intolerance Substance, Environmental | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.181 | PharmacyEncounterReason | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.182 | Encounter Reason | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.183 | Findings Related to Medication Management, Medication related | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.197 | PharmacyAllergies | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.198 | PharmacyInterventions | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.200 | PharmacyReasonsForInterventions | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.201 | PharmacyInterventionStatus | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.202 | PharmacyCareCoordination | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.203 | PharmacyReferralsTo | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.204 | PharmacyGoalStatusOutcome | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.205 | PharmacyTypeOfProfession | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.207 | PharmacyEnvironmentsOfCare | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.208 | PharmacyEncounterType | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.209 | PharmacytEncounterClass | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.211 | PharmacyAllergyIntoleranceType | active | 2018-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.212 | PharmacyAllergyIntoleranceManifestation | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.213 | PharmacyReasonForMedicationChange | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.214 | PharmacyEducation | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.215 | PharmacyEducationStatus | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.216 | PharmacyReferralsFrom | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.218 | Reasons for Interventions Related to Medication Management, Discontinue Medication | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.224 | Social Determinants of Health Problem Observation | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.225 | Laboratory results that are used in medication management | active | 2020-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.227 | Findings Related to Medication Management, Infectious Disease Symptoms | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.229 | COVID19 Related Disease, Test, or Exposure | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.230 | Maternity Health Interventions Value Set | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.231 | Social Determinants of Health Interventions | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.232 | Maternity Health Findings | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.233 | Reason Medication Discontinued Lack of Indication | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.234 | Reason Medication Discontinued Lack of Effectiveness | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.235 | Reason Medication Discontinued Safety Issue Occurred | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.236 | Reason Medication Discontinued Compliance Issue other than cost | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.237 | Recommendation to Resolve Medication Therapy Problem | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.239 | Reason Medication Discontinued Patient Unable to Afford | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.240 | Medication Lists | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.3 | Findings Related to Medication Management, Transitions Between Health Care Settings | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.35 | Interventions Related to Medication Management, Comprehensive Medication Review | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.5 | Reasons for Interventions Related to Medication Management, Unnecessary Therapy | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.53 | Reasons for Interventions Related to Medication Management, Adverse Events | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.55 | Reasons for Interventions Related to Medication Management, Adherence | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.56 | Findings Related to Medication Management, Multiple Providers | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.58 | Findings Related to Medication Management, Chronic Disease Present | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.59 | Findings Related to Medication Management, Taking Medication for Chronic Disease | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.6 | Reasons for Interventions Related to Medication Management, New or Additional Therapy Required | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.60 | Findings Related to Medication Management, Health Literacy | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.61 | Findings Related to Medication Management | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.7 | Reasons for Interventions Related to Medication Management, Ineffective Therapy | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.8 | Reasons for Interventions Related to Medication Management, Dose Too Low | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.83 | Assessments Related to Medication Management, General Assessments | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.84 | Assessments Related to Medication Management | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.85 | Assessments Related to Medication Management, Assessments Using Assessment Scales | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.86 | Interventions Related to Medication Regimen, Monitoring | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.87 | Interventions Related to Care Coordination, Consultations | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.88 | Interventions Related to Care Coordination, Referrals to Other Providers | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.89 | Interventions Related to Care Coordination, Referrals for Specific Services | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.9 | Reasons for Interventions Related to Medication Management, Dose Too High | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.90 | Recommendations Related to Medication Regimen, Continue Medication | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.91 | Recommendations Related to Medication Regimen, Initiate Medication | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.92 | Recommendations Related to Medication Regimen, Change Medication | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.93 | Recommendations Related to Medication Regimen, Change Medication Dose | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.94 | Recommendations Related to Medication Regimen, Change Medication Dosage Form | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.95 | Recommendations Related to Medication Regimen, Change Medication Course | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.97 | Recommendations Related to Medication Regimen, Change Medication Dosing Interval | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.98 | Recommendations Related to Medication Regimen, Discontinue Medication | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.99 | Recommendations Related to Medication Regimen, Monitoring | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.10 | Care Plan Document Type | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.11 | Medication Status | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.12 | Medication Route | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.24 | Extended Pregnancy Status | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.27 | Care Team Member Function (SNOMEDCT) | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.28 | Problem Type (LOINC) | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.29 | Allergy Clinical Status | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.30 | Care Team Member Function | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.33 | External Cause of Injury/Morbidity | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.35 | Arthritis Feedback Types (SNOMED) | active | 2019-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.36 | Arthritis Feedback Types (LOINC) | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.4 | DIRSectionTypeCodes LOINC | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.45 | Bidirectional Services eReferral Type | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.46 | Bidirectional Services eReferral Reason | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.49 | Disability Status Assessment | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.50 | Transport vehicle type | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.53 | Sex | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.54 | Specimen type | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.55 | At Home In Vitro Patient Questions | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.57 | Advance Directives Content Type | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.58 | Acute COVID 19 Diagnosis | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.59 | Medication Adherence SCT | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.1 | Case Management for Behavioral Health | active | 2021-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.63 | Case Management for Behavioral Health | active | 2021-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.64 | Case Management for Behavioral Health | active | 2021-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.10 | Medicare FFS Payer | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.12 | Medicare Advantage Payer | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.101 | Myocardial Infarction | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.124 | Follow Up Within 6 Months | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.125 | Follow Up Within 6 Months | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.126 | Bone Scan | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.127 | Bone Scan | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.15 | Hospice Care Ambulatory | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.175 | Office and Wellness Visits for General Screening | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.176 | Office and Wellness Visits for General Screening | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.177 | Office and Wellness Visits for General Screening | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.178 | Office and Wellness Visits for General Screening | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.179 | Hypertensive disorders in pregnancy | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.180 | Outpatient Prenatal Visit | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.182 | Eclampsia | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.183 | Gestational Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.184 | Preexisting Hypertension in Pregnancy | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.185 | Postpartum Encounter | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.186 | Postpartum Encounter | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.187 | Postpartum Encounter | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.188 | Preexisting Hypertension in Pregnancy | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.189 | Spontaneous or Elective Abortion | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.190 | Spontaneous or Elective Abortion | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.191 | Preeclampsia or Eclampsia | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.192 | Spontaneous or Elective Abortion Procedure | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.193 | Spontaneous or Elective Abortion | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.28 | Non Acute Encounter Codes CPT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.29 | Non Acute Encounter Codes HCPCS | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.31 | Bleeding Event Diagnosis Codes ICD9 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.78 | Statin Associated Muscle Symptoms | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.84 | Statin Associated Muscle Symptoms | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.85 | Statin Associated Muscle Symptoms | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.99 | Underweight | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.11 | Cornual Ectopic Pregnancy | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.12 | Cornual Ectopic Pregnancy | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.13 | Perforation of Uterus | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.14 | Perforation of Uterus | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.15 | Uterine Rupture | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.16 | Uterine Rupture | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.17 | Transabdominal Cerclage | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.18 | Transabdominal Cerclage | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.2 | Transabdominal Cerclage | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.21 | Intravenous or Intraarterial Thrombolytic tPA Therapy Prior to Arrival | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.23 | Intensive Care Unit | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.24 | Uterine Horn | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.25 | Metroplasty | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.3 | Medical Induction of Labor | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.35 | Placenta Previa | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.36 | Placenta Accreta Spectrum Previa or Vasa Previa | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.37 | Placenta Accreta Spectrum Previa or Vasa Previa | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.38 | Outpatient Surgery Service | active | 2019-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.41 | Statin Allergen | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.42 | Statin Allergen | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.50 | Rivaroxaban for VTE Prophylaxis | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.51 | Prasugrel | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.52 | Pharmacological Contraindications For Antithrombotic Therapy | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.53 | Acute Renal Failure | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.54 | Total Parenteral Nutrition | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.55 | Intravenous Thrombolytic tPA Therapy | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.56 | Intraarterial Thrombolytic tPA Therapy | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.57 | Ischemic Stroke Thrombosis | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.58 | Ischemic Stroke Thrombosis | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.59 | Ischemic Stroke Other | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.60 | Ischemic Stroke Other | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.61 | Antithrombotic Therapy Antiplatelet | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62 | Antithrombotic Therapy for Ischemic Stroke | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.63 | Present On Admission is Yes or Exempt | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.64 | Application of Venous Foot Pumps | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.65 | Application of Intermittent Pneumatic Compression Devices | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.66 | Application of Graduated Compression Stockings | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.67 | 20 to 42 Plus Weeks Gestation | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.68 | 37 to 42 Plus Weeks Gestation | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.69 | 37 to 38 Weeks Gestation | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.70 | 20 to 42 Plus Weeks Gestation | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.71 | 20 to 42 Plus Weeks Gestation | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.72 | 37 to 42 Plus Weeks Gestation | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.73 | 37 to 42 Plus Weeks Gestation | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.74 | 37 to 38 Weeks Gestation | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.75 | 37 to 38 Weeks Gestation | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.76 | History of Atrial Ablation | active | 2022-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.77 | Placenta Accreta Spectrum Previa or Vasa Previa | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.78 | Placenta Previa | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.126 | Hospital Settings | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.143 | Observation Services | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.146 | Buprenorphine | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.159 | All Primary and Secondary Cancer | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.161 | All Primary and Secondary Cancer | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.163 | Emergency Department Evaluation | active | 2020-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.164 | Admit Inpatient | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.166 | Codeine Schedule II and III | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.167 | Alfentanil | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.168 | Remifentanil | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.169 | Sufentanil | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.171 | Opioid Use Disorder | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.173 | Sickle Cell Disease with and without Crisis SNOMED | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.174 | Sickle Cell Disease with and without Crisis ICD | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.175 | Sickle Cell Disease with and without Crisis | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.176 | Opioid Medication Assisted Treatment (MAT) HCPCS | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.177 | Opioid Medication Assisted Treatment (MAT) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.178 | Cancer Related Pain ICD 10 | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.179 | Cancer Related Pain SNOMED | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.180 | Cancer Related Pain | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1114.14 | Medication drug class for allergen intolerance SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.10 | Care Experience Preferences at End of Life LOINC | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.11 | Care Experience Preferences Grouping | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.12 | Healthcare Agent Ordinality | active | 2020-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.13 | Healthcare Agent Powers or Limitations Indicator | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.14 | ADIClauseTypeVS | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.15 | Upon Death Preferences | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.17 | Preconditions for Treatment Preferences | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.18 | Treatment Intervention Preferences at End of Life Ordinal LOINC | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.19 | Obligation or Prohibition Instruction Type Grouping | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.2 | InstructionActStatus | active | 2017-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.20 | Advance Healthcare Directive Witness roleCode | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.21 | Witness Categories | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.22 | Advance Directive Document Types | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.23 | AD Conditions and Prognosis Scenarios | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.26 | Healthcare Agent or Advisor Indicator | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.27 | Initial Treatment portable medical order options | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.28 | Cardiopulmonary Resuscitation Order Options | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.30 | Cardiopulmonary Resuscitation Order Procedures | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.31 | Cardiopulmonary Resuscitation Procedures Grouping | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.32 | Additional Portable Medical Order Procedures | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.33 | Initial Treatment Portable Medical Order Procedures Grouping | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.34 | Additional portable medical order Procedures Grouping | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.35 | Medically Assisted Nutrition Order Options | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.36 | Medically Assisted Nutrition Portable Medical Order Procedures Grouping | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.37 | Healthcare Agent Powers | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.38 | Personal Health Goal Options LOINC | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.39 | Personal Health Goal Options Grouping | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.40 | Portable Medical Order Document Types | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.41 | Advance Healthcare Directive Document Types Grouper | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.5 | Advance Directive Content Type SCT | active | 2022-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.6 | Personal Health Goals LOINC | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.7 | Health Goals Grouping | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.8 | Treatment Intervention Preferences at End of Life LOINC | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.9 | Treatment Intervention Preferences Grouping | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.1 | Rituximab Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.100 | Pathological M Stage M1c | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.101 | Pathological N Stage N3 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.102 | N Stage pN1a | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.103 | N Stage pN1b | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.105 | Pathological N Stage pN1mi | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.106 | Pathological N Stage N2b | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.107 | Pathological N Stage N2a | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.108 | Pathological N Stage N2 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.109 | Pathological N Stage N1b | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.110 | Pathological N Stage N1a | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.112 | Pathological N Stage N0 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.114 | Pathological T Stage T4d | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.115 | Pathological T Stage T4c | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.116 | Pathological T Stage T4b | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.117 | Pathological T Stage T4a | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.118 | Pathological T Stage T4 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.120 | N Stage N2C | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.121 | T Stage T3c | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.122 | T Stage T3b | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.123 | T Stage T3a | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.124 | Pathological T Stage T3 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.125 | T Stage T2c | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.126 | T Stage T2b | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.127 | T Stage T2a | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.128 | Pathological T Stage T2 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.129 | Pathological T Stage T1c | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.132 | Pathological T Stage T1b | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.135 | Pathological T Stage T1a | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.136 | Pathological T Stage T1 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.137 | Pathological T Stage T1mic | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.139 | Pathological T Stage T0 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.142 | Cancer Stage III | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.143 | Cancer Stage IIIA | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.144 | Cancer Stage IIIB | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.145 | Cancer Stage IIIC | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.146 | Cancer Stage IV | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.147 | Cancer Stage IVA | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.148 | Cancer Stage IVB | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.149 | Cancer Stage IVC | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.151 | Cisplatin Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.153 | Vinorelbine Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.154 | Gemcitabine Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.155 | Docetaxel | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.156 | Pemetrexed Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.158 | Vinblastine Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.160 | ECOG Performance Status | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.161 | ECOG Performance Status | active | 2020-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.162 | ECOG Performance Status | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.164 | Karnofsky Performance Status | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.165 | Carboplatin Injectable | active | 2020-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.166 | Paclitaxel | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168 | Doxorubicin Injectable | active | 2022-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.169 | Irinotecan Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.179 | Bevacizumab Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.181 | Methotrexate | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.184 | Breast Cancer | active | 2022-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.185 | Breast Cancer | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.191 | Cancer Stage II | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.192 | Cancer Stage IIA | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.193 | Cancer Stage IIB | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.194 | Pertuzumab Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.196 | Ixabepilone Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.197 | Goserelin | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200 | Epirubicin Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.202 | Ramucirumab Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.204 | Letrozole | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.206 | Exemestane | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.209 | Fluorouracil | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.210 | Capecitabine Oral | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222 | Aprepitant Oral | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223 | Fosaprepitant Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.255 | Colorectal Cancer | active | 2021-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.256 | Colorectal Cancer | active | 2021-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.257 | Colorectal Cancer Chemotherapy | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.280 | Cancer Stage IA | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.281 | Cancer Stage IB | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.286 | Cancer Stage IIC | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.291 | Positive Result | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.292 | Negative Result | active | 2015-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.300 | Pathological N Stage N1C | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332 | Daunorubicin Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.336 | Palonosetron Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.341 | External Beam Radiotherapy | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.349 | Metastatic Cancer | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.365 | Hospice Care Referral or Admission | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.439 | T Category | active | 2018-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.440 | N Category | active | 2018-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.441 | M Category | active | 2018-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.442 | TNM Stage Group | active | 2018-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.449 | Opioids | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.492 | Pharmacological interventions for depression | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.535 | Ovarian Cancer | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.536 | Ovarian Cancer | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.537 | Fallopian Tube Cancer | active | 2022-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.539 | Fallopian Tube Cancer | active | 2022-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.541 | Peritoneal Cancer | active | 2022-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.542 | Peritoneal Cancer | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.547 | Cancer Stage 1C | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.555 | Gender Female | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.556 | Gender Male | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.557 | Pathological N Stage N3a | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.558 | Pathological N Stage N3b | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.560 | Rolapitant Oral | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.599 | Obinutuzumab Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.600 | Ofatumumab Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.602 | Neurokinin 1 Receptor Antagonist | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.604 | Serotonin Receptor Antagonist | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.61 | Cetuximab Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.63 | Panitumumab Injectable | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.81 | Palonosetron Oral | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.88 | Lung Cancer | active | 2015-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.89 | Lung Cancer | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.95 | M Stage M0 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.97 | Pathological M Stage M1 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.98 | Pathological M Stage M1a | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.99 | Pathological M Stage M1b | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1121.5 | Most/Moderately Effective Contraceptive Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1121.6 | Most/Moderately Effective Contraceptive SNOMED Findings | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.1 | Schedule IV Benzodiazepines | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.7 | PROMIS Depression Assessment | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.11 | Sleep Apnea | active | 2018-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.12 | Toxic Megacolon in adults | active | 2019-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.13 | Septic Shock due to C. Diff | active | 2019-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.15 | Body Temperature | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.16 | Diarrhea Potentially due to CDI | active | 2019-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.17 | Abdominal Distension | active | 2019-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.18 | Vomiting potentially due to CDI | active | 2019-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.19 | Ileus due to infection | active | 2019-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.20 | Clostridium difficile infection | active | 2019-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.3 | Radiation Therapy Indicators from CPT | active | 2017-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.4 | Diagnostic Radiology Surrounding Face and Sinus | active | 2017-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.5 | Ear Surgery Affecting the Tympanic Membrane | active | 2017-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.6 | Allergic Rhinitis Immunotherapy | active | 2017-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.8 | Radiology to Head and Sinus | active | 2017-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.9 | Immunotherapy For Allergic Rhinitis | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1136.63 | Aortic Dissection or Ruptured Aortic Aneurysm | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.564 | CABG or PCI Procedure | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.565 | CABG or PCI Procedure | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.566 | CABG or PCI Procedure | active | 2018-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.1 | C2S Alcohol Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.11 | C2S Amphetamine Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.12 | C2S Cannabis Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.13 | C2S Cannabis Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.14 | C2S Cannabis Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.15 | C2S Cannabis Use DIsorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.16 | C2S Cocaine Use Disorder | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.17 | C2S Cocaine Use Disorder | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.18 | C2S Cocaine Use Disorder | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.19 | C2S Hallucinogens | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.2 | C2S Alcohol Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.20 | C2S Hallucinogens | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.21 | C2S Hallucinogens | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.22 | C2S Hallucinogens | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.23 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.24 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.25 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.26 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.27 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.28 | C2S Inhalants | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.29 | C2S Inhalants | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.3 | C2S Alcohol Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.30 | C2S Inhalants | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.32 | C2S Mental Health Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.33 | C2S Mental Health Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.34 | C2S Mental Health Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.35 | C2S Mental Health Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.36 | C2S Mental Health Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.38 | C2S Opioids | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.39 | C2S Opioids | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.4 | C2S Alcohol Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.40 | C2S Opioids | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.42 | C2S Opioids | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.43 | C2S Other Psychoactive Substance
Use Disorder | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.44 | C2S Other Psychoactive Substance Use Disorder | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.45 | C2S Other Psychoactive Substance Use Disorder | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.46 | C2S Sedative Hypnotic, or anxiolytic related disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.47 | C2S Sedative Hypnotic, or anxiolytic related disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.48 | C2S Sedative Hypnotic, or anxiolytic related disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.49 | C2S Sexuality and reproductive health information sensitivity | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.5 | C2S Alcohol Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.51 | C2S Tobacco Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.52 | C2S Tobacco Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.53 | C2S Tobacco Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.54 | C2S Tobacco Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.55 | C2S Substance Use Information Sensitivity | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.56 | C2S Substance Use Information Sensitivity | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.58 | C2S Sensitive Categories | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.59 | C2S Opioids | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.6 | C2S Amphetamine Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.60 | C2S HIV/AIDS information Sensitivity | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.65 | Test C2S Alcohol Use Disorders | active | 2019-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.67 | Test C2S HIV/AIDS Information Sensitivity | active | 2019-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.7 | C2S Amphetamine Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.8 | C2S Amphetamine Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.9 | C2S Amphetamine Use Disorders | active | 2016-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.10 | Diphtheria (Tests for Corynebacterium diphtheriae by Culture and Identification Method) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1002 | Tuberculosis (Tests for Mycobacterium species by Culture and Identification Method) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1012 | S. Typhi Infection (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1016 | S. Paratyphi Infection (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1017 | S. Typhi Infection (Tests for S. Typhi by Culture and Identification Method) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1021 | Dark Urine (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1022 | Acute Onset [Qualifier Value] (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1024 | Acute Viral Hepatitis (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1027 | Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1029 | Listeriosis [Listeria species] (Organism or Substance in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1030 | Meningitis [Unspecified Cause] (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1032 | Encephalitis [Unspecified Cause] (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1033 | Encephalitis [Unspecified Cause] (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1035 | Indeterminate or Equivocal Lab Result Value | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1037 | Smoking Status [Current Nonsmoker] (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1040 | Organisms (Tests by Unspecified Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1041 | Organisms (Tests by Culture and Identification) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1044 | Candida auris Infection (Tests for Candida auris by Culture and Identification Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1045 | Candida auris Infection (Tests for Candida auris Nucleic Acid) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1047 | Parkinson’s disease (Disorders) (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1048 | Parkinson’s disease (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1049 | Parkinsonism [Secondary] (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1050 | Parkinsonism [Secondary] (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1053 | Carbidopa Levodopa Combination (RXNORM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1065 | Consciousness [Decreased Level] (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1071 | Drug Use [IV Evidence] (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1072 | Miosis (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1076 | Opioid Overdose and Poisoning (Tests for Opioids [Quantitative]) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1077 | Poisoning or Overdose by Other Opioids (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1078 | Opioid Overdose and Poisoning (Naloxone) (RxNorm) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1083 | Rash [Pustular Vesicular] (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1084 | Salivary Gland Swelling [Unspecified Cause] (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1090 | Syphilis [Congenital] (Disorders) (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1999 | Lymphocytic Choriomeningitis (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2000 | Lymphocytic Choriomeningitis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2001 | Lymphocytic Choriomeningitis (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2002 | Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2003 | Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2004 | Lymphocytic Choriomeningitis (Tests for LCMV Antibody) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2005 | Lymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2006 | Angiostrongyliasis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2007 | Eosinophilic meningitis (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2009 | Angiostrongyliasis (Tests for Angiostrongylus Nucleic Acid) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2010 | Eosinophils [Concentration] (Tests in CSF by Any Method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2011 | Eosinophils [Percentage] (Tests in CSF by Any Method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2012 | Mpox (Tests for mpox virus by Genomic Sequencing) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2013 | Mpox (Test Panels for mpox virus by Genomic Sequencing) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2017 | Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2018 | Interpretation of an Observation (High) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2019 | Interpretation of an Observation (Low) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.202 | Trichinellosis (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2020 | Lymphadenopathy [Acute] (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2023 | Tick Paralysis (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2024 | Bacillary angiomatosis (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2025 | Animal Bite or Scratch [Cat] (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2026 | Animal Bite or Scratch [Cat] (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2027 | Bartonellosis (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2028 | Bartonellosis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2029 | Bartonellosis (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2030 | Bartonella henselae infection (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2031 | Bartonella quintana infection (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2032 | Bartonella bacilliformis infection (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2033 | Bartonella henselae infection (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2034 | Bartonella quintana infection (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2036 | Bartonella henselae (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2037 | Bartonella quintana (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2038 | Bartonella bacilliformis (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2039 | Bartonella quintana infection (Tests for Bartonella quintana Nucleic Acid) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.204 | Giardiasis (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2040 | Bartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2041 | Bartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2042 | Bartonella henselae infection (Tests for Bartonella henselae Nucleic Acid) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2043 | Bartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2044 | Bartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2045 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2046 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2047 | Bartonellosis (Tests for Bartonella spp. Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2048 | Bartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2049 | Bartonella spp. (Tests by Microscopic Observation) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2050 | Bartonellosis (Tests for Bartonella spp. by Culture and Identification Method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2051 | Bartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2052 | Echinococcosis (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2053 | Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2054 | Cystic Echinococcosis (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2055 | Cystic Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2056 | Alveolar Echinococcosis (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2057 | Alveolar Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2058 | Echinococcosis (Tests for Echinococcus species Antibody) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2059 | Echinococcus species (Tests by Microscopic Observation) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2060 | Echinococcosis (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2061 | Genital Warts (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2062 | Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2063 | Genital Warts (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2064 | Diphyllobothriasis (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2065 | Diphyllobothriasis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2066 | Diphyllobothriasis (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2067 | Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2068 | Angiostrongyliasis (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2069 | Pelvic Inflammatory Disease (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2070 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2071 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2072 | Pelvic Inflammatory Disease (Disorders) (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2073 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2074 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2075 | Lower Abdominal Tenderness (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2076 | Lower Abdominal Tenderness (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2077 | Tenderness with motion of the cervix (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2078 | Adnexal Tenderness (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2079 | Uterine Tenderness (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2080 | Leukocytosis (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2081 | Leukocytosis (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2082 | Purulent material in the peritoneal cavity (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2083 | Pelvic Abscess (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2084 | Pelvic Abscess (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2085 | Leukocytes [Concentration] (Tests in Blood by Any Method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2087 | Nongonococcal Urethritis (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2088 | Nongonococcal Urethritis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2089 | Urethritis (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2090 | Urethritis (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2091 | Urethral discharge (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2092 | Urethral discharge (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2093 | Dysuria (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2094 | Dysuria (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2095 | Gonorrhea (Tests for Neisseria gonorrhoeae Antigen) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2096 | Cyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2098 | Rhinitis (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2100 | Rhinitis (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2101 | Pleuritis (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2102 | Pleuritis (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2103 | Gamma Glutamyl Transferase in Serum (Tests for Gamma Glutamyl Transferase in Serum) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2105 | Methemoglobinemia (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2106 | Methemoglobinemia [Non Congenital] (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2107 | Methemoglobinemia (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2108 | Methemoglobinemia [Non Congenital] (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2109 | Methemoglobinemia (Tests for Methemoglobin in Blood [Quantitative]) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2110 | Anencephaly (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2111 | Anencephaly (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2112 | Fetal Anencephaly (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2113 | Fetal Anencephaly (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2114 | Cleft Lip Alone (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2115 | Cleft Lip Alone (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2116 | Fetal Cleft Lip (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2117 | Cleft Palate Alone (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2118 | Cleft Palate Alone (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2119 | Cleft Lip with Cleft Palate (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2120 | Cleft Lip with Cleft Palate (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2121 | Fetal Spina Bifida (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2122 | Spina Bifida (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2123 | Spina Bifida (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2124 | Down Syndrome (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2125 | Down Syndrome (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2126 | Fetal Down Syndrome (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2127 | Fetal Down Syndrome (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2128 | Down Syndrome (Tests for Trisomy 21 Chromosomal Anomaly) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2129 | Bacteremia (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2130 | Bacteremia (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2131 | Gastroschisis (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2132 | Gastroschisis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2133 | Fatal Familial Insomnia (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2134 | Fatal Familial Insomnia (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2135 | Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2136 | Gerstmann Straussler Scheinker Syndrome (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2137 | Prion Disease (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2138 | Prion Disease (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2139 | Prion Disease (Tests for Abnormal PRNP Gene Variant) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2140 | Phenylketonuria (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2141 | Phenylketonuria (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2142 | Linezolid (RXNORM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2143 | Tuberculosis (Pretomanid) (RXNORM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2144 | Tuberculosis (Bedaquiline) (RXNORM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2145 | Tuberculosis [Suspected] (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2146 | Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2147 | Limb Reduction (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2148 | Limb Reduction (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2149 | NU_Influenza (Test Panels for Novel influenza A virus Nucleic Acid) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2150 | Congenital Hearing Loss (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2151 | Congenital Hearing Loss (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2152 | Naegleria fowleri PAM (Test Panels for Naegleria fowleri Nucleic Acid) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2153 | Primary Congenital Hypothyroidism (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2154 | Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2155 | Congenital Hypothyroidism [Unspecified] (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2156 | Thyroid_stimulating hormone (TSH) [Quantitative] (Tests in serum or plasma by any method) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2157 | Mpox (Combination Tests that include mpox virus Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2158 | Orthopox (Combination Tests that include Orthopoxvirus Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2159 | Mpox (Test Panels for mpox virus Nucleic Acid) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.216 | Pertussis (Tests for Bordetella pertussis Antibody [Excluding Pertussis Toxin Antibody]) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2160 | Orthopox (Test Panels for orthopoxvirus Nucleic Acid) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2161 | COVID_19 (Combination Tests that include SARS_CoV_2 Nucleic Acid) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2163 | Dengue Virus Infection [Suspected] (Disorders) (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2164 | Mumps [Suspected] (Disorders) (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2165 | Pertussis [Suspected] (Disorders) (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2166 | Hantavirus Infection (Test Panels for Hantavirus IgM IgG Total Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2167 | Organisms (Tests in Cerebrospinal Fluid by Culture and Identification Method) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2168 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Unspecified Specimen by Culture and Identification) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2169 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Cerebrospinal Fluid by Culture and Identification) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2170 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis in Unspecified Specimen by Culture and Identification) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2171 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis in Unspecified Specimen by Culture and Identification) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2172 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2173 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2174 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2175 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2176 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Unspecified Specimen) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2177 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Unspecified Specimen) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2178 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Antigen in Unspecified Specimen) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2179 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Antigen in Unspecified Specimen) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.218 | Listeriosis (Disorders) (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2180 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Unspecified Specimen by Microscopic Observation) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2181 | Organisms (Tests by Microscopic Observation in Cerebrospinal Fluid) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2183 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2187 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2188 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Cerebrospinal Fluid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2189 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Cerebrospinal Fluid by Microscopic Observation) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2190 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2192 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2193 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Cerebrospinal Fluid) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2194 | Organisms (Combination Tests by Culture and Identification) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2195 | Organisms (Combination Tests for Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2196 | Lung Tissue (Specimen Type) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2197 | Granuloma [Unspecified] (Finding by Microscopic Observation in Lab Results) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2198 | Anaplasmosis (Disorders) (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2199 | NU_Organisms (Tests in Specimen from Wound by Culture and Identification Method | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2200 | Organisms (Tests by Animal Inoculation Method) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2201 | Agricultural Chemical Poisoning [Unspecified Chemical] (Disorders) (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2202 | Abnormal Lung Sounds (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2203 | Abnormal Lung Sounds (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2204 | Anemia [Unspecified Cause] (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2205 | Anemia [Unspecified Cause] (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2206 | Creatinine (Tests in Serum by Any Method) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2207 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Unspecified Specimen) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2208 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Blood) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2209 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Organism or Substance in Lab Results) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2210 | Histopathology or Cytopathology Tests by Microscopic Observation | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2211 | Ehrlichiosis (Tests for Ehrlichia species IgG Antibody) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2212 | Invasive Cronobacter Infection (Organism or Substance in Lab Results) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2213 | Invasive Cronobacter Infection (Tests for Cronobacter species by Culture and Identification Method) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2214 | Necrotizing Enterocolitis (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2215 | Necrotizing Enterocolitis (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2216 | Abscess [Brain] (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2217 | Abscess [Brain] (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2218 | Urinary Tract Infection (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2219 | Urinary Tract Infection (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2220 | Amniotic Fluid (Specimen Type) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2221 | Congenital Cytomegalovirus (Organism or Substance in Lab Results) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2222 | Organisms (Tests in Amniotic Fluid by Culture and Identification Method) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2223 | Congenital Cytomegalovirus (Tests for CMV Antigen by Immunohistochemical Stain) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2224 | Congenital Cytomegalovirus (Tests for CMV Antigen in Tissue by Immunohistochemical Stain) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2225 | Congenital Cytomegalovirus (Tests for CMV in Amniotic Fluid by Culture and Identification Method) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2226 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid in Amniotic Fluid by NAAT) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2227 | Congenital Cytomegalovirus (Tests for CMV Antigen in Whole Blood) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2228 | Congenital Cytomegalovirus (Tests for CMV Antigen) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2229 | Congenital Cytomegalovirus (Tests for CMV by Culture and Identification Method) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2230 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid by NAAT) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2231 | Congenital Cytomegalovirus Infection (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2232 | Congenital Cytomegalovirus Infection (Disorders) (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2233 | Cytomegalovirus Disease (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2234 | Cytomegalovirus Disease (Disorders) (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2235 | Toxoplasmosis (Tests for Toxoplasma gondii Antigen by Immunohistochemical Stain) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2236 | Toxoplasmosis (Tests for Toxoplasma gondii Antigen in Tissue by Immunohistochemical Stain) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2237 | Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2238 | Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody in Blood) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2239 | Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2240 | Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody in Cerebrospinal Fluid) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2241 | Stillbirth (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2242 | Stillbirth (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2243 | Zika Virus Disease (Tests for Zika virus IgM Antibody in Blood or CSF) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2244 | Candida species (Tests by Culture and Identification Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2245 | Organisms (Tests in Extrapulmonary Specimen by Culture and Identification) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2246 | Organisms (Tests for Nucleic Acid in Extrapulmonary Specimen) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2247 | Extrapulmonary [NTM] (Specimen Type) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2248 | Plasmodium species (Tests by Microscopic Observation) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2249 | Baylisascariasis (Tests for Baylisascaris species Antibody in Serum or CSF) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2250 | Lower Respiratory [Excluding Sputum] (Specimen Type) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2251 | Organisms (Tests in Sputum Specimen by Culture and Identification Method) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2252 | Organisms (Tests in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2253 | Organisms (Tests for Nucleic Acid in Lower Respiratory Specimen [Including Sputum]Â ) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2254 | Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2255 | Carbapenem Resistant Bacterial Infection [Carbapenemase Producing] (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2256 | CP_CRE (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2257 | Organisms (Tests in Stool by Culture and Identification Method) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2258 | Loss of Consciousness (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2259 | Neonatal Abstinence Syndrome (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.226 | Lyme Disease (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2260 | Neonatal Abstinence Syndrome (Disorders) (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2261 | High Pitched Cry (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2262 | Inability to Console (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2263 | Inability to Console (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2264 | Hypertonia (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2265 | Hypertonia (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2266 | Tremors (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2267 | Tremors (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2268 | Myoclonus (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2269 | Myoclonus (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.227 | Lyme Disease (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2270 | Poor Sleep (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2271 | Poor Sleep (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2272 | Alterations in Feeding (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2273 | Alterations in Feeding (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2274 | Excoriation (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2275 | Excoriation (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2276 | Sneezing (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2277 | Sneezing (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2278 | Nasal Congestion (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2279 | Nasal Congestion (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2280 | Yawning (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2281 | Cutaneous Mottling (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2282 | Sweating (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2283 | Sweating (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2284 | Feeding Intolerance (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2285 | Feeding Intolerance (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2286 | Respiratory Distress or Nasal Flaring (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2287 | Respiratory Distress or Nasal Flaring (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2288 | In Utero Exposure to Opioids, Benzodiazepines, or Barbiturates (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2289 | In Utero Substance Exposure (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2290 | In Utero Substance Exposure (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2291 | Childbirth (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2292 | Childbirth (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2293 | Opioids, Benzodiazepines, or Barbiturates (Tests by Any Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2294 | NonOpioid, NonBenzodiazepine, and NonBarbiturate Substances (Tests by Any Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2295 | Opioids, Benzodiazepines, or Barbiturates (Organism or Substance in Lab Results) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2296 | NonOpioid, NonBenzodiazepine, or NonBarbiturate Substances (Organism or Substance in Lab Results) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2297 | Exposure or suspected exposure to harmful algae or algae toxins (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2298 | Exposure or suspected exposure to harmful algae or algae toxins (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2299 | Group A Streptococcus (Tests for Group A Strep in Specimen from Normally Sterile Site by Culture and Identification Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2300 | Babesia species (Tests by Microscopic Observation) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2301 | Babesia species (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2302 | Babesia species (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2303 | Organisms (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2304 | Organisms (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2305 | Gram_negative Diplococcus (Organism or Substance in Lab Results) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2306 | Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Culture and Identification Method) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2307 | D_Transposition of the Great Arteries (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2308 | L_Transposition of the Great Arteries (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2309 | Transposition of the Great Arteries [Unspecified] (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2310 | Transposition of the Great Arteries [Unspecified] (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2311 | Interrupted Aortic Arch (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2312 | Interrupted Aortic Arch (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2313 | Coarctation of the Aorta (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2314 | Coarctation of the Aorta (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2315 | Ebstein Anomaly (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2316 | Ebstein Anomaly (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2317 | Pulmonary valve atresia (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2318 | Pulmonary valve atresia (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2319 | Pulmonary valve stenosis (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2320 | Pulmonary valve stenosis (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2321 | Fetal Pulmonary valve stenosis (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2322 | Double Outlet Right Ventricle (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2323 | Double Outlet Right Ventricle (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2324 | Hypoplastic left heart syndrome (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2325 | Hypoplastic left heart syndrome (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2326 | Single Ventricle (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2327 | Single Ventricle (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2328 | Tetralogy of Fallot (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2329 | Tetralogy of Fallot (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2330 | Truncus Arteriosus (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2331 | Truncus Arteriosus (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2332 | Atrioventricular septal defect (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2333 | Atrioventricular septal defect (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2334 | Total Anomalous Pulmonary Venous Connection (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2335 | Total Anomalous Pulmonary Venous Connection (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2336 | Tricuspid valve atresia (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2337 | Tricuspid valve atresia (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2338 | Tricuspid valve stenosis (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2339 | Tricuspid valve stenosis (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2340 | Fetal Tricuspid valve stenosis (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2341 | Exposure to Measles (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2342 | Increased Risk for Exposure to Measles (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2343 | Giardiasis (Tests by Microscopic Observation) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2344 | Diphtheria (Tests for Diphtheria Toxin Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2345 | Lead in Blood (Tests for Lead in Venous Blood) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2346 | Lead in Blood (Tests for Lead in Capillary Blood) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2347 | Opioid Overdose and Poisoning (Test Panels for Opioids) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2348 | Rubella (Test Panels for rubella virus IgM Antibody) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2349 | Consistent with Tuberculosis (Finding in Chest Xray Imaging Results) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2350 | Acute Viral Hepatitis (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2351 | Shigellosis (Combination Tests that include Shigella species by Culture and Identification) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2352 | Acid Fast Bacilli (Tests by Microscopic Observation by Fite Stain) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2353 | Acid Fast Bacilli (Tests by Microscopic Observation in Skin or Unspecified Tissue by Fite Stain) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2354 | Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2355 | Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain in Skin) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2356 | Skin (Specimen Type) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2357 | Organisms (Tests by Microscopic Observation in Skin) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2358 | Unspecified Tissue (Specimen Type) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2359 | Organisms (Tests by Microscopic Observation in Unspecified Tissue) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2360 | S. Paratyphi Infection (Tests for S. Paratyphi by Culture and Identification Method) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2361 | S. Paratyphi Infection (Tests for S. Paratyphi Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2362 | Tuberculosis (Ethambutol) (RXNORM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2363 | Tuberculosis (Isoniazid [INH]) (RXNORM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2364 | Tuberculosis (Pyrazinamide [PZA]) (RXNORM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2365 | Tuberculosis (Rifabutin) (RXNORM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2366 | Tuberculosis (Rifampin) (RXNORM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2367 | Tuberculosis (Rifapentine) (RXNORM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2368 | Perinatal Hepatitis B (Maternal Hepatitis B Virus Infection) (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2369 | Necrotizing Fasciitis (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2370 | Necrotizing Fasciitis (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2371 | Renal Impairment [Acute or Unspecified] (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2372 | Renal Impairment [Acute or Unspecified] (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2373 | Coagulopathy [Unspecified Cause] (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2374 | Coagulopathy [Unspecified Cause] (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2375 | Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2376 | Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2377 | Soft Tissue Necrosis (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2378 | Soft Tissue Necrosis (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2379 | Group A Streptococcus (Tests for Group A Strep in Specimen from Nonsterile Site by Culture and Identification Method) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2380 | Organisms (Tests in Specimen from Nonsterile Site by Culture and Identification) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2381 | Specimen from a Nonsterile Site (Specimen Type) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2382 | Chagas Disease (Tests for Trypanosoma cruzi in specimen from donor) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2383 | Absence of Skin Lesions (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2384 | Neuralgia (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2385 | Neuralgia (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2386 | Peripheral Nerve Thickening (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2387 | Nerve (Specimen Type) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2388 | Hansen’s Disease (Tests for M. leprae or M. lepromatosis Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.239 | Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Nucleic Acid) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.240 | Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Antigen) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2403 | NU_Hepatitis D Virus Infection (Tests for hepatitis D virus Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2404 | Hepatitis D Virus Infection (Tests for hepatitis D virus IgG Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2405 | Hepatitis D Virus Infection (Test for hepatitis D virus Antigen) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2406 | Hepatitis B Virus Infection (Combination Tests that include hepatitis B virus Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2407 | Firearm Injury (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2408 | Firearm Injury (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2409 | Babesiosis (Tests for B. microti IgG or Total Antibody [Titer]) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2410 | Babesiosis (Tests for B. divergens IgG or Total Antibody [Titer]) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2411 | Babesiosis (Tests for B. duncani IgG or Total Antibody [Titer]) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2412 | Babesiosis (Tests for Babesia species IgG or Total Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2413 | Brucellosis (Tests for Brucella species IgG Antibody by ELISA) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2414 | Cranial Nerve Involvement (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2415 | Cranial Nerve Involvement (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2416 | Unusual Change in Behavior (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2417 | Radiculitis (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2418 | Subarachnoid Hemorrhage (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2419 | Subarachnoid Hemorrhage (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2420 | Discitis (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2421 | Discitis (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2423 | Respiratory Insufficiency [Unspecified Cause] (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2424 | Respiratory Insufficiency [Unspecified Cause] (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2425 | Conjunctival Suffusion (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2426 | Leptospira species (Tests by Microscopic Observation) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2427 | Leptospirosis (Tests for Leptospira Antibody by Agglutination) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2428 | Leptospirosis (Tests for Leptospira Antibody by Indirect Immunofluorescence) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2429 | Conjunctival Suffusion (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2430 | Pleural effusion (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2431 | Pleural effusion (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2432 | Abdominal swelling (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2433 | Abdominal swelling (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2434 | Neck swelling (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2435 | Neck swelling (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2436 | Diaphoresis (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2437 | Diaphoresis (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2438 | Edema (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2439 | Edema (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.244 | Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2440 | Anthrax (Tests for Bacillus anthracis Protective Antigen Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2441 | Anthrax (Tests for Bacillus species by Culture and Identification Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2442 | Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2443 | Influenza A (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2444 | Influenza B (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2445 | Influenza [Unspecified] (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2446 | Influenza A (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2447 | Influenza [Unspecified] (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2448 | Influenza (Tests for unspecified influenza virus Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2449 | Influenza (Tests for influenza B virus Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2450 | Influenza (Tests for unspecified influenza virus Antigen) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2451 | Influenza (Tests for influenza B virus Antigen) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2452 | Influenza (unspecified influenza virus in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2453 | Influenza (influenza B virus in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2454 | Influenza (Tests for unspecified influenza virus by Culture and Identification Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2455 | Influenza (Tests for influenza B virus by Culture and Identification Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2456 | Hepatitis B Virus Infection (Tests for Hepatitis B Virus Total Core Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2457 | Hepatitis C Virus Infection (Combination Tests that include hepatitis C virus Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2458 | Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2459 | Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid in Blood) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2460 | Borrelia species (Tests by Microscopic Observation) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2461 | Borrelia species (Tests by Microscopic Observation in Blood) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2462 | Spirochetes (Tests by Microscopic Observation) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2463 | Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2464 | CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2465 | CRE (Tests for Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] by Culture and Identification Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2466 | CRE (Tests for Proteus spp., Providencia spp., and Morganella spp. by Culture and Identification Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2467 | CRE (Tests for Enterobacterales species Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2468 | CRE (Combination Tests that include Enterobacterales by Culture and Identification) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2469 | Tests for Carbapenem Susceptibility [Meropenem and Doripenem] | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2470 | Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] (Organism or Substance in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2471 | Proteus spp., Providencia spp., and Morganella spp. (Organism or Substance in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2473 | Enterobacterales species [Carbapenem Resistant] (Organism or Substance in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2474 | Enterobacterales species [Carbapenemase Producing] (Organism or Substance in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2475 | Aortic valve stenosis (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2476 | Aortic valve stenosis (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2477 | Anotia (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2478 | Microtia (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2479 | Microtia (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2480 | Anotia (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2482 | Anophthalmia (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2483 | Anophthalmia (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2484 | Microphthalmia (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2485 | Microphthalmia (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2486 | Atrial septal defect (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2487 | Atrial septal defect (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2488 | Fetal Aortic valve stenosis (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2489 | Congenital Posterior Urethral Valves (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2490 | Congenital Posterior Urethral Valves (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2491 | Bladder Exstrophy (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2492 | Bladder Exstrophy (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2493 | Encephalocele (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2494 | Fetal Encephalocele (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2495 | Encephalocele (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2496 | Choanal Atresia (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2497 | Choanal Atresia (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2498 | Cloacal Exstrophy (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2499 | Cloacal Exstrophy (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2500 | Renal Agenesis or Hypoplasia (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2501 | Renal Agenesis or Hypoplasia (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2502 | Trisomy 13 (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2503 | Trisomy 13 (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2504 | Fetal Trisomy 13 (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2505 | Trisomy 13 (Tests for Trisomy 13 Chromosomal Anomaly) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2506 | Galactosemia (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2507 | Galactosemia (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2508 | Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative] in Blood) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2509 | Galactosemia (Tests for Galactokinase (GALK) [Quantitative] in Blood) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2510 | Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative] in Blood) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2511 | Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative]) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2512 | Galactosemia (Tests for Galactokinase (GALK) [Quantitative]) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2513 | Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative]) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2514 | Galactosemia (Tests for GALT gene allele 1) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2515 | Galactosemia (Tests for GALT gene allele 2) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2516 | Hypospadias (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2517 | Hypospadias (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2518 | Trisomy 18 (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2519 | Fetal Trisomy 18 (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2520 | Fetal Trisomy 18 (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2521 | Trisomy 18 (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2522 | Trisomy 18 (Tests for Trisomy 18 Chromosomal Anomaly) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2523 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species by Culture and Identification Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2524 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2525 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Antigen) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2526 | Chlamydia trachomatis Infection (Combination Tests that include Chlamydia trachomatis Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2527 | Chlamydia species [Unspecified] (Organism or Substance in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2528 | Ventricular septal defect (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2529 | Ventricular septal defect (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2530 | Gonorrhea (Combination Tests that include Neisseria Gonorrhea Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2531 | Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2532 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2533 | Congenital Cytomegalovirus (Tests for CMV Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.264 | Viral Hemorrhagic Fever (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.265 | Viral Hemorrhagic Fever (Disorders) (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.268 | Mumps (Tests for mumps virus IgM Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.272 | Present or Positive Lab Result Value | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.282 | Varicella (Tests for Varicella zoster virus by Culture and Identification Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.283 | Varicella (Tests for Varicella zoster virus Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.285 | Encephalitis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.287 | Varicella (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.289 | Carbon Monoxide Poisoning (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.293 | Toxic Effects of Lead (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.297 | Measles (Tests for measles virus Nucleic Acid) | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.299 | Measles (Tests for measles virus IgM Antibody) | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.300 | Meningococcal Disease (Organism or Substance in Lab Results) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.301 | Shigellosis (Tests for Shigella species by Culture and Identification Method) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.304 | Pesticide Related Illness (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.305 | Organisms (Tests by Microscopic Observation in Specimen from Normally Sterile Site by Gram Stain) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.307 | Leptospirosis (Tests for Leptospira IgM Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.308 | Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.310 | Bacteria (Tests by Culture and Identification Method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.311 | Viruses (Tests by Culture and Identification Method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.316 | Rubella (Tests for rubella virus IgM Antibody) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.317 | Shigellosis (Tests for Shigella species Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.319 | Fungi (Tests by Culture and Identification Method) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.322 | Pesticide Related Illness (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.326 | Arboviral Disease [Other] (Disorders) (ICD10CM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.329 | Apnea (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.330 | Apnea (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.333 | Shigellosis (Organism or Substance in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.335 | Influenza (Tests for influenza A virus by Culture and Identification Method) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.336 | Influenza (Tests for influenza A or B virus Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.340 | Influenza (influenza A or B virus in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.341 | Campylobacteriosis (Organism or Substance in Lab Results) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.342 | Campylobacteriosis (Tests for Campylobacter species by Culture and Identification Method) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.343 | Campylobacteriosis (Tests for Campylobacter species Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.344 | Campylobacteriosis (Tests for Campylobacter species Antigen) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.349 | Hepatitis A (Tests for hepatitis A virus IgM Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.353 | Diarrhea (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.356 | HIV Infection (Organism or Substance in Lab Results) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.359 | Botulism (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.362 | Hansen’s Disease (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.365 | Silicosis (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.366 | Silicosis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.371 | Cryptosporidiosis (Organism or Substance in Lab Results) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.372 | Cryptosporidiosis (Tests for Cryptosporidium species Nucleic Acid) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.375 | Cyclosporiasis (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.376 | Cyclosporiasis (Tests for Cyclospora cayetanensis Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.379 | Giardiasis (Tests for Giardia species Nucleic Acid) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.384 | Listeriosis (Tests for Listeria monocytogenes Nucleic Acid) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.386 | Vibriosis (Organism or Substance in Lab Results) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.388 | Vibriosis (Tests for Vibrionaceae species [except Toxigenic Vibrio cholera O1 and O139] Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.390 | Trichinellosis (Tests for Trichinella species Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.395 | Syphilis (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.396 | Syphilis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.398 | Hepatitis C Virus Infection (Tests for hepatitis C virus Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.399 | Hepatitis C Virus Infection (Tests for hepatitis C virus Antigen) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.40 | STEC Infection (Disorders) (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.400 | Hepatitis B Virus Infection (Tests for hepatitis B virus IgM Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.401 | Hepatitis B Virus Infection (Tests for hepatitis B virus surface Antigen) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.403 | Hepatitis B Virus Infection (Tests for hepatitis B virus Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.405 | Hantavirus Infection and Diseases (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.407 | Hepatitis C Virus Infection (Tests for hepatitis C virus Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.408 | Hepatitis B Virus Infection (Organism or Substance in Lab Results) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.422 | Tuberculosis (Disorders) (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.427 | STEC Infection (Tests for Shiga toxin genes, or STEC, EHEC, or E. coli O157 Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.43 | Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.436 | Coccidioidomycosis (Tests for Coccidioides species IgM Antibody) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.437 | Coccidioidomycosis (Tests for Coccidioides species Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.438 | Coccidioidomycosis (Tests for Coccidioides species Antigen) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.44 | Gonorrhea [Cervicitis Urethritis] (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.445 | Legionellosis (Tests for Legionella species Antigen) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.446 | Legionellosis (Tests for Legionella species Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.451 | Tuberculosis (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.460 | HIV Infection or AIDS (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.464 | Malaria (Tests for Plasmodium species Nucleic Acid) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.468 | Leptospirosis (Tests for Leptospira Nucleic Acid) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.471 | Leptospirosis (Tests for Leptospira Antibody [Quantitative] by Agglutination) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.472 | Leptospirosis (Tests for Leptospira Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.476 | Babesia species (Tests by Microscopic Observation in Blood) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.478 | Anthrax (Tests for Bacillus anthracis by Culture and Identification Method) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.479 | Anthrax (Tests for Bacillus anthracis Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.48 | Salmonellosis (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.480 | Anthrax (Tests for Bacillus anthracis Antigen) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.481 | Anthrax (Tests for Bacillus anthracis Antibody) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.494 | Ehrlichiosis (Organism or Substance in Lab Results) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.496 | Q Fever (Tests for Coxiella burnetii IgM IgG Antibody [Excluding Quantitative IFA Tests for IgG Antibody against Phase I or II Antigen]) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.500 | Q Fever (Tests for Coxiella burnetii Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.505 | Toxic Shock Syndrome (TSS) (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.507 | Toxic Shock Syndrome (TSS) (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.512 | Brucellosis (Tests for Brucella species Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.515 | Brucellosis (Tests for Brucella species Antibody [Quantitative]) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.516 | Brucellosis (Organism or Substance in Lab Results) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.519 | Dengue Virus Infection (Tests for dengue virus Nucleic Acid) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.523 | Dengue Virus Infection (Tests for dengue virus Antigen) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.524 | Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Quantitative]) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.525 | Dengue Virus Infection (Tests for dengue virus IgM Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.527 | Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Qualitative]) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.530 | Borrelia species (Tests for Nucleic Acid) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.531 | Lyme Disease (Tests for Borrelia burgdorferi IgM IgG Antibody by Immunoblot) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.532 | Lyme Disease (Tests for Borrelia burgdorferi Antibody by Immunoassay) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.534 | Smallpox (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.542 | Spotted Fever Rickettsiosis (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.548 | St. Louis Encephalitis Virus Infection (Tests for Saint Louis encephalitis virus Antibody [Qualitative]) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.550 | Syphilis (Tests for Treponema pallidum Nucleic Acid) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.553 | Anaplasma species (Tests by Microscopic Observation) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.555 | Yellow Fever (Tests for yellow fever virus Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.557 | Yellow Fever (Tests for yellow fever virus Antibody [Quantitative]) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.56 | Diarrhea (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.560 | West Nile Virus Infection (Tests for West Nile virus Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.569 | Plague (Tests for Yersinia pestis Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.575 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.576 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Antigen) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.577 | Arboviral Disease [Other] (Tests for Arbovirus [Other] IgM Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.578 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Quantitative]) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.579 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Qualitative]) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.58 | Pertussis (Tests for Bordetella pertussis Nucleic Acid) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.580 | Arboviral Disease [Other] (Organism or Substance in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.581 | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.584 | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus IgG Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.586 | Viral Hemorrhagic Fever (Organism or Substance in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.595 | Tularemia (Tests for Francisella tularensis Nucleic Acid) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.598 | Tularemia (Tests for Francisella tularensis Antibody) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.6 | Diphtheria (Disorders) (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.605 | Organisms (Tests by Microscopic Observation by Acid Fast Stain) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.606 | Tuberculosis (Organism or Substance in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.614 | Pertussis (Tests for Bordetella pertussis Toxin Antibody) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.621 | Inspiratory Whoop (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.632 | Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.645 | Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.648 | Vomiting (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.650 | Jaundice (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.652 | Bacteria (Tests in Specimen from Normally Sterile Site by Culture and Identification Method) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.660 | Hypertonia [Excluding Congenital Hypertonia] (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.662 | Chest Pain (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.663 | Erythema Nodosum (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.664 | Congenital Zika Syndromes (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.665 | Congenital Zika Syndromes (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.666 | Guillain Barré syndrome (Disorders) (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.668 | Rash (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.671 | Fever (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.672 | Arthralgia (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.673 | Arthralgia (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.674 | Conjunctivitis (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.675 | Conjunctivitis (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.676 | Pregnant (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.677 | Postpartum (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.678 | Postpartum (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.679 | Hearing Loss (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.680 | Abdominal Pain (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.681 | Abdominal Pain (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.686 | Erythema Multiforme (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.687 | Myalgia (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.689 | Periorbital Edema (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.691 | Eosinophilia (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.692 | Eosinophilia (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.70 | Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi by Culture and Identification Method) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.702 | Weight Loss (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.705 | Syphilis (Tests for Treponemal or Non Treponemal Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.709 | Cough [Non Productive] (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.71 | Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi Nucleic Acid) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.711 | Wound Infection (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.712 | Pneumonia (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.713 | Sepsis [Septicemia] [Unspecified Organism] (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.714 | Sepsis [Septicemia] [Unspecified Organism] (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.715 | Meningitis (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.717 | Cellulitis (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.718 | Cellulitis (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.719 | Myositis [Unspecified Cause] (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.720 | Myositis [Unspecified Cause] (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.721 | Otitis Media (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.722 | Otitis Media (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.723 | Otitis Externa (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.724 | Otitis Externa (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.727 | Acute Upper Respiratory Illness (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.728 | HIV Infection (Tests for HIV Nucleic Acid [Qualitative]) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.730 | HIV Infection (Tests for HIV Antibody) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.733 | Perinatal Hepatitis B Virus Infection (Disorders) (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.741 | Hepatitis B Immune Globulin (RXNORM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.744 | Coccidioidomycosis (Tests for Coccidioides species IgG Antibody) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.746 | Treponema pallidum (Tests by Microscopic Observation) | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.747 | Penicillin G [Benzathine] [Injectable] [Bicillin] (RXNORM) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.750 | Chest Pain (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.755 | Acute Upper Respiratory Illness (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.756 | Purpura (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.757 | Muscle Spasms (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.758 | Muscle Spasms (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.762 | Mumps (Test Panels for mumps virus IgM IgG Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.763 | Parotitis [Unspecified Cause] (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.764 | Mumps (Tests for mumps virus IgG Antibody) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.765 | Aseptic Meningitis (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.766 | Encephalitis (Disorders) (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.767 | Hearing Loss (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.770 | Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid in Specimen from Normally Sterile Site) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.773 | Invasive Haemophilus influenzae Disease (Tests for Haemophilus influenzae Nucleic Acid in Specimen from Normally Sterile Site) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.777 | Mastitis (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.779 | Pancreatitis (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.780 | Pancreatitis (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.782 | Rubella (Test Panels for rubella virus IgM IgG Antibody) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.785 | Opioid Overdose and Poisoning (Tests for Opioids [Qualitative]) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.789 | Purpura (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.79 | Campylobacteriosis (Disorders) (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.792 | Novel Influenza A Virus Infection (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.793 | Novel Influenza A Virus Infection (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.794 | Sore Throat (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.795 | Influenza (influenza A virus in Lab Results) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.796 | Influenza (Novel influenza A virus in Lab Results) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.797 | Influenza (Tests for influenza A or B virus by Culture and Identification Method) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.798 | Influenza (Tests for influenza A virus Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.799 | Influenza (Tests for influenza A virus Antigen) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.802 | Influenza (Tests for Novel influenza A virus Nucleic Acid) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.803 | Tests by Microscopic Observation in Tissue by H&E or PAS Stain | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.808 | Headache (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.809 | Headache (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.810 | Backache (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.811 | Backache (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.815 | NU_Anaplasmosis (Tests for Anaplasma species Antibody [Qualitative]) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.816 | Rubella (Tests for rubella virus IgG Antibody [Ratio] in Serum) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.818 | Measles (Tests for measles virus IgG Antibody [Ratio] in Serum) | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.820 | Rubella (Tests for rubella virus IgG Antibody [Quantitative] in Serum) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.822 | Pneumoconiosis (Unspecified) (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.823 | Pneumoconiosis (Unspecified) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.824 | Computerized Tomography of Chest (Imaging) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.830 | Poliovirus Infection (Tests for Poliovirus Antibody Titer in Serum Specimen) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.835 | Lead in Blood (Disorders) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.836 | Lead in Blood (Disorders) (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.839 | Acid Fast Bacilli (Organism or Substance in Lab Results) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.841 | Tuberculosis (Interferon Gamma Release Assays) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.842 | Tests by Microscopic Observation in Tissue | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.844 | Tuberculosis (Second Line Drugs for Treatment) (RXNORM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.846 | SARS (Tests for SARS_CoV by Culture and Identification Method) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.847 | SARS (Tests for SARS_CoV Nucleic Acid) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.86 | Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.864 | Nausea (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.865 | Confusion (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.867 | Dyspnea (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.869 | Loss of Consciousness (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.87 | Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.875 | SARS (Organism or Substance in Lab Results) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.878 | MERS (Tests for MERS_CoV Nucleic Acid) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.88 | Hemolytic Uremic Syndrome (HUS) (Disorders) (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.881 | Difficulty Breathing (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.884 | Tests by Microscopic Observation in Blood | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.889 | Hantavirus Infection (Tests for Hantavirus IgM IgG Total Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.892 | Organisms (Tests by Microscopic Observation in Tissue by Acid Fast Stain) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.895 | Rhinorrhea (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.896 | Tests by Microscopic Observation in Blood Smear | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.897 | Dengue Virus Infection (Test Panels for dengue virus IgM IgG Antibody) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.9 | Xray of Chest (Imaging) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.90 | Cough (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.900 | Organisms (Tests by Microscopic Observation) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.902 | Acute Renal Failure [Unspecified Cause] (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.907 | Arthritis [Unspecified Cause] (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.91 | Cough (SNOMED) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.910 | Epididymitis [Unspecified Cause] (SNOMED) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.911 | Epididymitis [Unspecified Cause] (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.914 | Osteomyelitis [Unspecified Cause] (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.915 | Osteomyelitis [Unspecified Cause] (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.918 | Spondylitis [Unspecified Cause] (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.919 | Arthritis [Unspecified Cause] (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.92 | Thrombotic Thrombocytopenic Purpura (TTP) (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.927 | Thrombocytopenia [Unspecified Cause] (ICD10CM) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.928 | Bleeding [Unspecified Cause] (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.930 | ECG Abnormalities [Unspecified Cause] (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.931 | Hematemesis [Unspecified Cause] (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.932 | Hematemesis [Unspecified Cause] (ICD10CM) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.934 | Hematuria [Unspecified Cause] (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.935 | Hemoptysis (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.937 | Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.942 | Petechiae [Non Traumatic] (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.952 | Thrombocytopenia [Unspecified Cause] (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.956 | Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.957 | Regional Lymphadenitis [Including Bubo] (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.958 | Regional Lymphadenitis (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.96 | Salmonellosis [Salmonella Species and Subspecies] (Organism or Substance in Lab Results) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.963 | Arboviral Disease [Other] (Disorders) (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.965 | Proteinuria [Unspecified Cause] (ICD10CM) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.969 | Proteinuria [Unspecified Cause] (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.970 | Bulbar Weakness (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.971 | Bulbar Weakness (ICD10CM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.976 | Dysphagia (SNOMED) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.978 | Impaired Respiration [Unspecified Cause] (SNOMED) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.979 | Botulism (Organism or Substance in Lab Results) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.98 | Shigellosis (Disorders) (SNOMED) | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.989 | Tests for Mycobacterium species by Culture and Identification Method | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.991 | Rifampin (RXNORM) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.994 | Organisms (Tests for Nucleic Acid) | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.998 | Shigellosis (Tests for Enteroinvasive E. coli Nucleic Acid) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.999 | Chlamydia species (Organism or Substance in Lab Results) | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.109 | Pressure Injury Stage 2, 3, 4 or Unstageable | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.110 | Pressure Injury Stage 2, 3, 4 or Unstageable | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.112 | Pressure Injury Deep Tissue | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.113 | Pressure Injury Stage 2, 3, 4 or Unstageable | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.119 | Inpatient Falls | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.120 | Major Injuries | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.122 | Inpatient Falls | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.125 | Bleeding at Non Critical Site | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.130 | Anticoagulants for VTE Prophylaxis | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.131 | Anticoagulants for Indications Other than VTE Prophylaxis | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.135 | Bleeding at Critical Site | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.143 | Bleeding at Critical Site | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.144 | Bleeding at Critical Site | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.145 | Bleeding at Non Critical Site | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.146 | Bleeding at Non Critical Site | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.160 | Abdominal or Pelvic CT Scan with Contrast | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.163 | Ultrasound of Lower Extremities | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.164 | Ultrasound of Lower Extremities | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.165 | Ultrasound of Lower Extremities | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.171 | Inpatient Falls | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.183 | Anti Factor Xa Assay | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.187 | Extracorporeal Membrane Oxygenation (ECMO) | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.188 | Extracorporeal Membrane Oxygenation (ECMO) | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.190 | Intra Aortic Balloon Pump | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.191 | Intra Aortic Balloon Pump | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.193 | Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.194 | Pressure Injury Deep Tissue Diagnoses | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.196 | Pressure Injury Stage 2, 3, 4, or Unstageable Diagnoses | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.197 | Present on Admission or Clinically Undetermined | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.198 | Not Present On Admission or Documentation Insufficient to Determine | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.1 | DEXA Dual Energy Xray Absorptiometry, Bone Density | active | 2016-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.11 | Bladder Cancer Staging Ta for Urology Care | active | 2016-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.12 | Bladder Cancer staging T1 for Urology Care | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.13 | Bladder Cancer staging Tis for Urology Care | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.15 | Carcinoma of urinary bladder, superficial | active | 2016-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.16 | Injection Leuprolide Acetate | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.17 | High grade bladder cancer Ta for Urology Care | active | 2017-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.18 | Immunocompromised state for Urology Care | active | 2017-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.19 | Systemic chemotherapy for urology care | active | 2017-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.2 | Bladder Cancer in Situ | active | 2016-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.20 | Corticosteroids for patients receiving Urology Care | active | 2017-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.21 | Calcineurin inhibitors for patients receiving Urology Care | active | 2017-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.23 | Immunomodulators for patients undergoing Urology Care | active | 2017-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.24 | Monoclonal antibody for patient undergoing Urology Care | active | 2017-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.28 | Radiotherapy for patients undergoing Urology Care | active | 2017-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.29 | Plasmacytoid cell, morphologic abnormality for urology care | active | 2017-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.3 | Bladder Cancer in Situ | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.30 | Sarcomatoid, morphologic abnormality for Urology Care | active | 2017-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.31 | Micropapillary, morphologic abnormality, for Urology Care | active | 2017-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.32 | Immunosuppressive Drugs for Urology Care | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.38 | DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Care | active | 2017-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.39 | Mixed histology urothelial cell carcinoma for Urology Care | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.4 | BCG Bacillus Calmette Guerin, Tice | active | 2016-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.40 | Cystectomy for Urology Care | active | 2017-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.44 | Unavailability of Bacillus Calmette Guerin for urology care | active | 2017-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.45 | Bladder Cancer for Urology Care | active | 2017-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.48 | Androgen deprivation therapy for Urology Care | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.5 | BCG Bacillus Calmette Guerin, Connaught | active | 2016-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.52 | BCG Bacillus Calmette Guerin for Urology Care | active | 2020-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.53 | Cystectomy for Urology Care | active | 2018-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.54 | Acute Tuberculosis for Urology Care | active | 2018-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.55 | Cystectomy for Urology Care | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.56 | Active Tuberculosis for Urology Care | active | 2018-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.57 | Bladder Cancer Staging Tis for Urology Care | active | 2019-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.58 | Bladder Cancer Staging Tis for Urology Care | active | 2019-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.59 | Hospital Services for Urology | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.6 | Peripheral DXA Scan | active | 2016-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.60 | Chemotherapy Agents for Advanced Cancer | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.8 | Tuberculosis Diagnosis Prior to Urology Care | active | 2016-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.9 | Leukemia Diagnosis Prior to Urology Care | active | 2016-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.13 | Preventative Clinical Encounters | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.14 | Intensive Lifestyle Interventions | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.15 | Intensive Lifestyle Interventions | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.16 | Intensive Lifestyle Interventions | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.17 | Intensive lifestyle interventions | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.21 | Outpatient Clinical Encounters | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.22 | Outpatient Clinical Encounters | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.23 | Outpatient Clinical Encounters | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.24 | Outpatient Clinical Encounters | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.25 | Reason for No Intensive Lifestyle Intervention | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.27 | Type 2 Diabetes Diagnoses | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.28 | Type 2 Diabetes Diagnoses | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.29 | Type 2 Diabetes Diagnoses | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.30 | Prediabetes HbA1c Tests | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.31 | Prediabetes HbA1c Tests | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.32 | Prediabetes HbA1c Tests | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.33 | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.34 | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.35 | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.36 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.37 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.38 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.4 | Glycemic Screening Tests | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.40 | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.41 | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.42 | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.43 | Analgesics for Acute Pain | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.49 | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.5 | Glycemic Screening Tests | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.52 | Remote Physiologic Blood Pressure Monitoring | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.57 | Aldosterone Receptor Blocker for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.58 | Alpha Blocker for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.59 | Angiotensin Converting Enzyme Inhibitor for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.6 | Glycemic Screening Tests | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.60 | Angiotensin II Receptor Blocker for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.61 | Beta Blocker for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.62 | Calcium Channel Blocker Dihydropyridine for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.63 | Calcium Channel Blocker Non Dihydropyridine for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.64 | Central Acting for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.65 | Direct Renin Inhibitor for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.66 | Loop Diuretic for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.67 | Neuronal Blocking Agent for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.68 | Potassium Sparing Diuretic for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.69 | Thiazide Diuretic for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.7 | Preventative Clinical Encounters | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.70 | Vasodilator for Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.73 | Analgesics for Acute Pain (Non Parenteral Route) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.74 | Analgesics for Acute Pain (Parenteral Route) | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.75 | Analgesics for Acute Pain Non Oral Enteral/Mucosal Routes | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.77 | Antihypertensive Medication Classes | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.78 | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.79 | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.8 | Preventative Clinical Encounters | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.84 | Renal Colic | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.85 | Renal Colic | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.86 | Renal Colic | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.88 | Direct LDL Cholesterol | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.89 | Calculated LDL Cholesterol | active | 2025-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.9 | Preventative Clinical Encounters | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.50 | Urinary retention | active | 2017-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.51 | Urinary retention | active | 2017-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.52 | Urinary retention | active | 2017-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.65 | Morbid Obesity | active | 2018-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.66 | Morbid Obesity | active | 2018-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.67 | Morbid Obesity | active | 2018-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.68 | BMI greater than 40 | active | 2019-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.69 | Morbid Obesity | active | 2019-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.1 | Pregnancy Status | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.10 | Pap Smear Tests | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.103 | Female Sterilization HCPCS Devices | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.105 | Female Sterilization ICD10CM Provision Encounters | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.109 | Sterilization SNOMED Findings | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.11 | HIV Tests | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.110 | Pregnancy Bundle Visits | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.111 | Prenatal Care Specific Visits CPT | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.112 | Prenatal Care Specific Visits HCPCS | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.113 | Prenatal Care Specific Visits SNOMED | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.114 | Prenatal Care Specific Visits | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.115 | Self Identified Need for Contraception (SINC) | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.117 | Syphilis Tests | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.118 | Infecund Not for Contraceptive Reasons CPT Procedures | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.119 | Infecund Not for Contraceptive Reasons HCPCS Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.12 | Human Papilloma Virus Tests | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.120 | Prenatal Care Visits CPT | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.121 | Prenatal Care Visits HCPCS | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.122 | Prenatal Care Visits SNOMED | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.123 | Pregnancy Related Diagnoses ICD10CM | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.124 | Pregnancy Related Diagnoses SNOMED | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.125 | Non Live Birth Diagnoses ICD10CM | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.126 | Non Live Birth Diagnoses SNOMED | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.127 | Non Live Birth CPT Procedures | active | 2022-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.128 | Non Live Birth ICD10PCS Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.129 | Contraceptive Ring RXNORM Medications | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.13 | Chlamydia Trachomatis Tests | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.130 | Contraceptive Implants RXNORM Medications | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.131 | Injectable Contraceptive RXNORM Medications | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.132 | Oral Contraceptive Pills RXNORM Medications | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.133 | Pregnancy Related Diagnoses | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.134 | Female Sterilization SNOMED Provision Procedures | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.135 | General Prenatal Care Visits | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.136 | Non Live Birth Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.137 | Non Live Birth Diagnoses | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.138 | IUD Surveillance | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.139 | IUD Provision Procedures | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.14 | Neisseria Gonorrhoeae Tests | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.140 | IUD Devices | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.141 | Contraceptive Patch SNOMED Devices | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.142 | Female Sterilization Provision Procedures | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.143 | Live Birth Delivery CPT Procedures | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.144 | Contraceptive Patch SNOMED Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.145 | Contraceptive Patch SNOMED Findings | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.146 | Contraceptive Patch ICD10CM Provision Encounters | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.147 | Contraceptive Patch ICD10CM Surveillance | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.148 | Live Birth Delivery ICD10PCS Procedures | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.149 | Contraceptive Patch HCPCS Devices | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.15 | Chlamydia trachomatis and Neisseria Gonorrhoeae combined Tests | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.150 | Contraceptive Patch LOINC | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.151 | Infecund Not for Contraceptive Reasons Procedures | active | 2022-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.152 | Live Birth Delivery Procedures SNOMED CT | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.153 | Contraceptive Ring SNOMED Surveillance Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.154 | Contraceptive Ring SNOMED Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.155 | Contraceptive Ring SNOMED Findings | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.156 | Contraceptive Ring ICD10CM Provision Encounters | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.157 | Contraceptive Ring ICD10CM Surveillance | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.159 | Contraceptive Ring HCPCS Devices | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.160 | Contraceptive Ring LOINC | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.161 | Contraceptive Implant SNOMED Devices | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.162 | Contraceptive Implant ICD10PCS Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.163 | Contraceptive Implant SNOMED Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.164 | Contraceptive Implant SNOMED Findings | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.165 | Infecund Not for Contraceptive Reasons SNOMED Procedures | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.167 | Contraceptive Implant LOINC | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.168 | Pregnancy Bundle CPT | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.169 | Pregnancy Bundle HCPCS | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.17 | Contraceptive Type | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.170 | Contraceptive Implant ICD10CM Provision Encounters | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.171 | Contraceptive Implant ICD10CM Surveillance | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.173 | Contraceptive Implant HCPCS Devices | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.174 | Contraceptive Patch Devices | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.177 | Live Birth Delivery Procedures | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.178 | Contraceptive Ring Surveillance | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.18 | Contraception Not Used Reason | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.180 | Contraceptive Implant CPT Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.181 | Injectable Contraceptive SNOMED Surveillance Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.182 | Injectable Contraceptive SNOMED Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.183 | Injectable Contraceptive SNOMED Findings | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.185 | Injectable Contraceptive ICD10CM Provision Encounters | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.186 | Injectable Contraceptive ICD10CM Surveillance | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.187 | Injectable Contraceptive HCPCS Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.188 | Injectable Contraceptive LOINC | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.189 | Oral Contraceptive Pill SNOMED Surveillance Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.190 | Oral Contraceptive Pill SNOMED Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.191 | Oral Contraceptive Pill SNOMED Findings | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.192 | Contraceptive Implant SNOMED Surveillance Procedures | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.193 | Oral Contraceptive Pill ICD10CM Provision Encounters | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.194 | Oral Contraceptive Pill ICD10CM Surveillance | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.195 | Oral Contraceptive Pill HCPCS Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.196 | Oral Contraceptive Pill LOINC | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.197 | Injectable Contraceptive Provision Procedures | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.198 | Injectable Contraceptive Surveillance | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.199 | Oral Contraceptive Pill Provision Procedures | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.200 | Oral Contraceptive Pill Surveillance | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.201 | Contraceptive Implant Devices | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.202 | Contraceptive Implant Provision Procedures | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.203 | Contraceptive Implant Surveillance | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.204 | Prenatal Care Bundle CPT | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.205 | Prenatal Care Bundle Visits | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.206 | Infecund Not for Contraceptive Reasons ICD10PCS Procedures | active | 2022-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.209 | Yes and No Answers | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.21 | Contraceptive Provision Method | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.210 | Pap Smear Results | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.211 | Contraceptive discussion | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.22 | Pregnancy Intention | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.24 | Clinical Provider Role | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.29 | Insurance Coverage Type | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.3 | Organism Detection | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.31 | English Proficiency | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.76 | Contraceptive Patch RXNORM Medications | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.78 | Intrauterine Devices CPT Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.79 | Intrauterine Devices HCPCS Devices | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.80 | Intrauterine Devices LOINC | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.81 | Intrauterine Devices HCPCS Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.83 | Intrauterine Devices ICD10CM Provision Encounters | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.84 | Intrauterine Devices ICD10CM Surveillance | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.85 | Intrauterine Devices RXNORM Medications | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.86 | Intrauterine Devices SNOMED Devices | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.87 | Intrauterine Devices SNOMED Findings | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.88 | Intrauterine Device SNOMED Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.89 | Intrauterine Devices SNOMED Surveillance Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.91 | Intrauterine Devices ICD10PCS Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.93 | Female Sterilization CPT Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.96 | Infecund Not for Contraceptive Reasons SNOMED Findings | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.97 | Infecund Not for Contraceptive Reasons ICD10CM | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.98 | Female Sterilization LOINC | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.99 | Female Sterilization ICD10PCS Provision Procedures | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.10 | ASN Screening Declined | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.11 | Transportation Insecurity Diagnosis | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.12 | Food Insecurity Diagnosis | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.13 | Homelessness Diagnosis | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.14 | Housing Instability Diagnosis | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.15 | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.16 | Intervention for Positive Food Insecurity Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.17 | Intervention for Positive Food Insecurity Screen | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.18 | Intervention for Positive Food Insecurity Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.19 | Intervention for Positive Food Insecurity Screen | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.2 | Intracranial or Intraspinal surgery | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.20 | Intervention for Positive Homelessness Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.21 | Intervention for Positive Housing Instability Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.22 | Emergency Department Observation | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.27 | Mental Health Diagnosis without Substance Use Disorders | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.28 | Mental Health Diagnosis without Substance Use Disorders | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.29 | Bed Assigned | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.3 | Malignant Intracranial Neoplasm Group | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.31 | Healthcare Agent & Power of Attorney Documentation | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.32 | Healthcare Agent and Power of Attorney Documentation | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.33 | Advance Directive Documentation | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.34 | Advance Directive Documentation | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.35 | Advance Directive Documentation | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.36 | Portable Medical Order(s) Documentation | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.37 | Portable Medical Order(s) Documentation | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.38 | Advance Care Planning Discussion Documentation | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.4 | Thrombolytic medications | active | 2021-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.40 | Advance Care Planning Documentation | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.41 | Advance Care Planning Documentation | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.42 | Healthcare Agent & Power of Attorney Documentation | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.43 | Advance Directive Documentation | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.45 | Advance Care Planning Documentation | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.46 | Advance Care Planning Documentation | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.47 | Portable Medical Order(s) Documentation | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.48 | Portable Medical Order(s) Documentation | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.49 | Intervention for Positive Utility Insecurity Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.5 | Allergy to thrombolytics | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.50 | Intervention for Positive Utility Insecurity Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.51 | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.52 | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.53 | Intervention for Positive Housing Instability Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.54 | Intervention for Positive Housing Instability Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.55 | Intervention for Positive Homelessness Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.56 | Intervention for Positive Homelessness Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.57 | Non Invasive Oxygen Therapy Device Codes | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.58 | Goals, preferences, and priorities for medical treatment | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.6 | Thrombolytics Adverse Event | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.7 | Intraspinal surgery | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.8 | Intervention for Positive Utility Insecurity Screen | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.9 | Utility Insecurity Diagnosis | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1176.58 | Food Insecurity Screening Positive | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.1 | Ezetimibe Therapy | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.10 | Antihypertensive Medications | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.100 | Allergy or Intolerance to ACE Medication | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.101 | Allergy or Intolerance to ARB Medication | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.102 | Chronic Kidney Disease Stage 1 | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.103 | Chronic Kidney Disease Stage 2 | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.104 | Chronic Kidney Disease Stage 3 | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.105 | Chronic Kidney Disease Stage 4 | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.106 | Chronic Kidney Disease Stage 5 | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.107 | ICD10 CM Chronic Kidney Disease Stage 1 | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.108 | ICD10 CM Chronic Kidney Disease Stage 2 | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.111 | AHA GWTG Chronic Kidney Disease Stage 2 | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.112 | ICD10 CM Chronic Kidney Disease Stage 3 | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.113 | ICD10 CM Chronic Kidney Disease Stage 4 | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.114 | ICD10 CM Chronic Kidney Disease Stage 5 | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.115 | AHA GWTG Chronic Kidney Disease Stage 1 | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.116 | AHA GWTG Chronic Kidney Disease Stage 3 | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.117 | AHA GWTG Chronic Kidney Disease Stage 4 | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.118 | SNOMED CT Atrial Fibrillation | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.119 | ICD10 CM Atrial Fibrillation | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.121 | AHA GWTG Atrial Fibrillation | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.123 | SNOMED CT Hyperlipidemia | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.124 | ICD10 CM Hyperlipidemia | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.125 | AHA GWTG Hyperlipidemia | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.126 | SNOMED CT Hypertriglyceridemia | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.127 | ICD10 CM Hypertriglyceridemia | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.129 | AHA GWTG Hypertriglyceridemia | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.130 | SNOMED CT Gestational Diabetes | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.131 | ICD10 CM Gestational Diabetes | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.132 | AHA GWTG Gestational Diabetes | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.133 | SNOMED CT Hyperglycemia | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.134 | ICD10 CM Hyperglycemia | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.135 | AHA GWTG Hyperglycemia | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.136 | SNOMED CT Nonobstructive CAD | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.137 | ICD10 CM Nonobstructive Coronary Artery Disease | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.138 | AHA GWTG Nonobstructive coronary artery disease | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.139 | AHA GWTG Anti Obesity Pharmacotherapy | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.15 | Non Tobacco Smoking Product User | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.16 | Antihypertensive Fixed Dose Combination Medications | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.2 | PCSK9 Inhibitors | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.20 | CCB and Thiazide and Thiazide Like Diuretics | active | 2021-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.21 | Referral to cardiac rehab | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.22 | Cardiac Rehabilitation | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.25 | 2 Hour Blood Glucose Test | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.26 | NYHA Functional Classification | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.27 | ARNI Therapy | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.29 | MRA Therapy | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.3 | Cholesterol non HDL Laboratory Test | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.30 | SGLT2 Inhibitors | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.31 | Heart Transplant | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.32 | Heart Transplant | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.33 | Heart Transplant | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.34 | Allergy to MRA Therapy | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.35 | Aspirin or Clopidogrel | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.39 | Cardiac Rehabilitation | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.4 | Hypothyroidism | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.40 | Cardiac Rehabilitation | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.43 | SGLT2 Ingredients | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.44 | MRA Ingredients | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.49 | Minnesota Living with Heart Failure Questionnaire | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.5 | Hypothyroidism | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.50 | Kansas City Cardiomyopathy Questionnaire | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.51 | Cardiac Pacer | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.52 | Cardiac Pacer | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.53 | Cardiac Pacer | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.54 | Heart Transplant Complications | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.55 | Heart Transplant Complications | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.56 | Heart Transplant Complications | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.57 | Left Ventricular Assist Device Complications | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.58 | Left Ventricular Assist Device Complications | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.59 | Left Ventricular Assist Device Placement | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.6 | Hypothyroidism | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.60 | Left Ventricular Assist Device Placement | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.61 | Left Ventricular Assist Device Placement | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.62 | Left Ventricular Assist Device Placement | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.63 | Heart Transplant | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.65 | Cardiac Pacer | active | 2022-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.66 | Diastolic Heart Failure | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.67 | Diastolic Heart Failure | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.68 | Diastolic Heart Failure | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.69 | Allergy to SGLT2 Inhibitors | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.7 | Anorexia Nervosa | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.70 | Intolerance to SGLT2 Inhibitors | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.71 | Intolerance to MRA Therapy | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.72 | ARNI Ingredient | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.73 | Mitral Stenosis | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.74 | Mitral Stenosis | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.75 | Mitral Stenosis | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.76 | Mechanical Prosthetic Heart Valve | active | 2022-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.77 | Mechanical Prosthetic Heart Valve | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.78 | Mechanical Prosthetic Heart Valve | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.79 | Mechanical Prosthetic Heart Valve in Situ | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.8 | Anorexia Nervosa | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.82 | Systolic Heart Failure | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.83 | Systolic Heart Failure | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.84 | Systolic Heart Failure | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.85 | Carotid Intervention | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.86 | Serum Creatinine | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.87 | Urine Creatinine | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.88 | Urine Albumin | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.9 | Anorexia Nervosa | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.90 | Non Steroidal Mineralcorticoid Receptor Antagonist | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.91 | Glucagon like peptide 1 medications | active | 2024-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.96 | AHA GWTG Long COVID19 | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.97 | AHA GWTG Long COVID19 SNOMEDCT | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.98 | AHA GWTG Long COVID19 ICD10CM | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.1 | Wound internal item and/or body structure visible value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.11 | Wound exudate appearance value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.12 | Wound exudate color value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.13 | Exudate odor value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.14 | Wound anatomic location value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.16 | Skin temperature value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.17 | Skin color enumerated value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.18 | Skin turgor value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.19 | Skin and mucous membrane integrity value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.2 | Periwound condition value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.20 | Skin moisture value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.3 | Wound Type Etiology value set | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.4 | Wound episode value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.6 | Wound bed appearance value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.60 | Wound type reference set | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.7 | Wound bed color value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.74 | Nonverbal pain indicators reference set | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.76 | Pain associated signs and symptoms reference set | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.77 | Pain body location reference set | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.8 | Wound edge description value set (foundation metadata concept) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.80 | Pain quality reference set | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.81 | Pain speed of onset reference set | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.9 | Presence absence value set (foundation metadata concept) | active | 2018-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.1 | Common drug substances for allergy and intolerance documentation | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.2 | Common drug classes for allergy and intolerance documentation | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.3 | Common dietary substances for allergy and intolerance documentation | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.4 | Common environmental substances for allergy and intolerance documentation | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.5 | Common refutations for substance causes for allergy and intolerance documentation | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.7 | Common substances for allergy and intolerance documentation | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.8 | Common substances for allergy and intolerance documentation including refutations | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.10 | NHSNCriterionOfDiagnosisCode(CDCNHSN) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.11 | NHSNCriterionOfDiagnosisCode(SNOMEDCT) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.12 | NHSNInfectionConditionCode(CDCNHSN) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.13 | NHSNInfectionConditionCode(SNOMEDCT) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.14 | NHSNInfectionTypeCode(CDCNHSN) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.15 | NHSNInfectionTypeCode(SNOMEDCT) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.16 | NHSNInfectionFirstReportedSource(CDCNHSN) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.17 | NHSNInfectionFirstReportedSource(SNOMEDCT) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.18 | NHSNLOS/MENDischargeDisposition(CDCNHSN) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.19 | NHSNLOS/MENDischargeDisposition(SNOMEDCT) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.20 | NHSNPopulationSummaryReportTypeCode(CDCNHSN) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.21 | NHSNPopulationSummaryReportTypeCode(LOINC) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.22 | NHSNSameDayOutcomeMeasure(CDCNHSN) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.23 | NHSNSameDayOutcomeMeasure(SNOMEDCT) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.24 | NHSNSignificantPathogenCode(CDCNHSN) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.25 | NHSNSignificantPathogenCode(SNOMEDCT) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.26 | NHSNSpinalFusionApproachCode(CDCNHSN) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.27 | NHSNSpinalFusionApproachCode(SNOMEDCT) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.28 | NHSNVascularAccessTypeCode(CDCNHSN) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.29 | NHSNVascularAccessTypeCode(SNOMEDCT) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.30 | NHSNVascularSpecimenCollectionSite(CDCNHSN) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.31 | NHSNVascularSpecimenCollectionSite(SNOMEDCT) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.38 | Blood Glucose Laboratory and Point of Care Tests | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.58 | Diabetes Medications | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.6 | NHSNPathogenCodeARO | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.62 | Lab Tests for Clostridioides difficile | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.63 | Bacterial and Fungal Blood Culture Tests | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.7 | NHSNRoleOfPerformerCode(CDCNHSN) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.74 | Enteral Medication Route | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.75 | Intravenous Medication Route | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.76 | Fidaxomicin | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.77 | Vancomycin | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.78 | Metronidazole | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.79 | Fidaxomicin, Vancomycin, and Metronidazole | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.8 | NHSNRoleOfPerformerCode(SNOMEDCT) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.85 | Baloxavir | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.86 | Peramivir | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.87 | Zanamivir | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.88 | Digestive, Intramuscular, Intravenous Route of Administration | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.89 | Maternal Diagnoses | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.9 | NHSNRoleOfPerformerCode(HealthCareProviderTaxonomy) | active | 2020-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.90 | NHSN LTC AU Antimicrobial Agents | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.91 | Long Term Care Discharge Disposition | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.94 | NHSNNeurogenicBladder | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.95 | NHSNSpinalCordInjury | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1139 | S4G Hyperlipidemia | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1291 | S4G Cardiomyopathy | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1292 | S4G Tricuspid valve disorder | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1293 | S4G Pompe disease | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1294 | S4G Malignant hyperthermia | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1295 | S4G Malignancy | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1297 | S4G Intestinal polyp | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1298 | S4G Hamartoma | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1299 | S4G Diabetes mellitus | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1300 | S4G Muscular dystrophy and weakness | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1325 | S4G Hamartoma and S4G Intestinal Polyp | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1326 | S4G Malignancy and S4G Intestinal Polyp | active | 2022-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1344 | Tests for Neisseria gonorrhoeae of unspecified site reported by presence | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1352 | Body weight | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1354 | Cefixime preparations for oral administration | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1358 | Beta lactam medicinal product SNOMED | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1370 | Beta lactam ingredients for allergy determination RXNORM | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.147 | SCIP Major Surgical Procedure | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.158 | Multiple Myeloma Regimen Drugs | active | 2019-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.226 | Opioids, All | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3483 | Financial Insecurity Screening Assessments Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3484 | Food Insecurity Screening Assessments Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3485 | Health Literacy Screening Assessments Questions | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3486 | Homelessness Screening Assessments Questions | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3487 | Housing Instability Screening Assessments Questions | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3488 | Less Than High School Education Screening Assessments Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3519 | Health Insurance Coverage Status Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3520 | Inadequate Housing Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.393 | Hypoglycemics Severe Hypoglycemia | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.394 | Hypoglycemics Treatment Medications | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4436 | Gentamicin medications | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4437 | Azithromycin medications | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4448 | Lidocaine | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4466 | Pharyngeal specimens | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4467 | Urogenital & Anorectal Specimens | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4469 | Cabotegravir Injectable Products | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4470 | Emtricitabine oral for HIV PrEP | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4474 | HIV Laboratory Based Tests | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4502 | Ceftriaxone all code types | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.491 | Medium Dose ICS Formoterol Preparations | active | 2021-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.495 | ICS LABA LAMA Preparations | active | 2021-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.788 | Social Determinants of Health Conditions | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.789 | Social Determinants of Health Procedures | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.790 | Social Determinants of Health Service Requests | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.93 | CPIC RxNORM abacavir SCDG | active | 2019-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.94 | CPIC RxNORM allopurinol SCDG | active | 2019-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.95 | CPIC RxNORM amitriptyline SCDG | active | 2019-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.96 | CPIC RxNORM atazanavir SCDG | active | 2019-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.97 | CPIC RxNORM atomoxetine SCDG | active | 2019-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.99 | CPIC RxNORM capecitabine SCDG | active | 2019-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.1 | Mechanical Complications Related To Hip and Knee Procedures | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.10 | Surgical Site Bleeding and Other Surgical Site Complications | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.11 | Procedures Resulted From Surgical Site Bleeding and Other Surgical Site Complications | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.12 | Opioid (Oral Tablets and Patches only) | active | 2019-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.13 | Comorbidity Risk Factors | active | 2020-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.14 | Treatment of Hemorrhage or Hematoma | active | 2020-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.15 | General Surgery | active | 2020-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.17 | Coagulation Disorder Conditions | active | 2020-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.18 | Acute Respiratory Failure | active | 2020-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.19 | Anticoagulant Medications | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.2 | Fracture Exclusions For Hip And Knee Procedures | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.20 | Anticoagulant Medications, Oral | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.21 | Anticoagulant Medications, Injection | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.28 | Active Bleeding | active | 2020-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.29 | Fall Risk Increasing Drugs (FRIDs) | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.3 | Pulmonary Embolism Complications Related To Hip and Knee Procedures | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.30 | Fall Risk Factors | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.32 | Total Hip Arthroplasty Surgery | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.33 | Total Knee Arthroplasty Surgery | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.34 | AbnormalityOfGaitAndMobility | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.35 | Assymetry Symptoms | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.36 | Hemiplegia Symptoms | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.37 | Leg Weakness Symptoms | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.38 | Osteopenia Symptoms | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.39 | Stroke Symptoms | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.4 | Sepsis Complications Related To Hip and Knee Procedures | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.40 | Vestibular Symptoms | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.41 | TricyclicAntidepressants | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.42 | Benzodiazepines | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.43 | LoopDiuretics | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.44 | Antiepileptics | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.45 | Antipsychotics | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.46 | Opioid Medications | active | 2021-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.47 | Imaging Related to VTE | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.48 | Anticoagulant Medication | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.49 | VTE Diagnoses | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.5 | Nonprimary Total Hip, Total Knee Replacement | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.50 | Bisphosphonate Therapy | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.51 | VTE Symptoms | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.52 | Oncology Critical Care Units | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.53 | Provider Types | active | 2022-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.56 | FOBT_Lab | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.57 | Colorectal Screening | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.58 | Screening Mammogram (CPT) | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.59 | Screening Mammogram (LOINC) | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.6 | Pneumonia Complications Related To Hip and Knee Procedures | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.60 | Screening Mammogram (SNOMEDCT) | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.61 | Screening Mammogram (Grouping) | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.62 | Diagnostic Mammography (CPT) | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.63 | Diagnostic Mammography (LOINC) | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.64 | Diagnostic Mammography (SNOMEDCT) | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.65 | Diagnostic Mammography | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.66 | Breast Cancer Biopsy and Surgical Excision | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.67 | BI_RADS Categories 0, 4, and 5 | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.68 | BI_RADS Categories 1, 2, and 3 | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.7 | Malignant Neoplasm Complications Related To Hip and Knee Procedures | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.8 | Periprosthetic Joint Infection/Wound Infection and Other Wound Complications | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.9 | Procedures Resulted From Periprosthetic Joint Infection/Wound Infections | active | 2019-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.101 | Local Anesthetics | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.102 | Ophthalmic Epinephrines | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.103 | Inhaled Epinephrines | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.104 | Clopidogrels | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.105 | Cytochrome P450 2C19 inhibitors | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.106 | Cytochrome P450 2C9 inhibitors | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.107 | Aspirin Ingredient and Risk of GI Bleeding | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.109 | Oral Anticoagulant Ingredients and Risk of GI Bleeding | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.110 | Corticosteroid Ingredients and Risk of GI Bleeding | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.111 | Antidepressant Ingredients and Risk of GI Bleeding | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.112 | PPI and Risk of GI Bleeding | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.113 | Antiplatelet Ingredients and Risk of GI Bleeding | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.114 | NSAIDs Ingredients and Risk of GI Bleeding | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.115 | Kratom containing compounds | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.117 | Clopidogrel Ingredients and Risk of GI Bleeding | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.121 | Gastrointestinal bleeding episode and Risk of GI Bleeding 1 | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.122 | Gastrointestinal bleeding episode and Risk of GI Bleeding 2 | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.123 | Gastrointestinal bleeding episode and Risk of GI Bleeding | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.24 | Oxycodones | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1217.2 | TESTSemanticBitsValueSet | active | 2020-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.1 | Bronchiectasis Disorder SNOMED | active | 2020-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.10 | Interstitial Lung Disease ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.100 | Occupational Therapy Procedure HCPCS | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.101 | Occupational Therapy Procedure | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.102 | Speech Language Therapy Procedure HCPCS | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.103 | Speech Language Therapy Procedure | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.104 | Home Health Procedure | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.105 | Intermittent Skilled Nursing Home Health Procedure | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.106 | pH, Hematocrit, Partial Pressure Carbon Dioxide, Partial Pressure Oxygen or Bicarbonate Laboratory Test for Breathing Assistance Device Evaluation Excluding Oxygen Saturation | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.107 | Breathing Test Procedure During Sleep | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.108 | Ambulance Transport Procedure | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.109 | Prefabricated Spinal Orthotic Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.11 | Interstitial Lung Disease SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.110 | Custom Fitted Spinal Orthotic Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.111 | Custom Fabricated Spinal Orthotic Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.112 | Orthotic Device Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.113 | Spinal Orthotic Device or Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.115 | Spine or Neck Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.116 | Spine or Neck Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.117 | Spine or Neck Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.118 | Total Electric Hospital Bed Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.119 | Hypoventilation Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.12 | Interstitial Lung Disease | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.120 | Hypoventilation Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.121 | Hypoventilation Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.122 | Respiratory Assist Device Qualifying Condition | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.123 | Apnea Hypopnea Index Rate Measurement | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.124 | Forced Expiratory Volume in One Second (FEV1)/Forced Vital Capacity (FVC) Measurement | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.125 | Maximal Inspiratory Pressure Measurement | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.126 | Forced Vital Capacity (FVC) Measurement by Spirometry | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.127 | Oxygen Saturation Measurement At Rest | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.128 | Respiratory Assist Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.129 | Respiratory Assist Device Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.13 | Cystic Fibrosis Lung Disease ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.130 | Home Oxygen Therapy Accessory | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.131 | Forced Vital Capacity (FVC) Measurement Prediction | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.132 | Oxygen Saturation Laboratory Test and Setting for Breathing Assistance Device Evaluation | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.133 | Respiratory Disturbance Index | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.134 | Sleep Related Symptom for Positive Airway Pressure Device Use Evaluation | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.135 | Past Medical History Condition Related to Need for Positive Airway Pressure Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.136 | Home or Facility Care Location | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.137 | Fracture of Bone Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.138 | Fracture of Bone Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.139 | Fracture of Bone Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.14 | Cystic Fibrosis Lung Disease SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.140 | Severe Obesity Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.141 | Severe Obesity Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.142 | Severe Obesity Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.143 | Transfer from Bed Impairment SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.144 | Bed Confinement Impairment | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.145 | Transfer from Bed Impairment | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.146 | Ability to Safely Sit in Chair or Wheelchair Impairment SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.147 | Mobility Impairment or Fall From Chair ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.148 | Ability to Safely Sit in Chair or Wheelchair Impairment | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.149 | Fall or Fall Risk from Wheelchair or Stretcher SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.15 | Cystic Fibrosis Lung Disease | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.150 | Fall or Fall Risk from Wheelchair or Scooter ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.152 | Muscle, Tendon or Joint Contracture Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.153 | Muscle, Tendon or Joint Contracture Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.154 | Muscle, Tendon or Joint Contracture Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.155 | Muscle Weakness or Myasthenia Gravis Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.156 | Muscle Weakness or Myasthenia Gravis Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.158 | Myocardial Infarction Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.159 | Myocardial Infarction Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.16 | Neoplasm of Lung or Trachea Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.160 | Myocardial Infarction Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.161 | Amputation Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.162 | Amputation Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.164 | Lower Extremity Deep Vein Thrombosis Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.165 | Lower Extremity Deep Vein Thrombosis Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.167 | Spinal Cord Injury or Paralysis Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.168 | Spinal Cord Injury or Paralysis Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.169 | Spinal Cord Injury or Paralysis Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.17 | Neoplasm of Lung or Trachea Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.170 | Demyelinating Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.171 | Demyelinating Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.172 | Demyelinating Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.173 | Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.174 | Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.176 | Wound Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.177 | Wound Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.178 | Wound Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.179 | Danger to Self or Others Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.18 | Neoplasm of Lung or Trachea Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.180 | Danger to Self or Others Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.181 | Danger to Self or Others Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.182 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.183 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.184 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.185 | Pain on Movement or Joint Pain Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.186 | Pain in Joint Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.187 | Pain on Movement or Joint Pain Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.188 | Non Emergency Ambulance Transport Reason | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.189 | Osteoarthritis Disorder SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.19 | Secondary Erythrocytosis Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.190 | Osteoarthritis Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.191 | Osteoarthritis Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.192 | Immunosuppressive Medication RxNorm | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.193 | Medication Supporting Immunosupressive Medication RxNorm | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.194 | Non Emergency Ambulance Transport Qualifying Procedure | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.197 | Turalio | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.198 | Hepatic Medical History | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.2 | Bronchiectasis Disorder ICD10CM | active | 2020-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.20 | Secondary Erythrocytosis Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.21 | Secondary Erythrocytosis Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.22 | Acute or Chronic Heart Failure Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.23 | Acute or Chronic Heart Failure Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.24 | Acute or Chronic Heart Failure Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.25 | Home Oxygen Therapy Qualifying Condition | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.26 | Device Use Patient Activity Level | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.27 | Portable Liquid Oxygen Therapy Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.28 | Stationary Liquid Oxygen Therapy Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.29 | Sleep Apnea or Breathing Related Sleep Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.3 | Bronchiectasis Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.30 | Sleep Apnea or Breathing Related Sleep Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.31 | Sleep Apnea or Breathing Related Sleep Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.32 | Positive Airway Pressure Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.33 | Diabetes Mellitus Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.34 | Diabetes Mellitus Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.35 | Diabetes Mellitus Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.36 | Restrictive Lung Disease SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.37 | Restrictive Lung Disease ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.38 | Restrictive Lung Disease | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.39 | Chest Wall Deformity Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.4 | Chronic Obstructive Lung Disease (COPD) ICD10CM | active | 2020-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.40 | Chest Wall Deformity Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.41 | Chest Wall Deformity Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.42 | Motor Neuron Disease or Spinal Muscular Atrophy Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.43 | Motor Neuron Disease or Spinal Muscular Atrophy Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.44 | Motor Neuron Disease or Spinal Muscular Atrophy Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.45 | Chronic Respiratory Failure Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.46 | Chronic Respiratory Failure Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.47 | Chronic Respiratory Failure Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.48 | Ventilator Therapy Qualifying Condition | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.49 | Ventilator Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.5 | Chronic Obstructive Lung Disease SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.50 | Fixed Height Hospital Bed Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.51 | Variable Height Hospital Bed Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.52 | Semi electric Hospital Bed Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.53 | Heavy Duty Extra Wide Hospital Bed Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.54 | Extra Heavy Duty Hospital Bed Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.55 | Hospital Bed Trapeze Accessory Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.56 | Hospital Bed Cradle Accessory Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.57 | Hospital Bed Side Rail or Safety Enclosure Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.58 | Hospital Bed Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.59 | Intermittent Urinary Catheter or Urological Supply for Intermittent Urinary Catheter Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.6 | Chronic Obstructive Lung Disease (COPD) | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.60 | Indwelling Urinary Catheter Supply or Urological Supply for Indwelling Urinary Catheter Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.61 | Urinary Collection and Irrigation System Device or Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.62 | External Catheter or Urinary Collection Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.63 | Miscellaneous Urinary Catheter Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.64 | Urinary Incontinence Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.65 | Urinary Incontinence ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.66 | Urinary Incontinence Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.67 | Chronic Urinary Retention Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.68 | Urinary Retention Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.69 | Chronic Urinary Retention Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.7 | Hypoxemia Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.70 | Urinary Incontinence or Chronic Urinary Retention Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.72 | Portable Compressed Gas Oxygen Therapy Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.73 | Stationary Oxygen Concentrator Therapy Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.74 | Compressed Gas Oxygen Therapy Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.75 | Stationary Compressed Gas Oxygen Therapy Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.76 | Portable Oxygen Concentrator Therapy Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.77 | Liquid Oxygen Therapy Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.78 | Oxygen Concentrator Therapy Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.79 | Portable Oxygen Therapy Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.8 | Hypoxemia Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.80 | Stationary Oxygen Therapy Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.81 | Organ Transplant History Significant to Immunosuppressive Therapy | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.82 | Immunosuppressive Medication HCPCS | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.83 | Medication Supporting Immunosuppressive Medication HCPCS | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.84 | Home Blood Glucose Monitor Device | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.85 | Insulin Medication | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.86 | Hyperglycemia or Hypoglycemia Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.87 | Hyperglycemia or Hypoglycemia Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.88 | Hyperglycemia or Hypoglycemia Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.89 | Diabetic Test Strip or Lancet Supply | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.9 | Hypoxemia Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.90 | Organ Transplant Procedure Significant to Immunosuppressive Therapy | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.91 | Pulmonary Hypertension Disorder SNOMEDCT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.92 | Pulmonary Hypertension Disorder ICD10CM | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.93 | Pulmonary Hypertension Disorder | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.94 | Laboratory Test for Home Glucose Monitor Evaluation | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.95 | Physical Therapy Procedure SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.96 | Occupational Therapy Procedure SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.97 | Speech Language Therapy Procedure SNOMED CT | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.98 | Physical Therapy Procedure HCPCS | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.99 | Physical Therapy Procedure | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.135 | Last Menstrual Period (LMP) | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.146 | Abortion, All (ICD 10 CM) | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.149 | Abortion, All (SNOMED CT) | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.150 | Abortion, All | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.151 | Abortion, All (CPT) | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.152 | Abortion, 1st Trimester | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.153 | Abortion, 2nd Trimester | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.154 | Abortion, 2nd Trimester | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.155 | Abortion, 3rd Trimester | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.156 | Abortion, Elective | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.157 | Abortion, Elective | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.158 | Abortion, Failed Attempt | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.159 | Abortion, Induced | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.160 | Abortion, Induced | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.161 | Abortion, Induced | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.162 | Abortion, Medical Management | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.163 | Abortion, Medical Management | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.164 | Abortion, Medical Management | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.165 | Abortion, Elective | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.166 | Abortion, Surgical Management | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.167 | Abortion, Surgical Management | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.168 | Abortion, Surgical Management | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.169 | Abortion, Spontaneous / Miscarriage | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.170 | Abortion, Spontaneous / Miscarriage | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.171 | Abortion, Spontaneous / Miscarriage | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.172 | Contraception, Counseling | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.173 | Contraception, Counseling | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.174 | Contraception, Counseling | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.175 | Contraception, Counseling | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.176 | Methotrexate Injection | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.177 | Mifepristone | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.178 | Misoprostol | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.179 | Abortion Medications | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.180 | Contraception, Surveillance | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.181 | Contraception, Surveillance | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.182 | Contraception, Surveillance | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.183 | Clomiphene (Selective Estrogen Receptor Modulator / SERM) | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.184 | Letrozole (Aromatase inhibitor) | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.185 | Infertility, Female Medications | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.186 | Infertility, Female | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.187 | Infertility, Female | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.188 | Infertility, Female | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.189 | Infertility, Male | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.190 | Infertility, Male | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.191 | Infertility, Male | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.192 | Infertility, All | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.193 | Gender Dysphoria | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.194 | Gender Identity | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.195 | Intersex Surgery, History | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.196 | Intersex Surgery, Non specific | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.197 | Intersex Surgery, Female to Male | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.198 | Intersex Surgery, Female to Male | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.199 | Intersex Surgery, Female to Male | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.200 | Intersex Surgery, Male to Female Sex | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.201 | Intersex Surgery, Male to Female Sex | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.202 | Intersex Surgery, Male to Female Sex | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.203 | Intersex Surgery, All | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.204 | Pregnancy Labs, Blood/Serum/Plasma/Urine | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.205 | Stillbirth | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.206 | Stillbirth | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.208 | Sexual Orientation | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.209 | Transfeminine Regimens, Antiandrogens | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.210 | Transfeminine Regimens, Estrogens | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.211 | Transfeminine Regimens, GnRH Agonists | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.212 | Transfeminine Regimens, All | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.213 | Transmasculine Regimens, Testosterone, Transdermal | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.214 | Transmasculine Regimens, Testosterone, Parenteral | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.215 | Transmasculine Regimens, All | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.216 | Abortion, 1st Trimester | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.100 | Sleep Apnea Disorders SCT | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1005 | Sexual Satisfaction | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.101 | Sleep Apnea Disorders ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1015 | Substance Use | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1016 | Tobacco Use | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.102 | Sleep Apnea Disorders | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1020 | Screen Time | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1022 | Fluid Management | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1023 | Fat Intake | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1024 | Unsaturated Fat Intake | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1025 | Saturated Fat Intake | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1026 | Carbohydrate Intake | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1027 | Salt Intake | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1028 | Vegetable Intake | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1029 | Fruit Intake | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.103 | PostTraumatic Stress Disorder PTSD | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1030 | English Proficiency | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.104 | PostTraumatic Stress Disorder PTSD ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1042 | Neglect | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1048 | Current or Former Occupation | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.105 | PostTraumatic Stress Disorder PTSD SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1050 | Work Productivity | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1053 | Income Level | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1057 | Caregiver Characteristics | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1058 | Caregiver Availability | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1060 | Living Situation | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1064 | Marital or Spousal Status | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1065 | Dependents in Home | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1068 | Physical Activity Level | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1069 | Leisure Activity Engagement | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1075 | Exposure to Environmental Hazards | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1076 | Neighborhood Safety | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1080 | Experiences of Discrimination | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1082 | Criminal Justice Involvement or Incarceration | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1083 | Immigration Status | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.111 | Creatinine in blood, serum or plasma | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.113 | Blood Urea Nitrogen | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.114 | Hemoglobin | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.118 | Iron Saturation (Transferrin Saturation/TSAT) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.119 | Hemoglobin A1C | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1197 | Sleep Behavior | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.120 | Potassium in blood, serum or plasma | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1203 | Medication Literacy | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1213 | Elder and Child Abuse SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.122 | Corrected Calcium | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1229 | Education Level SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.123 | Phosphorus in blood, serum or plasma | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.126 | Vitamin D Levels | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.128 | KT/V Hemodialysis Ratio | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1281 | Elder and Child Abuse | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.129 | Intact Parathyroid Hormone | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.130 | Bicarbonate in blood, serum or plasma | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.131 | Sodium in blood, serum or plasma | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.132 | Chloride in blood, serum or plasma | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1336 | Elder and Child Abuse ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.135 | High Density Lipoprotein | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.137 | Triglyceride in blood, serum or plasma | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1375 | Tinnitus | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1377 | Brain Fog | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1378 | Depression Symptoms | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1379 | Mood Swings | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.138 | Cystatin C | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1380 | Anxiety | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1381 | Lightheadedness | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1382 | Stress | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1383 | Grief and Suffering | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1384 | Insomnia and Other Sleep Difficulties | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1385 | Impaired Sense of Taste | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1386 | Pink Eye Diagnosis SCT | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1387 | Pink Eye Diagnosis ICD10 | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1388 | Pink Eye Diagnosis | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.139 | Total Cholesterol | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1392 | Lymphadenopathy Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1393 | Lymphadenopathy Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1394 | Lymphadenopathy Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1395 | Visual Changes | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1396 | Impaired Sense of Smell | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1398 | Fatigue | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1399 | Chills | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.140 | Ferritin | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1400 | Fever | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1401 | Functional and Mobility Impairment | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1403 | Orthostatic Intolerance | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1405 | Cough | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1406 | Dyspnea | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1409 | Wheezing | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.141 | Red Blood Cell Count (Erythrocytes) | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1413 | Sinonasal Congestion | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1414 | Respiratory Distress | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1415 | Edema | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1419 | Weight Changes | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.142 | White Blood Cell (Leukocytes) Count | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1422 | Immunologic Changes | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1424 | Pain | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1425 | Arthralgia | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1426 | Chest Pain | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1427 | Headache | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1428 | Myalgia | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1429 | Back Pain | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.143 | Hematocrit | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1430 | Pain in Extremities | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1431 | Pain in Throat | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1432 | Palpitations | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1433 | Tachycardia | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1434 | Bleeding | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1435 | Abdominal Pain | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1436 | Diarrhea | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1437 | Gastroesophageal Reflux | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1438 | Nausea | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1439 | Vomiting | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.144 | Mean Corpuscular Volume | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1440 | Constipation | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1441 | Difficulty Swallowing | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1442 | Bronchiectasis Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1443 | Loss of Appetite | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1444 | Paresthesia | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1445 | Rash | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1446 | Covid Toes (Toes and/or Fingers) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1447 | Itching | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1448 | Menstrual Cycle Irregularities | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1449 | Lower Urinary Tract Symptoms | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.145 | Mean Corpuscular Hemoglobin Concentration | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1450 | Urinary Incontinence | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1451 | Dizziness | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1453 | Hair Loss | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1455 | Disability Severity | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1456 | Hypercoagulability | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1457 | Post Exertional Malaise | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1458 | Chronic Pain | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1459 | Neurogenic Pain | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.146 | Platelet Count | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1460 | Impaired Hearing | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1461 | Parkinsonia Like Symptoms | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1462 | Bronchiectasis Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1463 | Bronchiectasis Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1464 | Chronic obstructive pulmonary disease (COPD) Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1465 | Chronic obstructive pulmonary disease (COPD) Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1466 | Chronic obstructive pulmonary disease (COPD) Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1467 | Interstitial lung disease Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1468 | Interstitial lung disease Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1469 | Interstitial lung disease Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.147 | Erythrocyte Distribution Width | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1470 | Asthma Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1471 | Asthma Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1472 | Asthma Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1473 | Fibromyalgia Diagnosis SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1474 | Fibromyalgia Diagnosis ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1475 | Fibromyalgia Diagnosis | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1476 | Herpes zoster Diagnosis ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1477 | Herpes zoster Diagnosis SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1478 | Herpes zoster | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1479 | Pulmonary embolism Diagnosis SCT | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.148 | Platelet Distribution Width | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1480 | Pulmonary embolism Diagnosis ICD10 | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1481 | Pulmonary embolism Diagnosis | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1482 | Hypertension, Pulmonary Hypertension SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1483 | Hypertension, Pulmonary Hypertension Diagnosis ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1484 | Hypertension, Pulmonary Hypertension | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1485 | Language and Speech Problems | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1486 | Postural tachycardia syndrome (POTS) Diagnosis SCT | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1487 | Postural tachycardia syndrome (POTS) Diagnosis ICD10 | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1488 | Postural tachycardia syndrome (POTS) Diagnosis | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1489 | Functional disorder of gastrointestinal tract Diagnosis SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.149 | Platelet Mean Volume | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1490 | Functional disorder of gastrointestinal tract Diagnosis ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1491 | Functional disorder of gastrointestinal tract Diagnosis | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1492 | Autonomic dysfunction | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1496 | Mast Cell Activation Syndrome (MCAS) Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1497 | Mast Cell Activation Syndrome (MCAS) Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1498 | Mast Cell Activation Syndrome (MCAS) Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.150 | Estimated Average Glucose | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1500 | Debility or Frailty SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1501 | Debility or Frailty ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1502 | Debility or Frailty | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1503 | Ehlers Danlos syndrome (EDS) Diagnosis SCT | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1504 | Ehlers Danlos syndrome (EDS) Diagnosis ICD10 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1505 | Ehlers Danlos syndrome (EDS) Diagnosis | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1506 | Malnutrition Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1507 | Malnutrition Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1508 | Narcolepsy Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1509 | Narcolepsy Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.151 | Albumin in Blood, Plasma, or Serum | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1510 | Narcolepsy | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1514 | Small Fiber Neuropathy Diagnosis SCT | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1515 | Small Fiber Neuropathy Diagnosis ICD10 | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1516 | Small Fiber Neuropathy Diagnosis | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1517 | Malnutrition Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1518 | Neuropathy Diagnosis | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1519 | Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1520 | Multisystem Inflammatory Syndrome in Adults (MIS A) ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1521 | Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1522 | Congestive heart failure Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1523 | Congestive heart failure Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1524 | Congestive heart failure Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1525 | Cognitive disorder Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1526 | Cognitive disorder SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1527 | Post Acute Sequelae of Sars Cov 2 infection (PASC) SCT | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1529 | Post Acute Sequelae of Sars Cov 2 infection (PASC) ICD10 | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.153 | Anion Gap | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1530 | Post Acute Sequelae of Sars Cov 2 infection (PASC) Diagnosis | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1531 | Hypertension, Persistent SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1532 | Acute Renal Failure Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1533 | Acute Renal Failure Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1534 | Acute Renal Failure Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1535 | Complication due to Diabetes Mellitus Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1536 | Complication due to Diabetes Mellitus Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1537 | Complication due to Diabetes Mellitus Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1538 | Coronary Revascularization History SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1539 | Coronary Revascularization History ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.154 | Urine Urea Nitrogen | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1540 | Coronary Revascularization History | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1541 | Heart Failure Diagnosis SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1542 | Heart Failure Diagnosis ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1543 | Heart Failure Diagnosis | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1547 | Hypertension, Primary and Secondary Diagnosis | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1548 | Cerebrovascular Disease Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1549 | Cerebrovascular Disease Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.155 | Bone Density | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1550 | Migraine Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1551 | Migraine Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1552 | Migraine Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1553 | Chronic Tension type Headache Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1554 | Chronic Tension type Headache Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1555 | Chronic Tension type Headache Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1556 | Low Back Pain SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1557 | Low Back Pain ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1558 | Low Back Pain | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1559 | Metabolic Syndrome Diagnosis SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.156 | Bone Survey X Rays | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1560 | Metabolic Syndrome Diagnosis ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1561 | Metabolic Syndrome Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1562 | Hypertension, Persistent ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1563 | Hypertension, Persistent | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1564 | Pregnancy SCT | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1565 | Pregnancy ICD10 | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1566 | Pregnancy | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1568 | Low Density Lipoprotein | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1569 | Physical findings of the abdomen | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.157 | Chronic Kidney Disease All Stages (1 through 5) SNOMED | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1571 | Chest US | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1572 | Sleep Disorder Assessment | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1573 | Cerebral Spinal Fluid (CSF) Analysis | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1574 | Comprehensive Metabolic Panel (CMP) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1575 | Arterial Blood Gas (ABG) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1576 | Coagulation Assay (PT, aPTT, Fibrinogen) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1577 | D Dimer Test | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1578 | Procalcitonin in Blood, Serum, or Plasma | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1579 | Creatine Kinase (CK, CK MB) in Blood, Serum, or Plasma | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.158 | Chronic Kidney Disease All Stages (1 through 5) ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1580 | COVID 19 (SARS CoV 2), SARS CoV, Influenza virus A and B Tests | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1581 | Microorganisms Detection by Blood Culture | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1582 | Microorganisms Detection by Sputum Culture | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1583 | Cystography | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1584 | Cognitive Health Related Questionnaire Panel Codes | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1585 | Alcohol Use Related Questionnaire Panel Codes | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1586 | Functional Status Related Questionnaire Panel Codes | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1587 | Kidney Disease Related Questionnaire Panel Codes | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1588 | Long Covid Related Questionnaire Panel Codes | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1589 | Nutrition Status Related Questionnaire Panel Codes | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.159 | Chronic Kidney Disease All Stages (1 through 5) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1590 | Pain Perception Related Questionnaire Panel Codes | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1591 | Patient Goal Related Questionnaire Panel Codes | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1592 | Social Determinant of Health Related Questionnaire Panel Codes | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1593 | Covid 19 Related Health Questionnaire Panel Codes | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1594 | Caregiver Considerations Related Questionnaire Panel Codes | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1595 | Acute COVID 19 Diagnosis SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1597 | Drugs of Abuse Screen | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1598 | Criminal Justice Involvement or Incarceration History | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1599 | Cardiomyopathy Diagnosis SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1600 | Cardiomyopathy Diagnosis ICD10 | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1601 | Atherosclerotic Cardiovascular Disease SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1602 | Neuropathy Diagnosis ICD10 | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1603 | Neuropathy Diagnosis SCT | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1605 | Left Ventricular Hypertrophy ICD10 | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1606 | Left Ventricular Hypertrophy | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1607 | Alanine Aminotransferase (ALT) in Blood, Plasma, or Serum | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1608 | Aspartate Aminotransferase (AST) in Blood, Plasma, or Serum | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1609 | Erythrocyte Sedimentation Rate (ESR) in Blood | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1610 | Oxygen Saturation in Blood | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.176 | Urine Sediment | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.179 | Estimated Glomerular Filtration Rate (eGFR) | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.22 | Alcohol Use Disorder SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.23 | Alcohol Use Disorder ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.24 | Alcohol Use Disorder | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.25 | Peripheral Vascular Disease SCT | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.26 | Peripheral Vascular Disease ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.27 | Peripheral Vascular Disease | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.28 | Hepatitis C Condition SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.30 | Hepatitis C Conditions | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.31 | Diabetic Neuropathy SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.32 | Diabetic Neuropathy ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.33 | Diabetic Neuropathy Conditions | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.35 | Obesity ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.36 | Obesity Conditions | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.37 | Obesity SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.4 | Chronic Kidney Disease Type or Cause SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.41 | Tuberculosis (Disorders) SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.417 | Prediabetes (Borderline Diabetes) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.418 | Prediabetes (Borderline Diabetes) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.419 | Prediabetes (Borderline Diabetes) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.420 | Maturity Onset Diabetes of the Young (MODY) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.43 | Tuberculosis Disorders | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.44 | Tuberculosis (Disorders) Ext | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.45 | Hypoalbuminemia Conditions SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.450 | CKD Progression Risk | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.46 | Hypoalbuminemia Conditions ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.47 | Hypoalbuminemia Conditions | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.48 | Hyperkalemia Conditions SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.480 | Diabetic Coma | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.481 | Diabetic Coma | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.482 | Diabetic Coma | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.49 | Hyperkalemia Conditions ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.490 | Diabetic Peripheral Angiopathy | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.491 | Diabetic Peripheral Angiopathy | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.492 | Diabetic Peripheral Angiopathy | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.496 | Cataract of the Eye | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.497 | Cataract of the Eye | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.498 | Cataract of the Eye | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.499 | Rubeosis Iridis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.5 | Chronic Kidney Disease Type or Cause ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.50 | Hyperkalemia Conditions | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.500 | Rubeosis Iridis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.501 | Rubeosis Iridis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.502 | Rubeosis Iridis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.506 | Emotional Distress caused by Chronic Condition | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.507 | Emotional Distress caused by Chronic Condition | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.508 | Emotional Distress caused by Chronic Condition | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.51 | Anemia Conditions SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.510 | Hypoglycemic Event | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.512 | Hypoglycemic Event | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.513 | Hypoglycemic Event | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.514 | Hypoglycemia Unawareness | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.515 | Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.516 | Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.517 | Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.518 | Ketoacidosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.519 | Ketoacidosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.52 | Anemia Conditions ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.520 | Ketoacidosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.521 | Diabetic Foot | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.522 | Diabetic Foot | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.523 | Diabetic Foot | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.524 | Diabetic Foot Ulcer | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.525 | Diabetic Foot Ulcer | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.526 | Diabetic Foot Ulcer | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.529 | Charcot Foot | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.53 | Anemia Conditions | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.530 | Charcot Foot | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.531 | Charcot Foot | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.533 | Cellulitis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.535 | Diabetic Hand or Diabetic Cheiroarthropathy | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.538 | Necrobiosis Lipoidica (Skin Lesions) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.539 | Necrobiosis Lipoidica (Skin Lesions) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.540 | Necrobiosis Lipoidica (Skin Lesions) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.541 | Gangrene | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.542 | Gangrene | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.543 | Gangrene | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.544 | Dupuytren's Contracture | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.545 | Dupuytren's Contracture | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.546 | Dupuytren's Contracture | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.547 | Scleroderma or Thick Skin Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.548 | Scleroderma or Thick Skin Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.549 | Scleroderma or Thick Skin Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.554 | Acanthosis Nigricans | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.555 | Acanthosis Nigricans | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.556 | Acanthosis Nigricans | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.557 | Eruptive Xanthomatosis | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.558 | Periodontitis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.559 | Periodontitis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.560 | Periodontitis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.561 | Amputated Limb (Not Traumatic) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.562 | Amputated Limb (Not Traumatic) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.563 | Amputated Limb (Not Traumatic) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.564 | Hypertension, Essential or Primary ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.565 | Hypertension, Essential or Primary SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.567 | Hypertension, Secondary ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.568 | Hypertension, Secondary SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.571 | Hypertension Stage | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.579 | Cardiomyopathy | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.58 | Hypercalcemia Conditions SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.580 | NYHA Heart Failure Functional Classifications | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.581 | American Heart Association Heart Failure Stage | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.582 | Framingham Risk Assessments | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.583 | American College of Cardiology or American Heart Association Ascvd Risk Score (acc/aha Ascvd Risk) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.584 | Atherosclerotic Cardiovascular Disease | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.586 | Gout | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.587 | Psoriatic Arthritis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.588 | Reactive Arthritis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.59 | Hypercalcemia Conditions ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.590 | Experience of Traumatic Events | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.591 | Cannabis Use | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.592 | Hearing Impairment | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.6 | Chronic Kidney Disease Type or Cause | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.60 | Hypercalcemia Conditions | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.606 | Angina | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.607 | Angina | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.608 | Angina | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.609 | Unstable Angina | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.61 | Hypocalcemia Conditions | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.610 | Unstable Angina | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.611 | Unstable Angina | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.613 | Ischemic Heart Disease | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.614 | Ischemic Heart Disease | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.615 | Left Ventricular Hypertrophy SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.616 | Stroke History | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.618 | Stroke | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.619 | Transient Ischemic Attack | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.62 | Hypocalcemia Conditions ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.620 | Transient Ischemic Attack | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.621 | Transient Ischemic Attack | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.625 | Aneurysm | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.626 | Aneurysm | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.627 | Aneurysm | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.63 | Hypocalcemia Conditions SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.634 | Aortic Disease | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.635 | Aortic Disease | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.636 | Aortic Disease | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.637 | Carotid Stenosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.638 | Carotid Stenosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.639 | Carotid Stenosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.64 | Hyperphosphatemia Conditions SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.640 | Intracranial Stenosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.641 | Intracranial Stenosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.642 | Intracranial Stenosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.643 | Pulmonary Edema | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.644 | Pulmonary Edema | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.645 | Pulmonary Edema | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.646 | Osteoarthritis (Oa) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.647 | Osteoarthritis (Oa) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.648 | Osteoarthritis (Oa) | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.649 | Rheumatoid Arthritis (Ra) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.65 | Hyperphosphatemia Conditions ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.650 | Rheumatoid Arthritis (Ra) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.651 | Rheumatoid Arthritis (Ra) | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.652 | Infectious Arthritis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.653 | Infectious Arthritis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.654 | Infectious Arthritis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.656 | Temporomandibular Disorder Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.658 | Irritable Bowel Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.659 | Irritable Bowel Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.66 | Hyperphosphatemia Conditions | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.660 | Irritable Bowel Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.661 | Neuropathic Pain (Neuralgia) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.662 | Neuropathic Pain (Neuralgia) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.663 | Neuropathic Pain (Neuralgia) | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.664 | Neuromas | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.665 | Neuromas | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.666 | Neuromas | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.667 | Phantom Pain | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.668 | Phantom Pain | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.669 | Phantom Pain | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.67 | Hematuria Conditions | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.670 | Entrapment Neuropathy | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.671 | Entrapment Neuropathy | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.672 | Entrapment Neuropathy | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.673 | Myalgic Encephalomyelitis or Chronic Fatigue Syndrome | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.674 | Myalgic Encephalomyelitis or Chronic Fatigue Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.675 | Myalgic Encephalomyelitis or Chronic Fatigue Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.676 | Psychotic Depression | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.677 | Psychotic Depression | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.678 | Psychotic Depression | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.679 | Post Partum Depression | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.68 | Hematuria Conditions ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.680 | Post Partum Depression | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.681 | Post Partum Depression | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.682 | Seasonal Affective Disorder | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.683 | Seasonal Affective Disorder | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.684 | Seasonal Affective Disorder | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.685 | Psychological Trauma | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.686 | Psychological Trauma | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.687 | Psychological Trauma | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.688 | Grief or Loss | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.689 | Grief or Loss | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.69 | Hematuria Conditions SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.690 | Grief or Loss | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.691 | Suicide Risk | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.692 | Suicide Risk | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.693 | Suicide Risk | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.694 | Vaping | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.695 | Vaping | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.696 | Vaping | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.697 | Tobacco Use or Exposure | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.699 | Tobacco Use or Exposure | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.70 | Metabolic Acidosis Conditions | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.701 | Binge Drinking | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.702 | Binge Drinking | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.703 | Binge Drinking | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.704 | Drug Misuse | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.705 | Drug Misuse | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.706 | Drug Misuse | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.707 | Drug Misuse | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.708 | Sensory Status | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.709 | Sensory Status | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.71 | Metabolic Acidosis Conditions ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.711 | Fall Risk | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.713 | Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.714 | Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.715 | Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.716 | Urinary Incontinence | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.717 | Urinary Incontinence | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.718 | Urinary Incontinence | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.719 | Urinary Urgency | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.72 | Metabolic Acidosis Conditions SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.720 | Urinary Urgency | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.721 | Urinary Urgency | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.722 | Urinary Frequency | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.723 | Urinary Frequency | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.724 | Urinary Frequency | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.725 | Nocturia | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.726 | Nocturia | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.727 | Nocturia | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.728 | Pelvic Organ Prolapse | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.729 | Pelvic Organ Prolapse | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.73 | Hyperlipidemia Conditions | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.730 | Pelvic Organ Prolapse | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.731 | Erectile Dysfunction | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.732 | Erectile Dysfunction | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.733 | Erectile Dysfunction | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.734 | Interstitial Cystitis or Bladder Pain Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.735 | Interstitial Cystitis or Bladder Pain Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.736 | Interstitial Cystitis or Bladder Pain Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.737 | Recurrent Urinary Tract Infections | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.738 | Recurrent Urinary Tract Infections | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.739 | Recurrent Urinary Tract Infections | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.74 | Hyperlipidemia Conditions ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.740 | Hypertriglyceridemia | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.741 | Hypertriglyceridemia | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.742 | Hypertriglyceridemia | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.743 | Hypothyroidism | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.744 | Hypothyroidism | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.745 | Hypothyroidism | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.746 | Menopause | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.747 | Menopause | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.748 | Menopause | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.749 | Testicular Hypofunction | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.75 | Hyperlipidemia Conditions SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.750 | Testicular Hypofunction | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.751 | Testicular Hypofunction | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.752 | Primary Aldosteronism | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.753 | Primary Aldosteronism | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.754 | Primary Aldosteronism | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.755 | Restless Leg Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.756 | Restless Leg Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.757 | Restless Leg Syndrome | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.759 | Claudication | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.76 | Chronic Pain Conditions | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.760 | Claudication | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.761 | Claudication | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.762 | Angioedema | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.763 | Angioedema | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.764 | Angioedema | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.768 | Nonalcoholic Fatty Liver Disease | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.769 | Nonalcoholic Fatty Liver Disease | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.77 | Chronic Pain ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.770 | Nonalcoholic Fatty Liver Disease | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.771 | Thalassemia | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.772 | Thalassemia | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.773 | Thalassemia | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.78 | Chronic Pain SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.79 | Arthritis Disorders SCT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.790 | Urine Protein to Creatinine Ratio (UPCR) | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.791 | 24 Hour Urine Volume | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.792 | 24 Hour Urine Protein Excretion | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.793 | Total Carbon Dioxide or Bicarbonate in blood, serum or plasma | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.794 | Calcium (Not Corrected for Serum Albumin) in Blood, Plasms, or Serum | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.795 | B Type Natriuretic Peptide [Bnp] in Blood, Serum or Plasma | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.797 | N Terminal Pro_B_Type Natriuretic Peptide [Nt_Probnp] in blood, serum or plasma | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.799 | Temporomandibular Disorder Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.80 | Arthritis Disorders ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.800 | Temporomandibular Disorder Diagnosis | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.801 | High Sensitivity Troponin | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.804 | Aspartate Transaminase or Alanine Aminotransferase Ratio | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.805 | Alkaline Phosphatase (Alp) in Blood, Serum or Plasma | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.806 | Gamma Glutamyl Transpeptidase (Ggt) in blood, serum or plasma | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.807 | Triiodothyronine in serum or plasma | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.808 | Fasting Blood Glucose | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.809 | Random Blood Glucose Test | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.81 | Arthritis Disorders | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.810 | Uric Acid (Urate) in blood, serum or plasma | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.811 | Aldosterone/Renin Ratio | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.812 | Serum Rheumatoid Factor | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.813 | Blood Ethanol Level | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.814 | Drugs of Abuse Screen in Hair | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.815 | Drugs of Abuse Screen in Urine | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.816 | Drugs of Abuse Screen in Blood | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.817 | Drugs of Abuse Screen in Tissue | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.818 | Drugs of Abuse Screen in Body Fluid | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.819 | Urea Reduction Ratio | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.82 | Preeclampsia Disorders SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.822 | Bowel Sounds | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.823 | Uroflowmetry | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.826 | Gait Quality | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.828 | Balance Assessments | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.83 | Preeclampsia Disorders ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.836 | Sit to Stand Ability | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.84 | Preeclampsia Disorders | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.840 | Spinal Cord Compression | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.841 | Spinal Cord Compression | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.842 | Alcohol Use (Revised 2021) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.843 | Alcohol Use (Revised 2021) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.844 | Alcohol Use (Revised 2021) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.845 | Alcohol Use | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.85 | Hyperuricemia Conditions | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.86 | Hyperuricemia Conditions ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.864 | Kidney Biopsy Report | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.867 | Skin Biopsy Report | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.868 | Muscle Biopsy Report | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.869 | Gastric Tissue Biopsy Report | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.87 | Hyperuricemia Conditions SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.870 | Bone Biopsy Report | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.873 | Echocardiogram | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.88 | Vitamin D Deficiency Conditions SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.880 | Spinal or Back CT | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.881 | Chest CT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.882 | Abdominal or Pelvic CT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.883 | Limb CT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.884 | Heart Calcium Score | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.885 | Coronary CT Angiogram | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.886 | Limb CT Angiogram | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.888 | Chest CT Angiogram | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.889 | Head and Neck CT Angiogram | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.89 | Vitamin D Deficiency Conditions ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.891 | Gastrointestinal Tract X Ray | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.892 | Gallbladder X Ray | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.893 | Kidney X Ray | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.894 | Abdomen X Ray | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.895 | Pelvis X Ray | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.896 | Hand X Ray | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.897 | Wrist X Ray | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.898 | Forearm X Ray | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.899 | Elbow X Ray | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.90 | Vitamin D Deficiency Conditions | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.900 | Upper Arm X Ray | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.901 | Shoulder X Ray | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.902 | Upper Extremity X Ray | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.903 | Foot X Ray | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.904 | Ankle X Ray | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.905 | Shin X Ray | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.906 | Knee X Ray | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.907 | Thigh X Ray | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.908 | Hip X Ray | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.909 | Lower Extremity X Ray | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.91 | Alkaline Phosphatase Deficiency Conditions SCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.910 | Abdominal MRI | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.911 | Adrenal Gland MRI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.912 | Kidney MRI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.913 | Pancreas MRI | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.915 | Kidney MRA | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.916 | Chest Region MRI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.917 | Pulmonary MRI | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.918 | Cardiac MRI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.92 | Alkaline Phosphatase Deficiency Conditions ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.920 | Spine MRI | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.921 | Head and Neck MRI | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.922 | Brain MRI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.923 | Pelvic Region MRI | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.924 | Knee MRI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.925 | Foot MRI | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.927 | Shoulder MRI | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.928 | Lower Extremity MRA | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.93 | Alkaline Phosphatase Deficiency Conditions | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.930 | Spine X Ray | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.933 | Hip MRI | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.934 | Thigh or Femur MRI | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.935 | Ankle MRI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.936 | Lower Extremity MRI | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.937 | Forearm MRI | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.938 | Elbow MRI | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.939 | Wrist MRI | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.94 | Uremic Pruritus Conditions ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.940 | Hand MRI | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.942 | Upper Extremity MRI | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.943 | Abdominal MRA | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.944 | Chest MRA | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.945 | Upper Extremity MRA | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.947 | Head and Neck MRA | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.948 | Pelvic Region MRA | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.949 | Functional MRI | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.95 | Uremic Pruritus Conditions SCT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.951 | Optical Coherence Tomography | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.954 | Bathing or grooming/hygiene (ADL/IADL) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.955 | Dressing (ADL or IADL) | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.956 | Toileting (ADL or IADL) | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.957 | Transferring (ADL or IADL) | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.958 | Walking or ambulation/locomotion (ADL/IADL) | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.96 | Uremic Pruritus Conditions | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.960 | Domestic Duties or Household Tasks (ADL/IADL) | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.961 | Telephone Use (ADL or IADL) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.962 | Bed Mobility (ADL or IADL) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.963 | Stair Use (ADL or IADL) | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.964 | Medication Management (ADL or IADL) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.967 | Electromyography | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.968 | Electroencephalogram | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.969 | Exercise Stress Test | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.97 | Insomnia Disorders | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.976 | Sleep Duration, Device | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.977 | Steps Per Time, Device | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.978 | Physical Activity Level, Device | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.979 | Cognitive Function Clinician Interpretation | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.98 | Insomnia Disorders ICD10 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.987 | Psychosis | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.99 | Insomnia Disorders SCT | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.991 | Suicidal Ideation and Behaviors | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.994 | Sleep Duration | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.996 | Pain Intensity or Severity | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.997 | Pain Quality | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1225.4 | Glaucoma ICD10 | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1225.5 | Glaucoma SNOMED | active | 2022-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.1 | Scleritis | active | 2021-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.2 | Scleritis | active | 2021-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.3 | Scleritis | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.1 | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography | active | 2021-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.2 | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography Non Diagnostic or Non CT | active | 2021-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.3 | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography Nuclear Medicine With CT | active | 2021-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.4 | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography CT Without Specified Body Region | active | 2021-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.6 | Outpatient Encounter Locations | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.7 | Outpatient Activity Codes | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.6 | Anaphylaxis, ICD10CM codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.60 | Guillain Barre Syndrome, diagnosis codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.61 | Febrile seizure, diagnosis codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.62 | Encephalomyelitis and encephalitis, diagnosis codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.63 | Disseminated Intravascular Coagulation, diagnosis codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.64 | Deep Vein Thrombosis, diagnosis codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.65 | Bells Palsy, diagnosis codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.66 | Appendicitis, diagnosis codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.67 | Anaphylaxis, diagnosis codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.68 | Acute Myocardial Infarction, diagnosis codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.69 | Multisystem Inflammatory Syndrome, SNOMED codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.7 | Anaphylaxis, SNOMED codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.70 | Multisystem Inflammatory Syndrome, diagnosis codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.71 | Transfusion CPT codes for exposure identification | active | 2021-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.72 | Transfusion ICD9 codes for exposure identification | active | 2021-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.73 | Transfusion ICD10PCS codes for exposure identification | active | 2021-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.74 | Transfusion CPT, ICD9, ICD10PCS codes for exposure identification | active | 2021-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.75 | COVID19 vaccine ICD10PCS codes for exposure identification | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.8 | Appendicitis, SNOMED codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.9 | Appendicitis, ICD10CM codes for AE reporting | active | 2021-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.1 | Test Diabetes codes | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.100 | Cardiomyopathy Hypertrophic Condition | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.12 | Metabolic Syndrome LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.15 | MetabolicSyndromeCondition | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.16 | Annual Physical ICD9 CN5 | active | 2023-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.164 | Diabetic Retinal Screening HD CPT for Tax Pair | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.165 | Optometrist and Ophthalmologist Taxonomy HD Taxonomy | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.167 | End Stage Renal Disease (ESRD)_HD_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.168 | End Stage Renal Disease (ESRD)_HD_ICD9 | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.169 | End Stage Renal Disease (ESRD)_HD_ICD10 | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.17 | Annual Physical ICD10 CN5 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.170 | End Stage Renal Disease (ESRD)_HD_HCPCS | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.171 | End Stage Renal Disease (ESRD)_HD_LOINC | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.172 | End Stage Renal Disease (ESRD)_HD_Clinical Condition Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.173 | Systolic Blood Pressure_HD_SNOMED | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.174 | Systolic Blood Pressure_HD_CPT | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.175 | Systolic Blood Pressure_HD_LOINC | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.176 | Systolic Blood Pressure_HD | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.177 | Diastolic Blood Pressure_HD_SNOMED | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.178 | Diastolic Blood Pressure_HD_CPT | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.179 | Diastolic Blood Pressure_HD_LOINC | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.18 | Annual Physical SNOMED CN5 | active | 2023-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.180 | Diastolic Blood Pressure_HD | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.181 | Remote Blood Pressure_HD_SNOMED | active | 2023-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.182 | Remote Blood Pressure_HD | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.183 | Remote Blood Pressure_HD_CPT | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.184 | Acute Inpatient_CN_HD_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.185 | Acute Inpatient_CN_HD_CPT | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.186 | Acute Inpatient_HD_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.187 | ED Visit_CN_HD_CPT | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.188 | ED Visit_CN_HD_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.19 | Annual Physical Taxonomy CN5 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.190 | Pregnancy_HD_Grouping | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.191 | Pregnancy_CN_HD_SNOMED | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.192 | Pregnancy_CN_HD_ICD10 | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.193 | ED Visit_HD_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.194 | Lipid Panel_Event_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.195 | Lipid Panel_Event_HCPCS | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.196 | Lipid Panel_Event_LOINC | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.197 | Lipid Panel_Event_CPT | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.198 | Lipid Panel_Event_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.199 | Unknown Glucose_Event_ICD9 | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.20 | Annual Physical CN5 | active | 2023-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.200 | Unknown Glucose_Event_ICD10 | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.201 | Unknown Glucose_Event_LOINC | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.202 | Unknown Glucose_Event_CPT | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.203 | Unknown Glucose_Event_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.204 | Unknown Glucose_Lab_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.205 | Bone Marrow Transplant CN_HD_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.206 | Bone Marrow Transplant CN_HD_ICD10 | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.207 | Bone Marrow Transplant_HD_CN_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.208 | Immunocompromising Conditions CN_HD_ICD9 | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.209 | Immunocompromising Conditions CN_HD_ICD10PCS | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.21 | Annual Physical CPT CN5 | active | 2023-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.210 | Immunocompromising Conditions CN_HD_ICD10CM | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.211 | Immunocompromising Conditions_HD_CN_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.212 | Immunocompromising Conditions CN_HD_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.213 | Cerebrospinal Fluid Leak CN_HD_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.214 | Cerebrospinal Fluid Leak CN_HD_ICD10 | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.215 | Cerebrospinal Fluid Leak_HD_CN_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.216 | Anatomic or Functional Asplenia CN_HD_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.217 | Anatomic or Functional Asplenia CN_HD_ICD9 | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.218 | Anatomic or Functional Asplenia CN_HD_ICD10 | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.219 | Anatomic or Functional Asplenia_HD_CN_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.22 | Annual Physical HCPCS CN5 | active | 2023-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.220 | Sickle cell Anemia and HB S Disease CN_HD_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.221 | Sickle cell Anemia and HB S Disease CN_HD_ICD10 | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.222 | Sickle cell Anemia and HB S Disease_HD_CN_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.223 | Pneumococcal Vaccine CN_HD_SNOMED | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.224 | Pneumococcal Vaccine CN_HD_HCPCS | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.225 | Pneumococcal Vaccine CN_HD_CVX | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.226 | Pneumococcal Vaccine CN_HD_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.227 | Pneumococcal Vaccine_HD_CN_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.228 | Influenza Vaccine CN_HD_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.229 | Influenza Vaccine CN_HD_HCPCS | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.23 | Annual Physical CPT for Tax Pair CN5 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.230 | Influenza Vaccine CN_HD_CVX | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.231 | Influenza Vaccine CN_HD_CPT | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.232 | Influenza Vaccine_HD_CN_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.233 | Cochlear Implant CN_HD_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.234 | Cochlear Implant CN_HD_ICD10 | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.235 | Cochlear Implant CN_HD_HCPCS | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.236 | Cochlear Implant CN_HD_CPT | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.237 | Cochlear Implant_HD_CN_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.238 | Chemotherapy CN_HD_SNOMED | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.239 | Chemotherapy CN_HD_ICD10 | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.24 | Annual Physical ICD9 for Tax Pair CN5 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.240 | Chemotherapy CN_HD_CPT | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.241 | Chemotherapy_HD_CN_Grouping | active | 2023-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.244 | Fasting Blood Glucose_Lab_Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.245 | Chronic Heart Failure (CHF)_ICD9 | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.246 | Chronic Heart Failure (CHF)_ICD10 | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.251 | Asthma_LOINC | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.253 | Asthma_Clinical Condition Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.254 | Pregnancy Loss_HD_SNOMED | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.255 | Pregnancy Loss_HD_ICD10 | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.257 | Pregnancy Loss_HD_Clinical Condition Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.258 | Heart Failure (CHF)_ICD9 | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.259 | Heart Failure (CHF)_ICD10 | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.260 | Heart Failure (CHF)_SNOMED | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.261 | Heart Failure (CHF)_HCPCS | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.262 | Heart Failure (CHF)_LOINC | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.263 | Heart Failure (CHF)_CPT | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.264 | Heart Failure (CHF)_RxNorm | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.265 | Heart Failure (CHF)_Clinical Condition Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.270 | Triglyceride_Lab_Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.274 | Total Cholesterol_CPT | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.275 | Total Cholesterol_Lab_Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.276 | LDL_SNOMED | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.280 | LDL_Lab_Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.284 | HDL_LOINC | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.285 | HDL_Lab_Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.286 | Colectomy_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.288 | Colectomy_ICD9 | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.29 | Hospice Exclusions Grouping | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.290 | Colectomy_Event_Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.291 | CT Colonography_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.292 | CT Colonography_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.294 | CT Colonography_Event_Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.295 | FIT DNA_LOINC | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.296 | FIT DNA_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.297 | FIT DNA_HCPCS | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.298 | FIT DNA_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.299 | FIT DNA Test_Lab_Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.30 | Annual Physical Codes for Tax Pair CN5 | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.300 | Sigmoidoscopy_CPT | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.302 | Sigmoidoscopy_ICD9 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.303 | Sigmoidoscopy_SNOMED | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.304 | Sigmoidoscopy_Event_Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.305 | Colonoscopy_CPT | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.306 | Colonoscopy_HCPCS | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.307 | Colonoscopy_ICD9 | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.308 | Colonoscopy_SNOMED | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.309 | Colonoscopy_Event_Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.310 | FOBT Lab_CPT | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.311 | FOBT Lab_HCPCS | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.312 | FOBT Lab_LOINC | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.313 | FOBT Lab_SNOMED | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.314 | FOBT Lab Test_Lab_Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.315 | Colorectal Cancer_HD_ICD10 | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.316 | Colorectal Cancer_HD_ICD9 | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.317 | Colorectal Cancer_HD_SNOMED | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.318 | Colorectal Cancer_HD_Grouping | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.319 | Absence of Cervix Diagnosis_HD_ICD10 | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.320 | Absence of Cervix Diagnosis_HD_ICD9 | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.321 | Absence of Cervix Diagnosis_HD_SNOMED | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.322 | Absence of Cervix Diagnosis_HD_Grouping | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.323 | Hysterectomy With No Residual Cervix_HD_CPT | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.324 | Hysterectomy With No Residual Cervix_HD_ICD10 | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.325 | Hysterectomy With No Residual Cervix_HD_ICD9 | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.326 | Hysterectomy With No Residual Cervix_HD_SNOMED | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.327 | Hysterectomy With No Residual Cervix_HD_Grouping | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.328 | High Risk HPV Test_HD_CPT | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329 | High Risk HPV Test_HD_HCPCS | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.330 | High Risk HPV Test_HD_LOINC | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.331 | High Risk HPV Test_HD_SNOMED | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332 | High Risk HPV Test_HD_Grouping | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.333 | Cervical Cytology_HD_CPT | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.334 | Cervical Cytology_HD_HCPCS | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.335 | Cervical Cytology_HD_LOINC | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.336 | Cervical Cytology_HD_SNOMED | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.337 | Cervical Cytology_HD_Grouping | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.338 | AFib (Atrial Fibrillation)_ICD9 | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.339 | AFib (Atrial Fibrillation)_ICD10 | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.340 | AFib (Atrial Fibrillation)_SNOMED | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.341 | AFib (Atrial Fibrillation)_LOINC | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.342 | AFib (Atrial Fibrillation)_RxNORM | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.343 | AFib (Atrial Fibrillation)_CPT | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.344 | AFib (Atrial Fibrillation)_Clinical Condition Grouping | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.345 | COVID19 Vaccine_CPT | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.346 | COVID19 Vaccine_HCPCS | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.348 | COVID19 Vaccine_RxNorm | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.349 | COVID19 Vaccine_CVX | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.350 | COVID19 Vaccine_Event Clinical Grouping | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.351 | Coronary Artery Disease (CAD)_ICD9 | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.352 | Coronary Artery Disease (CAD)_ICD10PCS | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.353 | Coronary Artery Disease (CAD)_ICD10CM | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.354 | Coronary Artery Disease (CAD)_CPT | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.355 | Coronary Artery Disease (CAD)_HCPCS | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.356 | Coronary Artery Disease (CAD)_LOINC | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.357 | Coronary Artery Disease (CAD)_SNOMED | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.358 | Coronary Artery Disease (CAD)_CUI_UMLS | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.359 | Coronary Artery Disease (CAD)_Clinical Condition Grouping | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.360 | Allergy List_SNOMED | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.361 | Allergy List_ICD10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.362 | Allergy List_Clinical Grouping Event | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.363 | Statin Use_RxNorm | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.364 | Other Revascularization_SNOMED | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.365 | Other Revascularization_CPT | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.366 | Other Revascularization_Grouping | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.367 | Ischemic Vascular Disease (IVD)_SNOMED | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.368 | Ischemic Vascular Disease (IVD)_ICD10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.369 | Ischemic Vascular Disease (IVD)_Grouping | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.370 | Muscular Pain and Disease_SNOMED | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.371 | Muscular Pain and Disease_ICD10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.372 | Muscular Pain and Disease_Grouping | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.373 | Cirrhosis_SNOMED | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.374 | Cirrhosis_ICD10 | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.375 | Cirrhosis_Grouping | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.376 | IVF_SNOMED | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.377 | IVF_HCPCS | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.378 | IVF_Grouping | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.379 | Estrogen Agonists Medications_RXNORM | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.382 | Pre_Hypertension (Pre_HTN)_Clinical Condition Grouping | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.384 | Family History Hypertension (HTN)_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.385 | Family History Hypertension (HTN)_Clinical Condition Grouping | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.386 | Obesity_Condition_UMLS | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.387 | Podiatry_Taxonomy | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.388 | Cardiology _Taxonomy | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.393 | BMI >=40_Event_Clinical Condition Grouping | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.400 | Smoker Status_Event_Clinical Condition Grouping | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.401 | First Trimester_ICD10 | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.402 | First Trimester_SNOMED | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.403 | First Trimester_LOINC | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.404 | First Trimester_CPT | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.405 | First Trimester_UMLS CUI | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.406 | First Trimester_Clinical Grouping Event | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.408 | Birth Event_ICD10 | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.409 | Birth Event_SNOMED | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.413 | Birth Event_Clinical Grouping Event | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.414 | Obesity_Condition_SNOMED | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.415 | Obesity_Condition_ICD10 | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.416 | Obesity_Condition_ICD9 | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.417 | Obesity_Clinical Grouping Condition | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.418 | Pre_Hypertension (Pre_HTN)_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.419 | Pre_Hypertension (Pre_HTN)_ICD9 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.420 | Pre_Hypertension (Pre_HTN)_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.424 | BMI >=30_Event_Clinical Condition Grouping | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.427 | Obesity_Condition_LOINC | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.428 | Vitals Body Height LOINC | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.429 | Vitals Body Height SnoMed | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.430 | Vitals Body Height | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.431 | bwell_Vital_Blood Glucose_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.432 | Anxiety_Clinical Grouping Condition_ICD9 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.433 | Anxiety_Clinical Grouping Condition_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.434 | Anxiety_Clinical Grouping Condition_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.435 | Anxiety_Clinical Grouping Condition_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.436 | Anxiety_Clinical Grouping Condition | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.437 | bwell_Vital_Blood Oxygen_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.438 | bwell_Vital_Systolic Blood Pressure_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.439 | bwell_Vital_Diastolic Blood Pressure_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.440 | bwell_Vital_Heart Rate_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.441 | bwell_Vital_BMI_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.442 | bwell_Vital_Body Fat_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.443 | bwell_Vital_Body Temperature_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.444 | bwell_Vital_Body Height_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.445 | bwell_Vital_Body Weight_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.446 | bwell_Vital_Respiratory Rate_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.447 | bwell_Vital_Waist Circumference_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.448 | bwell_Vital_Blood Glucose_Clinical Grouping Lab | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.449 | bwell_Vital_Blood Oxygen_Clinical Grouping Event | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.450 | bwell_Vital_Systolic Blood Pressure_Clinical Grouping Event | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.451 | bwell_Vital_Diastolic Blood Pressure_Clinical Grouping Event | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.452 | bwell_Vital_Heart Rate_Clinical Grouping Event | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.453 | bwell_Vital_BMI_Clinical Grouping Event | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.454 | bwell_Vital_Body Fat_Clinical Grouping Event | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.455 | bwell_Vital_Body Temperature_Clinical Grouping Event | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.456 | bwell_Vital_Body Height_Clinical Grouping Event | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.457 | bwell_Vital_Body Weight_Clinical Grouping Event | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.458 | bwell_Vital_Respiratory Rate_Clinical Grouping Event | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.459 | bwell_Vital_Waist Circumference_Clinical Grouping Event | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.460 | Pregnancy_CN_HD_LOINC | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.461 | Pregnancy_CN_HD_CPT | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.462 | Pregnancy_CN_HD_UMLS | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.463 | Second Trimester_ICD10 | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.464 | Second Trimester_SNOMED | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.465 | Second Trimester_Clinical Grouping Event | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.466 | Third Trimester_SNOMED | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.467 | Third Trimester_ICD10 | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.468 | Third Trimester_Clinical Grouping Event | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.469 | Pregnancy Due Date_LOINC | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.470 | Second Trimester_LOINC | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.472 | OGTT_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.473 | OGTT_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.475 | OGTT_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.476 | OGTT_Grouping | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.477 | Second Trimester_CPT | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.479 | Prostate Cancer Screening_HD_ICD9 | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.482 | Prostate Cancer Screening_HD_Grouping | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.484 | Prostate Dysplasia_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.486 | Prostate Dysplasia_Grouping | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.487 | Prostectomy_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.488 | Prostectomy_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.490 | Prostectomy_Grouping | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.494 | PSA Testing _LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.495 | PSA Testing_Grouping | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.496 | Active Pregnancy_CPT | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.497 | Active Pregnancy_ICD10 | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.498 | Active Pregnancy_LOINC | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.499 | Active Pregnancy_SNOMED | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.5 | ADD/ADHD Condition | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.500 | Active Pregnancy_Clinical Grouping Event | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.501 | Abnormal PSA Testing _SNOMED | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.502 | Prediabetes_Clinical Grouping Condition_ICD10 | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.503 | Prediabetes_Clinical Grouping Condition_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.504 | Prediabetes_Clinical Grouping Condition | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.505 | Third Trimester_CPT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.506 | Third Trimester_LOINC | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.508 | bwell_Vital_Waist Circumference_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.509 | bwell_Vital_Blood Oxygen_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.510 | bwell_Vital_Body Temperature_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.511 | bwell_Vital_Diastolic Blood Pressure_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.512 | bwell_Vital_Systolic Blood Pressure_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.513 | bwell_Vital_Systolic_and_Diastolic Blood Pressure_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.514 | bwell_Vital_Systolic_and_Diastolic Blood Pressure_Clinical Grouping Event | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.515 | bwell_Vital_Heart Rate_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.516 | bwell_Vital_Respiratory Rate_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.517 | Lupus_Clinical_Condition_ICD10 | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.519 | Lupus_Clinical_Condition_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.520 | Lupus_Clinical Condition Grouping | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.523 | UTI_Clinical_Condition_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.524 | UTI_Clinical Condition Grouping | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.525 | Postpartum_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.526 | Postpartum_HCPCS | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.527 | Postpartum_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.528 | Postpartum_ICD9CM | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.529 | Postpartum_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.530 | Postpartum_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.531 | Postpartum_Clinical Grouping Event | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.532 | bwell_Vital_Head Circumference_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.533 | bwell_Vital_Head Circumference_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.534 | bwell_Vital_Head Circumference_Clinical Grouping Event | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.535 | bwell_Vital_Body Surface Area_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.536 | bwell_Vital_Body Surface Area_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.537 | bwell_Vital_Body Surface Area_Clinical Grouping Event | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.538 | bwell_Vital_Vital Signs Panel_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.539 | bwell_Vital_Vital Signs Panel_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.540 | bwell_Vital_Vital Signs Panel_Clinical Grouping Event | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.541 | bwell_Vital_Blood Pressure Panel_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.542 | bwell_Vital_Blood Pressure Panel_Clinical Grouping Event | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.543 | Depression_Clinical Grouping Condition_CPT | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.544 | Depression_Clinical Grouping Condition_HCPCS | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.545 | Depression_Clinical Grouping Condition_ICD10 | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.546 | Depression_Clinical Grouping Condition_ICD9 | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.547 | Depression_Clinical Grouping Condition_LOINC | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.548 | Depression_Clinical Grouping Condition_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.549 | Depression_Clinical Grouping Condition | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.550 | MI (Myocardial Infarction)_Clinical Grouping Condition_ICD9 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.551 | MI (Myocardial Infarction)_Clinical Grouping Condition_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.552 | MI (Myocardial Infarction)_Clinical Grouping Condition_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.553 | MI (Myocardial Infarction)_Clinical Grouping Condition | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.554 | CABG_Clinical Grouping Condition_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.555 | CABG_Clinical Grouping Condition_HCPCS | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.556 | CABG_Clinical Grouping Condition_ICD10PCS | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.557 | CABG_Clinical Grouping Condition_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.558 | CABG_Clinical Grouping Condition | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.559 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.56 | Diabetic Retinal Screening HD CPT | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.560 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_HCPCS | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.561 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD10PCS | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.562 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD9PCS | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.563 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.564 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.565 | Essential HTN_HD_Clinical Grouping Condition_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.566 | Essential HTN_HD_Clinical Grouping Condition_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.567 | Essential HTN_HD_Clinical Grouping Condition | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.568 | Total and Partial Neph_HD_Clinical Grouping Condition_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.569 | Total and Partial Neph_HD_Clinical Grouping Condition_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.570 | Total and Partial Neph_HD_Clinical Grouping Condition_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.571 | Total and Partial Neph_HD_Clinical Grouping Condition | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.572 | Kid Trans and Hx_HD_Clinical Grouping Condition_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.573 | Kid Trans and Hx_HD_Clinical Grouping Condition_HCPCS | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.574 | Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10CM | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.575 | Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10PCS | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.576 | Kid Trans and Hx_HD_Clinical Grouping Condition_ICD9 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.577 | Kid Trans and Hx_HD_Clinical Grouping Condition_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.578 | Kid Trans and Hx_HD_Clinical Grouping Condition | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.579 | HbA1c Level Less Than 8.0_HD_Clinical Grouping Condition_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.580 | HbA1c Level Less Than 8.0_HD_Clinical Grouping Condition | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.581 | Systolic Less than 140_HD_Clinical Grouping Event_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.582 | Diastolic Less than 90_HD_Clinical Grouping Event_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.583 | Systolic Less than 140_HD_Clinical Grouping Event | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.584 | Diastolic Less than 90_HD_Clinical Grouping Event | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.585 | COPD_Clinical_Grouping_Condition_ICD9 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.586 | COPD_Clinical_Grouping_Condition_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.587 | COPD_Clinical_Grouping_Condition_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.588 | COPD_Clinical Condition Grouping | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.589 | Polypharmacy_Clinical_Grouping_Condition_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.590 | Polypharmacy_Clinical_Grouping_Condition_ICD9 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.591 | Polypharmacy_Clinical_Grouping_Condition_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.592 | Polypharmacy_Clinical_Grouping_Condition_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.593 | Polypharmacy_Clinical Condition Grouping | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.595 | Thyroid Cancer_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.596 | Thyroid Cancer_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.597 | Thyroid Cancer_Grouping | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.598 | Allergy Iodine_SNOMED | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.599 | Allergy to contrast_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.600 | Allergy to contrast_ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.601 | Allergy to contrast_Grouping | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.602 | Contrast induced nephropathy_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.603 | Contrast induced nephropathy_ICD10 | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.604 | Contrast induced nephropathy_Grouping | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.605 | Systolic Blood Pressure_Compliant | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.606 | Diastolic Blood Pressure_Compliant | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.607 | Diastolic Blood Pressure_Compliant_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.608 | Systolic Blood Pressure_Compliant_CPT | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.609 | bwell Systolic Blood Pressure Vitals_UI_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.610 | bwell Systolic Blood Pressure Vitals_UI_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.611 | bwell Diastolic Blood Pressure Vitals_UI_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.612 | bwell Diastolic Blood Pressure Vitals_UI_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.613 | bwell Combo Blood Pressure Vitals_UI_LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.614 | bwell Combo Blood Pressure Vitals_UI_SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.615 | bwell Systolic Blood Pressure_UI | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.616 | bwell Diastolic Blood Pressure_UI | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.617 | bwell Combo Blood Pressure_UI | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.618 | b.well Herpes Zoster Vaccine CN_HD | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.619 | b.well Herpes Zoster Vaccine CN_HD_SNOMED | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.620 | b.well Herpes Zoster Vaccine CN_HD_CVX | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.621 | b.well Herpes Zoster Vaccine CN_HD_CPT | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.622 | b.well Herpes Zoster Vaccine CN_HD_2dose | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.623 | b.well Herpes Zoster Vaccine CN_HD_2dose_CPT | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.624 | b.well Herpes Zoster Vaccine CN_HD_2dose_CVX | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.625 | b.well Herpes Zoster Vaccine CN_HD_2dose_SNOMED | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.626 | b.well Herpes Zoster Vaccine CN_HD_Exclusions | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.627 | b.well Herpes Zoster Vaccine CN_HD_Exclusions_SNOMED | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.628 | b.well Adult RSV Vaccine CN_CVX | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.629 | b.well Adult RSV Vaccine CN_CPT | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.630 | b.well Adult RSV Vaccine CN_HCPCS | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.631 | b.well Adult RSV Vaccine CN_SNOMED | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.633 | Lp(a) Test_SNOMED | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.634 | Lp(a) Test_LOINC | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.635 | LP(a) Test_ICD | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.636 | Lp(a) Test_CPT | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.637 | LP(a) Test | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.638 | b.well Adult Tetanus Vaccine CN | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.639 | BWellAdultTetanusVaccineCN_SNOMED | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.640 | b.well Adult Tetanus Vaccine CN_CPT | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.641 | b.well Adult Tetanus Vaccine CN_CVX | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.642 | b.well Adult Tetanus Vaccine CN_Exclusions_SNOMED | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.643 | b.well Adult Tetanus Vaccine CN_Exclusions | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.644 | BWellAdultTetanusVaccineCN_RxNorm | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.645 | Pneumococcal Vaccine HD_CN_ Allergy | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.646 | bwell COVID Vaccine CN_Allergy | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.647 | bwell Covid Vaccine CN_Allergy_SNOMED | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.648 | bwell COVID Vaccine CN_Met | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.9 | Metabolic Syndrome ICD10 | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.91 | Cardiomyopathy Dilated ICD9 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.92 | Cardiomyopathy Dilated ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.93 | Cardiomyopathy Dilated SNOMED | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.94 | Cardiomyopathy Dilated Condition | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.95 | Cardiomyopathy Dilated LOINC | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.96 | Cardiomyopathy Hypertrophic ICD9 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.97 | Cardiomyopathy Hypertrophic ICD10 | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.98 | Cardiomyopathy Hypertrophic SNOMED | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.99 | Cardiomyopathy Hypertrophic LOINC | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.12 | SNOMEDFindingValuesQualifierValue | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.13 | SNOMED Organism from LOINC Answer List | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.18 | Medication Prescribable Brand Name | active | 2021-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.2 | SNOMED Organisms | active | 2021-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.22 | Medicinal Ingredients RXNORM | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.1 | Mental Status Observation | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.10 | Other Unknown Nulls | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.11 | Sexual Orientation Including nulls and Data Absent Reason | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.12 | Pregnancy Status Observation | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.2 | No Healthcare Agent Included Reason | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.3 | Sex | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.4 | Asked Declined Data Absent Reason | active | 2023-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.5 | Act Encounter Codes | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.6 | Completed or Nullified Act Status | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.7 | Data Absent Reason Types of Unknown | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.8 | Medication Adherence | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1242.2 | Sickle Cell Disease | active | 2022-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1242.4 | Depression | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.1 | Food Insecurity Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.100 | Intimate Partner Violence Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.101 | Less Than High School Education Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.102 | Less Than High School Education Diagnoses ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.103 | Less Than High School Education Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.106 | Transportation Insecurity Interventions SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.107 | Financial Insecurity Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.108 | Financial Insecurity Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.109 | Financial Insecurity Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.11 | Food Insecurity Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.110 | Medical Cost Burden Goals SNOMED CT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.111 | Health Insurance Coverage Status Goals SNOMED CT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.112 | Health Literacy Diagnoses SNOMED CT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.113 | Health Literacy Diagnoses ICD10CM | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.114 | Health Literacy Goals SNOMED CT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.115 | Health Literacy Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.116 | Health Literacy Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.117 | Health Literacy Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.118 | Health Literacy Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.119 | Health Literacy Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.120 | Medical Cost Burden Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.121 | Health Insurance Coverage Status Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.122 | Medical Cost Burden Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.123 | Medical Cost Burden Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.124 | Health Insurance Coverage Status Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.125 | Health Insurance Coverage Status Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.126 | Social Determinants of Health Screening Assessments | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.127 | Food Insecurity Screening Assessments | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.128 | Transportation Insecurity Screening Assessments | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.129 | Homelessness Screening Assessments | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.13 | Homelessness Diagnoses ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.130 | Housing Instability Screening Assessments | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.131 | Inadequate Housing Screening Assessments | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.132 | Less Than High School Education Screening Assessments | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.133 | Unemployment Screening Assessments | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.134 | Veteran Status Screening Assessments | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.135 | Social Connection Screening Assessments | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.136 | Stress Screening Assessments | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.137 | Cognitive disorder Diagnosis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.138 | Financial Insecurity Screening Assessments | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.139 | Material Hardship Screening Assessments | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.14 | Homelessness Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.140 | Intimate Partner Violence Screening Assessments | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.141 | Health Literacy Screening Assessments | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.142 | Medical Cost Burden Screening Assessments | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.143 | Health Insurance Coverage Status Screening Assessments | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.144 | Elder Abuse Screening Assessments | active | 2022-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.145 | Less Than High School Education Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.146 | Financial Insecurity Diagnoses ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.147 | Health Insurance Coverage Status Diagnoses ICD10CM | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.148 | Health Insurance Coverage Status Diagnoses | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.149 | Health Insurance Coverage Status Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.15 | Food Insecurity Interventions CPT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.150 | Material Hardship Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.151 | Medical Cost Burden Diagnoses ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.152 | Medical Cost Burden Diagnoses SNOMED CT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.153 | Medical Cost Burden Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.154 | Medical Cost Burden Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.157 | Transportation Insecurity Diagnoses ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.158 | Homelessness Goals SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.159 | Homelessness Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.16 | Food Insecurity Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.160 | Housing Instability Goals SNOMED CT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.161 | Housing Instability Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.162 | Transportation Insecurity Goals SNOMED CT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.163 | Transportation Insecurity Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.164 | Veteran Status Interventions SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.167 | Inadequate Housing Screening Assessments Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.168 | Material Hardship Screening Assessments Questions | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.169 | Stress Screening Assessments Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.17 | Food Insecurity Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.170 | Transportation Insecurity Screening Assessments Questions | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.171 | Unemployment Screening Assessments Questions | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.172 | Veteran Status Screening Assessments Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.173 | Financial Insecurity Screening Assessments Answers | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.174 | Food Insecurity Screening Assessments Answers | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.175 | Health Literacy Screening Assessments Answers | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.176 | Homelessness Screening Assessments Answers | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.177 | Housing Instability Screening Assessments Answers | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.178 | Inadequate Housing Screening Assessments Answers | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.179 | Less Than High School Education Screening Assessments Answers | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.18 | Homelessness Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.180 | Material Hardship Screening Assessments Answers | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.181 | Stress Screening Assessments Answers | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.182 | Transportation Insecurity Screening Assessments Answers | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.183 | Unemployment Screening Assessments Answers | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.184 | Veteran Status Screening Assessments Answers | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.185 | Health Insurance Coverage Status Screening Assessments Answers | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.186 | Health Insurance Coverage Status Screening Assessments Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.187 | Medical Cost Burden Screening Assessments Answers | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.188 | Medical Cost Burden Screening Assessments Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.189 | Elder Abuse Screening Assessments Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.19 | Homelessness Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.190 | Elder Abuse Screening Assessments Answers | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.191 | Elder Abuse Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.192 | Veteran Status Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.193 | Financial Insecurity Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.194 | Food Insecurity Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.195 | Health Literacy Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.196 | Homelessness Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.197 | Housing Instability Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.198 | Intimate Partner Violence Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.199 | Less Than High School Education Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.20 | Homelessness Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.200 | Material Hardship Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.201 | Medical Cost Burden Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.202 | Social Connection Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.203 | Stress Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.204 | Transportation Insecurity Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.205 | Unemployment Screening Assessments And Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.206 | Social Determinants of Health Screening Assessments And Questions | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.207 | Social Determinants of Health Screening Assessments Questions | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.208 | Social Determinants of Health Screening Assessments Answers | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.209 | Intimate Partner Violence Screening Assessments Answers | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.21 | Homelessness Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.210 | Social Connection Screening Assessments Answers | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.211 | Intimate Partner Violence Screening Assessments Questions | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.212 | Social Connection Screening Assessments Questions | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.213 | Health Insurance Coverage Status Diagnoses SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.214 | Veteran Status Goals | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.215 | Veteran Status Goals SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.217 | Digital Literacy Diagnoses SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.218 | Digital Literacy Diagnoses ICD10CM | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.219 | Digital Literacy Goals SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.22 | Housing Instability Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.220 | Digital Literacy Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.224 | Digital Literacy Diagnoses | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.225 | Digital Literacy Goals | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.226 | Digital Literacy Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.227 | Digital Literacy Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.229 | Digital Access Diagnoses SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.23 | Housing Instability Diagnoses ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.230 | Digital Access Diagnoses ICD10CM | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.231 | Digital Access Diagnoses | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.232 | Digital Access Goals SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.233 | Digital Access Goals | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.234 | Digital Access Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.235 | Digital Access Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.236 | Digital Access Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.237 | Digital Access Screening Assessments | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.238 | Digital Access Screening Assessments Questions | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.239 | Digital Access Screening Assessments Answers | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.24 | Housing Instability Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.240 | Digital Access Screening Assessments And Questions | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.241 | Utility Insecurity Diagnoses SNOMED CT | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.242 | Utility Insecurity Diagnoses ICD10CM | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.243 | Utility Insecurity Diagnoses | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.244 | Utility Insecurity Goals SNOMED CT | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.245 | Utility Insecurity Goals | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.246 | Utility Insecurity Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.247 | Utility Insecurity Procedures | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.248 | Utility Insecurity Screening Assessments | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.249 | Utility Insecurity Screening Assessments Questions | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.25 | Transportation Insecurity Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.250 | Utility Insecurity Screening Assessments Answers | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.251 | Utility Insecurity Screening Assessments And Questions | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.252 | Utility Insecurity Service Requests | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.253 | Social Determinants of Health General Interventions HCPCS | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.254 | Incarceration Status Diagnoses ICD10CM | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.255 | Incarceration Status Diagnoses SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.256 | Incarceration Status Goals SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.257 | Incarceration Status Goals | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.258 | Incarceration Status Diagnoses | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.259 | Incarceration Status Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.26 | Transportation Insecurity Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.260 | Incarceration Status Procedures | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.261 | Incarceration Status Service Requests | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.262 | Language Access Diagnoses | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.263 | Language Access Diagnoses ICD10CM | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.264 | Language Access Diagnoses SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.265 | Language Access Goals SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.266 | Language Access Goals | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.267 | Language Access Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.268 | Language Access Procedures | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.269 | Language Access Service Requests | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.27 | Transportation Insecurity Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.270 | Language Access Screening Assessments | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.271 | Language Access Screening Assessments Answers | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.272 | Language Access Screening Assessments Questions | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.273 | Language Access Screening Assessments And Questions | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.28 | Transportation Insecurity Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.29 | Financial Insecurity Goals SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.3 | Food Insecurity Diagnoses ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.30 | Financial Insecurity Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.31 | Financial Insecurity Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.32 | Financial Insecurity Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.33 | Material Hardship Diagnoses ICD10CM | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.34 | Material Hardship Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.35 | Material Hardship Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.36 | Material Hardship Goals SNOMED CT | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.37 | Material Hardship Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.38 | Material Hardship Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.39 | Material Hardship Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.4 | Food Insecurity Goals SNOMED CT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.40 | Unemployment Diagnoses ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.41 | Unemployment Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.42 | Unemployment Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.43 | Housing Instability Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.44 | Housing Instability Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.45 | Housing Instability Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.46 | Inadequate Housing Diagnoses SNOMED CT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.47 | Inadequate Housing Diagnoses ICD10CM | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.48 | Inadequate Housing Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.49 | Inadequate Housing Goals SNOMED CT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.5 | Social Determinants of Health General Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.50 | Inadequate Housing Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.51 | Inadequate Housing Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.52 | Inadequate Housing Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.53 | Inadequate Housing Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.54 | Less Than High School Education Goals SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.55 | Less Than High School Education Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.56 | Less Than High School Education Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.57 | Less Than High School Education Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.58 | Unemployment Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.59 | Unemployment Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.6 | Food Insecurity Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.60 | Unemployment Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.61 | Elder Abuse Diagnoses ICD10CM | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.62 | Elder Abuse Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.63 | Elder Abuse Diagnoses | active | 2022-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.64 | Elder Abuse Goals SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.65 | Elder Abuse Goals | active | 2022-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.66 | Elder Abuse Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.67 | Elder Abuse Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.68 | Elder Abuse Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.69 | Unemployment Goals SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.7 | Food Insecurity Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.70 | Unemployment Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.71 | Social Determinants of Health Goals | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.72 | Stress Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.73 | Stress Interventions SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.74 | Stress Diagnoses ICD10CM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.75 | Stress Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.76 | Veteran Status Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.77 | Veteran Status Diagnoses ICD10CM | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.78 | Veteran Status Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.79 | Social Connection Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.8 | Social Determinants of Health General Interventions CPT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.80 | Social Connection Diagnoses ICD10CM | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.81 | Social Connection Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.82 | Intimate Partner Violence Diagnoses SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.83 | Intimate Partner Violence Diagnoses ICD10CM | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.84 | Intimate Partner Violence Diagnoses | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.85 | Stress Goals SNOMED CT | active | 2023-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.86 | Stress Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.87 | Stress Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.88 | Social Connection Goals SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.89 | Social Connection Goals | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.9 | Food Insecurity Interventions HCPCS | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.90 | Veteran Status Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.91 | Veteran Status Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.92 | Stress Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.93 | Social Connection Interventions SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.94 | Social Connection Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.95 | Social Connection Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.96 | Intimate Partner Violence Interventions SNOMED CT | active | 2024-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.97 | Intimate Partner Violence Procedures | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.98 | Intimate Partner Violence Service Requests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.99 | Intimate Partner Violence Goals SNOMED CT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.105 | Mechanical Ventilation Procedures | active | 2022-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.106 | Mechanical Ventilation | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.107 | Mechanical Ventilation | active | 2022-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.109 | aPTT Tests | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.119 | Opioid Antagonist | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.12 | High Risk Diagnosis for AKI | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.120 | Opioids | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.124 | Immune Modulators | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.130 | Suicide Attempt | active | 2023-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.134 | Central Nervous System Depressants | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.136 | Leukemia or Lymphoma | active | 2022-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.137 | Liver Disease Moderate to Severe | active | 2022-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.138 | COVID19 | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.139 | COVID 19 | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.14 | Hemolytic Uremic Syndrome (HUS) | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.140 | COVID 19 | active | 2022-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.162 | Obesity | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.163 | Antidepressants | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.164 | Antihypertensives | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.165 | Delirium | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.166 | Dementia | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.167 | Psychosis | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.168 | Delirium or Dementia and Other Psychoses | active | 2022-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.169 | Depression | active | 2022-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.170 | Diuretics | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.171 | Epilepsy | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.172 | Neurologic Movement Disorders | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.173 | Neurologic Disorders, Other | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.174 | Neurologic Movement and Related Disorders | active | 2022-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.175 | Peripheral Neuropathy | active | 2022-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.176 | Stroke | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.177 | Abnormal Weight Loss and Malnutrition | active | 2022-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.178 | Intubation | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.179 | Intubation | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.180 | Tracheostomy Procedures | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.181 | Tracheostomy Procedures | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.182 | Head and Neck Surgeries with High Risk Airway Compromise | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.185 | Spinal Surgery | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.187 | Routes of Administration for Opioid Antagonists | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.19 | High Risk Procedures for AKI | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.197 | Hospital Based Dialysis Services | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.198 | Hospital Based Dialysis Services | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.199 | Hospital Based Dialysis Services | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.200 | Nephrectomy | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.201 | Thrombotic Thrombocytopenic Purpura | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.204 | VTE Prophylaxis | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.205 | Moderate Injuries | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.206 | General and Neuraxial Anesthesia | active | 2023-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.207 | General and Neuraxial Anesthesia | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.208 | General and Neuraxial Anesthesia | active | 2023-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.209 | Non Invasive Oxygen Therapy by Nasal Cannula or Mask | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.21 | Creatinine Mass Per Volume | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.210 | Continuous and Bilevel Positive Airway Pressure | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.211 | Continuous and Bilevel Positive Airway Pressure | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.213 | Non Invasive Oxygen Therapy | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.214 | Non Invasive Oxygen Therapy Devices | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.216 | Procedural Hospital Locations | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.217 | ASA physical status class | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.218 | Blood urea nitrogen lab test | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.219 | Hemoglobin lab test | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.22 | Anticoagulants for All Indications | active | 2022-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.220 | Smoking status | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.221 | Albumin lab test | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.222 | Leukocyte count lab test | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.223 | Bilirubin lab test | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.224 | Aspartate transaminase lab test | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.226 | Cardiac Arrest | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.23 | Coagulation Disorders | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.230 | PO Antibacterials | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.231 | Injectable Antifungals | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.238 | Neuromuscular Disorder | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.239 | Neuromuscular Disorder | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.24 | Malignant Bone Disease | active | 2022-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.240 | Degenerative Neurological Disorder | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.241 | Degenerative Neurological Disorder | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.242 | Heart and Lung Transplants | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.243 | Heart and Lung Transplants | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.245 | Lung Resections and Excisions | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.246 | Lung Resections and Excisions | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.247 | Chest Wall Procedures | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.248 | Chest Wall Procedures | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.249 | Maxillary Procedures | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.250 | Maxillary Procedures | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.251 | Head, Neck, and Thoracic Surgeries with High Risk Airway Compromise | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.252 | Anesthesia Requiring Monitored Care | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.253 | Anesthesia Requiring Monitored Care | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.255 | Anesthesia Requiring Monitored Care | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.256 | Osteoporosis | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.260 | Rivaroxaban Anticoagulant | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.262 | Fondaparinux Anticoagulant | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.263 | Dalteparin Anticoagulant | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.264 | Heparin | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.268 | Enoxaparin Anticoagulant | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.271 | Undetectable Lab Result Value | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.272 | Undetectable Lab Result Value | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.274 | Dietary Recommendations | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.275 | Bariatric Procedures | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.276 | Telemedicine Services | active | 2025-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.277 | Prostate Cancer Treatment | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.28 | Traumatic Avulsion of Kidney | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.29 | Rapidly Progressive Nephritic Syndrome | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.301 | LDL Cholesterol | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.33 | Obstetrics and VTE Obstetrics | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.34 | Glucose Lab Test Mass Per Volume | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.349 | Tuberculosis for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.350 | Tuberculosis for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.351 | Tuberculosis for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.352 | Androgen Deprivation Therapy for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.353 | Bacillus Calmette Guerin for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.354 | Bladder Cancer for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.355 | Chemotherapy Agents for Advanced Cancer | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.356 | Cystectomy for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.357 | Cystectomy for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.358 | Cystectomy for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.359 | DEXA Bone Density for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.360 | Hospital Services for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.361 | Immunocompromised Conditions | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.362 | Immunocompromised Conditions | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.363 | Immunocompromised Conditions | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.364 | Immunosuppressive Drugs for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.365 | Mixed Histology Urothelial Cell Carcinoma for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.366 | Morbid Obesity | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.367 | Morbid Obesity | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.368 | Morbid Obesity | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.369 | Unavailability of Bacillus Calmette Guerin for Urology Care | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.370 | Urinary Retention | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.371 | Urinary Retention | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.372 | Urinary Retention | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.374 | Face to Face Interaction | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.375 | Face to Face Interaction | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.376 | HIV Viral Load Tests | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.377 | HIV Viral Load Tests | active | 2025-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.389 | Syphilis Tests | active | 2025-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.4 | Nephrectomy | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.79 | Acute Brain or Spinal Injury or Hemorrhage | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.8 | Large Body Surface Area (BSA) Burns | active | 2022-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.80 | Pulmonary Arterial Thrombectomy | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.81 | Extracorporeal Membrane Oxygenation | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.85 | Elective Inpatient Encounter | active | 2023-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.86 | Intubation | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.88 | Acute Respiratory Failure | active | 2023-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.89 | Tracheostomy Diagnoses | active | 2022-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.90 | Tracheostomy Procedures | active | 2023-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.91 | Neuromuscular Disorder | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.92 | Degenerative Neurological Disorder | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.93 | Head and Neck Surgeries with High Risk Airway Compromise | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.94 | Oxygen Partial Pressure in Arterial Blood | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.95 | Carbon Dioxide Partial Pressure in Arterial Blood | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.96 | Arterial Blood pH | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1250.2 | Psychological Neuropsychological or Neurobehavioral Testing | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1250.3 | Psychological or Neuropsychological Testing | active | 2023-11 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.10 | Tricuspid Valve Regurgitation | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.12 | Hypertension | active | 2022-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.2 | Valvular Heart Disease | active | 2022-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.22 | Acute Kidney Injury | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.23 | Anemia | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.24 | Cardiac Arrhythmias | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.25 | Attention Deficit and Hyperactivity Disorder | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.26 | Cerebrovascular Disease | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.27 | Seizure Disorder | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.28 | Proteinuria | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.29 | Thyroid Hormone Disorder | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.30 | Thromboembolic Disease | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.31 | Parkinson's Disease and Parkinsonism | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.32 | Upper GI Diseases | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.33 | Failure to Thrive | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.34 | Osteoporosis | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.35 | Mood Disorders | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.36 | Dyslipidemia | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.37 | Heart Failure | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.38 | Coronary Artery Disease | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.39 | Chronic Kidney Disease | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.40 | Chronic Obstructive Pulmonary Disease | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.41 | Diabetes Mellitus | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1254.1 | EventTiming-TimingEvent | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1254.2 | EventTiming-EventTiming | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1258.1 | Gonorrhea Screening | active | 2025-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1258.2 | Abnormal Weight Loss | active | 2024-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.2 | Prescribable brand and generic non insulin drugs for hyperglycemia in Type 2 Diabetes | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.3 | Prescribable brand and generic insulins and analogues | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.4 | eGFR Using 2021 Race Free Formulas | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.5 | Fructosamine in Serum or Plasma | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.6 | Glucose tests in venous blood, capillary blood, serum/plasma for Diabetes | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.7 | Creatinine in serum/plasma | active | 2023-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.9 | IgE Agonists, prescribable | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.10 | Estrogen Receptor Testing for Orserdu | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.100 | MMR Proficient | active | 2024-01 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.101 | Systemic Cancer Directed Therapy | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.102 | Face To Face Interaction | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.104 | Erdafitinib | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.107 | Chemotherapy Encounter | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.108 | Urothelial Cancers ICD9 | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.109 | Urothelial Cancer ICD10 | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.11 | Estrogen Receptor Test for Orserdu | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.110 | Urothelial Cancers | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.111 | Prior Therapies for Erdafitinib | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.112 | Urothelial Cancer Histologies | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.113 | Malignant Tumor Behavior | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.114 | Localized Bladder Cancer Stage SNOMED | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.116 | Localized Bladder Cancer Staging | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.117 | Advanced Bladder Cancer Stage | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.118 | Localized Bladder Cancer T Stage | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.119 | Localized Bladder Cancer T Stage | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.12 | Negative | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.120 | Localized Bladder Cancer N Stage | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.121 | Localized Bladder Cancer M Stage | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.122 | Advanced Bladder Cancer M Stage | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.124 | Locoregional Urothelial Cancer ICD9 | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.125 | Locoregional Urothelial Cancer ICD10 | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.126 | Locoregional Urothelial Cancer SNOMED | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.127 | Locoregional Urothelial Cancer | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.128 | FGFR3 Gene | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.129 | FGFR3 Gene Interpretation Positive SNOMED | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.13 | HER2 Negative | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.130 | FGFR3 Gene Interpretation Positive LOINC | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.131 | FGFR3 Gene Interpretation Positive NCI | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.133 | FGFR3 Gene Interpretation Positive | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.134 | FGFR3 Gene Interpretation Negative SNOMED | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.135 | FGFR3 Gene Interpretation Negative NCI | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.137 | FGFR3 Gene Interpretation Negative | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.138 | FGFR3 Molecular Variants | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.139 | Tumor Behavior | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.14 | Endocrine Therapy | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.140 | Physcological Support for Cancer | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.141 | Referral For Pain From Cancer | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.142 | Cancer Pain Education | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.143 | Telehealth Encounters | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.144 | Pain Assessment Score | active | 2024-02 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.146 | Telehealth Encounters SNOMEDCT | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.147 | Telehealth Encounters CPT | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.148 | Telehealth Encounters HCPCS | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.149 | Telehealth Encounters All | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.15 | All Metastatic Sites | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.150 | Chemo Admin SNOMEDCT | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.151 | Chemo Admin CPT | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.152 | Chemo Admin HCPCS | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.153 | Chemotherapy Administration All | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.154 | Radiation Treatment CPT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.155 | Radiation Treatment HCPCS | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.156 | Radiation Treatment SNOMEDCT | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.157 | Radiation Treatment All | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.158 | Bipolar Diagnosis Codes | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.159 | Telephone Visits SNOMED | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.16 | All Metastatic Sites | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.160 | Telephone Visit CPT | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.161 | Telephone Visits All | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.162 | Adolescent depression screening assessment | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.163 | Adult depression screening assessment LOINC | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.165 | Referral for Depression Adult | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.166 | Referrals for Adolescent Depression | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.167 | Follow Ups for Adolescent Depression | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.168 | FollowUps for Adult Depression | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.169 | Depression Screen Declined for Medical Reason | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.17 | Metastatic Breast Cancer | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.170 | Physical Therapy Evaluations SNOMEDCT | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.171 | Physical Therapy Evaluation CPT | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.172 | Physical Therapies Evaluations | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.173 | Non Opioid Analgesics | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.174 | Adjuvant Analgesics | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.176 | Lung Cancer ICD9 | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.177 | Lung Cancer ICD10 | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.178 | Lung Cancer | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.179 | Prior Therapies for Osimertinib | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.18 | Stage IA | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.181 | Plan of Care for Pain | active | 2024-03 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.182 | All Antineoplastic Agents | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.183 | Locally Advanced NSCLC Stage Group | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.185 | Localized NSCLC Stage Group SNOMED | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.186 | Radiation Treatment Management | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.187 | Plan of Care | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.188 | Documentation of Plan of Care | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.189 | Pain Present | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.19 | Stage IB | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.190 | Localized NSCLC Stage Group NCIM | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.192 | Localized NSCLC Stage Group | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.193 | Advanced NSCLC Stage Group | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.194 | NSCLC M Stage (metastatic) | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.195 | NSCLC T Stage | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.196 | NSCLC N Stage | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.197 | SCLC and rarer lung cancer histology | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.198 | EGFR Gene | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.199 | EGFR Gene Interpretation Positive SNOMED | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.20 | Stage IIA | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.200 | EGFR Gene Interpretation Positive LOINC | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.201 | EGFR Gene Interpretation Positive | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.202 | EGFR Osimertinib Molecular Variants | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.203 | EGFR Generic Molecular Variant NCIM | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.204 | EGFR Generic Molecular Variant SNOMED | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.205 | EGFR Generic Molecular Variant LOINC | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.206 | EGFR Molecular Variants Osimertinib PM | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.207 | Osimertinib | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.208 | Pemetrexed | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.209 | Radiation Treatment Management SNOMEDCT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.21 | Stage IIB | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.210 | Radiation Treatment Management Codes | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.211 | Radiation Treatment Delivery CPT | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.212 | 77427 Management Code | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.213 | Radiation Treatment Delivery HCPCS | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.214 | Radiation Treatment Delivery NCIM | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.215 | Radiation Treatment Delivery SNOMED | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.216 | Radiation Treatment Delivery | active | 2024-04 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.217 | MET Gene Test | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.219 | Tepotinib | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.22 | Stage IIIA | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.220 | MET Positive gene interpretation | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.227 | MET Exon 14 skipping molecular variant | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.23 | Stage IIIB | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.230 | All Cancer Directed therapies | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.231 | EGFR Amivantamab Molecular Variants | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.232 | EGFR Molecular Variants Amivantamab PM | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.233 | test43 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.234 | ROS1 Molecular Variants Repotrectinib PM | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.235 | ROS1 Repotrectinib Molecular Variants | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.236 | ROS1 Negative (geneinterpretation) SNOMEDCT | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.237 | ROS1 Negative (geneinterpretation) NCI | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.238 | ROS1 Negative (geneinterpretation) SNOMEDCT,NCI | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.239 | ROS1 Positive (geneinterpretation) | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.24 | Stage IIIC | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.240 | ROS1 results (HGNC) | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.241 | ROS1 Gene Rearrangement | active | 2024-05 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.242 | RET Test (HGNC) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.243 | RET Positive (Genei interpretation ) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.244 | RET Gene Rearrangement | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.245 | RET Negative (geneinterpretaion) SNOMED | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.246 | RET Negative (geneinterpretaion) NCI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.247 | RET Negative (geneinterpretaion) SNOMEDCT,NCI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.248 | RET Fusion Molecular Variants | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.249 | pralsetinib | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.25 | ESR1 Gene Test | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.250 | Repotrectinib Value set | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.251 | Amivantamab | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.252 | Alectinib Drug | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.253 | Gemcitabine Drug Value set | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.254 | vinorelbine Drug | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.255 | NSCLC_Tumor_resection SNOMEDCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.256 | NSCLC_Tumor_resection CPT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.257 | NSCLC_Tumor_resection SNOMEDCT CPT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.258 | ALK results (HGNC) | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.259 | ALK Positive (geneinterpretation) SNOMED | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.26 | ESR1 Genetic Mutation | active | 2023-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.260 | ALK Positive (geneinterpretation) NCI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.261 | ALK Positive (geneinterpretation) SNOMEDCT NCI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.262 | ALK Negative (geneinterpretation) SNOMEDCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.263 | ALK Negative (geneinterpretation) NCI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.264 | ALK Negative (geneinterpretation) SNOMEDCT NCI | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.265 | Locoregional Sites | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.266 | NSCLC N2 Stage | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.267 | NSCLC N1 Stage | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.268 | NSCLC N0 Stage | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.269 | NSCLC T3_T4 Stage | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.27 | Genetic Test Finding | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.270 | NSCLC T2 Stage | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.271 | NSCLC T1 Stage | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.272 | Locally_Advanced_Metastatic_NSCLC Stage Group | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.273 | Localized_Inclusion_NSCLC Stage Group | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.274 | Localized_Exclusion_NSCLC Stage Group | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.275 | tarlatamab dlle | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.276 | Extensive SCLC Stage Group SNOMEDCT | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.277 | Extensive SCLC Stage Group NCIM | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.278 | Extensive SCLC Stage Group | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.279 | Localized SCLC Stage Group | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.28 | Her2 Negative | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.280 | SCLC M Stage (metastatic) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.281 | SCLC T Stage | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.282 | SCLC N Stage | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.283 | SCLC histology (to include those patients) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.284 | Binimetinib | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.285 | Encorafenib | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.286 | Encorafenib PM Molecular variant | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.288 | BRAF Positive (geneinterpretation) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.289 | BRAF test (HGNC) | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.29 | HER2 Positive | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.292 | Prior therapy for Amivantamab | active | 2024-06 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.293 | ENHERTU Drug | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.294 | Metastatic_Solid_Cancer_Stage Group SNOMED CT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.295 | Locally_Advanced_Solid_Cancer_Stage Group SNOMED CT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.296 | Localized_Solid_Cancer_Stage Group SNOMED CT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.297 | Solid cancer M Stage (metastatic) | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.298 | Solid Cancer T Stage | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.299 | Solid Cancer N Stage | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.30 | HER2 Positive | active | 2023-12 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.302 | HER2_IHC_Positive | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.303 | HER2 Negative (geneinterpretation/Labtestvalue) SNOMED | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.304 | HER2 Negative (geneinterpretation/Labtestvalue) LOINC | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.305 | HER2 Negative (geneinterpretation/Labtestvalue) NCI | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.307 | HER2 Negative (geneinterpretation/Labtestvalue) | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.308 | Solid Cancer Diagnosis ICD 9 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.309 | Solid Cancer Diagnosis SNOMED CT | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.31 | HER2 Positive | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.310 | Solid Cancer Diagnosis | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.311 | Localized_Solid_Cancer_Stage Group NCIM | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.313 | Localized_Solid_Cancer_Stage Group | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.314 | Locally_Advanced_Solid_Cancer_Stage Group NCIM | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.315 | Locally_Advanced_Solid_Cancer_Stage Group | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.316 | Metastatic_Solid_Cancer_Stage Group NCIM | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.317 | Metastatic_Solid_Cancer_Stage Group | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.318 | Solid Cancer T Stage LOINC | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.319 | Solid Cancer T Stage NCI | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.32 | HER2 Positive | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.320 | Solid Cancer T Stage codes | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.321 | Prior_Systemic_therapy_Enhertu | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.322 | RET test_Solid_cancer (HGNC) | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.323 | RET Positive_Solid_Cancer (geneinterpretation) | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.324 | RET Negative_Solid_Cancer (geneinterpretation) | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.325 | RET fusion Molecular Variants_Solid_Cancer | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.326 | Prior_systemic_therapy_Retevmo | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.327 | Selpercatinib (Retevmo) Drug | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.328 | Breast Cancer Diagnosis ICD9 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.329 | Breast Cancer Diagnosis ICD10 | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.33 | Metastatic Breast Cancer | active | 2023-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.330 | Breast Cancer Diagnosis | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.331 | Metastatic_Breast_Cancer_Stage Group | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.332 | Locally_Advanced_Breast_Cancer_Stage Group | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.333 | Localized_Breast_Cancer_Stage Group | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.334 | Breast cancer M Stage (metastatic) | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.335 | Breast Cancer T Stage | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.336 | Breast Cancer N Stage | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.337 | Metastatic Sites All Breast SNOMEDCT | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.338 | Metastatic Sites All Breast ICD9 | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.339 | Metastatic Sites All Breast ICD10 | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.340 | Metastatic Sites All Breast (grouped, SNOMEDCT/ICD9/ICD10) | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.341 | Aromatase_Inhibitor therapy | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.342 | Capivasertib_therapy | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.343 | Fulvestrant_therapy | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.344 | PTEN_gene | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.345 | PTEN_geneinterpretation | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.346 | PIK3CA_gene | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.347 | PI3KCA_geneinterpretation | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.348 | AKTI_gene | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.349 | AKTI_geneinterpretation | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.35 | All Metastatic Sites | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.350 | Progesterone_receptor_gene | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.351 | Progesterone_receptor_geneinterpretation | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.352 | Estrogen_receptor_gene | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.353 | Estrogen_receptor_geneinterpretation | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.354 | Progesterone_receptor_labtest | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.355 | Progesterone_receptor_labinterpretation | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.356 | Estrogen_receptor_labtest | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.357 | Estrogen_receptor_labinterpretation | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.358 | NSCLC M0 Stage | active | 2024-07 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.359 | HER2_IHC_test_Gene | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.36 | All Metastatic Sites | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.360 | HER2_IHC_test_Lab | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.361 | HER2_Fish_test | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.362 | HER2_IHC_Negative | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.363 | Trodelvy | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.364 | Chemotherapy_breast_cancer | active | 2024-09 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.365 | Cyclin_dependent_kinase | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.366 | Taxane_Trodelvy | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.367 | Endocrine_therapy | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.368 | HER2_Fish_test_Negative | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.369 | HER2_IHC_Equivocal | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.37 | Locoregional Breast Cancer | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.370 | HER2 Positive_PM_results | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.371 | HER2 test_Lab | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.372 | HER2 test_gene | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.374 | Thyroid Cancer Diagnosis | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.375 | Metastatic_Thyroid_Stage Group | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.376 | RET mutation_Molecular Variants | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.377 | RET Gene mutation | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.378 | Locally_Advanced_Localized_Thyroid_Cancer_Stage Group | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.379 | Thyroid cancer M1_Stage | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.38 | Locoregional Breast Cancer | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.380 | Thyroid_cancer_M0_Stage | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.381 | Thyroid_cancer_T_Stage | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.382 | Thyroid_cancer_T1_T2_T3_Stage | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.383 | Thyroid_cancer_T4_Stage | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.384 | Thyroid_cancer_N1b_Stage&Above | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.385 | Thyroid_cancer_N_Stage | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.386 | Medullary_thyroid_histology | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.387 | RET test_Thyroid_cancer (HGNC) | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.388 | RET Positive | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.389 | NSCLC N3 Stage | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.39 | Locoregional Breast Cancer | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.390 | CRC Cancer Diagnosis ICD9 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.391 | CRC Cancer Diagnosis ICD10 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.392 | CRC Cancer Diagnosis ICD9/ICD10 | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.393 | Metastatic_CRC_Cancer_Stage Group | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.394 | Locally_Advanced_Localized_CRC_Stage Group | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.395 | CRC cancer M Stage (metastatic) | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.396 | CRC Cancer T Stage | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.397 | CRC Cancer N Stage | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.398 | KRAS_gene | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.399 | KRAS_negative | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.40 | Locoregional Breast Cancer | active | 2023-10 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.400 | Fluoropyrimidine_CRC | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.401 | Oxaliplatin | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.402 | Irinotecan_based_therapy | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.403 | anti_VEGF_therapy_CRC | active | 2024-08 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.404 | anti_EGFR_therapy_CRC | active | 2024-08 |
XIG built as of 18 Jun 2025. Found 77274 resources in 1236 packages.
FHIR